LOKIASV2_1322_ESMFold_hypothetical_protein	1mru-assembly1.cif.gz_A	1mru-assembly1.cif.gz_A Intracellular Ser/Thr protein kinase domain of Mycobacterium tuberculosis PknB.	1.297E-13	1.000	470	176	471	621	9	261	269	304	0.477	0.941
LOKIASV2_1322_ESMFold_hypothetical_protein	1o6y-assembly1.cif.gz_A	1o6y-assembly1.cif.gz_A Catalytic domain of PknB kinase from Mycobacterium tuberculosis	3.846E-13	1.000	469	164	470	621	1	259	260	315	0.494	0.996
LOKIASV2_1322_ESMFold_hypothetical_protein	5u94-assembly1.cif.gz_A	5u94-assembly1.cif.gz_A Crystal structure of the Mycobacterium tuberculosis PASTA kinase PknB in complex with the potential theraputic kinase inhibitor GSK690693.	2.066E-13	1.000	457	164	470	621	1	262	263	316	0.494	0.996
LOKIASV2_1322_ESMFold_hypothetical_protein	2fum-assembly2.cif.gz_B	2fum-assembly2.cif.gz_B Catalytic domain of protein kinase PknB from Mycobacterium tuberculosis in complex with mitoxantrone	6.454E-13	1.000	449	164	470	621	1	261	262	318	0.494	0.996
LOKIASV2_1322_ESMFold_hypothetical_protein	5l4q-assembly2.cif.gz_B	5l4q-assembly2.cif.gz_B Crystal Structure of Adaptor Protein 2 Associated Kinase 1 (AAK1) in Complex with LKB1 (AAK1 Dual Inhibitor)	7.728E-14	1.000	444	165	470	621	3	269	287	324	0.493	0.930
LOKIASV2_1322_ESMFold_hypothetical_protein	8gmd-assembly2.cif.gz_B	8gmd-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH (5P)-3-({(8R)-5-[(4-aminopiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-[2-(propan-2-yl)-2H-tetrazol-5-yl]phenol	1.680E-13	1.000	435	165	470	621	7	284	299	324	0.493	0.930
LOKIASV2_1322_ESMFold_hypothetical_protein	8gmc-assembly1.cif.gz_A	8gmc-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine	9.506E-14	1.000	432	164	484	621	1	292	293	342	0.517	0.997
LOKIASV2_1322_ESMFold_hypothetical_protein	2fum-assembly4.cif.gz_D	2fum-assembly4.cif.gz_D Catalytic domain of protein kinase PknB from Mycobacterium tuberculosis in complex with mitoxantrone	1.265E-12	1.000	430	176	469	621	9	257	258	302	0.473	0.965
LOKIASV2_1322_ESMFold_hypothetical_protein	2fum-assembly1.cif.gz_A	2fum-assembly1.cif.gz_A Catalytic domain of protein kinase PknB from Mycobacterium tuberculosis in complex with mitoxantrone	1.726E-12	1.000	430	164	469	621	1	262	263	314	0.493	0.996
LOKIASV2_1322_ESMFold_hypothetical_protein	8gmd-assembly1.cif.gz_A	8gmd-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH (5P)-3-({(8R)-5-[(4-aminopiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-[2-(propan-2-yl)-2H-tetrazol-5-yl]phenol	2.176E-13	1.000	430	164	484	621	1	294	294	339	0.517	1.000
LOKIASV2_1322_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_C	6b2q-assembly2.cif.gz_C Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	2.750E-12	1.000	427	169	470	621	5	256	265	310	0.486	0.951
LOKIASV2_1322_ESMFold_hypothetical_protein	7lvi-assembly1.cif.gz_A	7lvi-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND (2R)-2-AMINO-N-[3-METHOXY-4- (1,3-OXAZOL-5-YL)PHENYL]-4-METHYLPENTANAMIDE	3.468E-13	1.000	425	164	470	621	1	279	294	327	0.494	0.949
LOKIASV2_1322_ESMFold_hypothetical_protein	6b2p-assembly1.cif.gz_A-2	6b2p-assembly1.cif.gz_A-2 Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	2.236E-12	1.000	422	176	470	621	8	254	255	304	0.475	0.969
LOKIASV2_1322_ESMFold_hypothetical_protein	3orm-assembly1.cif.gz_A	3orm-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain D76A mutant	2.896E-12	1.000	422	176	471	621	2	255	266	303	0.477	0.955
LOKIASV2_1322_ESMFold_hypothetical_protein	4o38-assembly1.cif.gz_B	4o38-assembly1.cif.gz_B Crystal structure of the human cyclin G associated kinase (GAK)	2.819E-13	1.000	422	166	478	621	5	262	276	320	0.504	0.935
LOKIASV2_1322_ESMFold_hypothetical_protein	6b2q-assembly1.cif.gz_A	6b2q-assembly1.cif.gz_A Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	3.383E-12	1.000	421	163	470	621	1	253	262	316	0.496	0.966
LOKIASV2_1322_ESMFold_hypothetical_protein	6i2p-assembly1.cif.gz_A	6i2p-assembly1.cif.gz_A Crystal structure of the Mycobacterium tuberculosis PknB kinase domain (L33E mutant) in complex with its substrate GarA	5.526E-13	1.000	418	170	470	621	6	271	272	309	0.485	0.978
LOKIASV2_1322_ESMFold_hypothetical_protein	8gmc-assembly2.cif.gz_B	8gmc-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine	6.128E-13	1.000	415	166	470	621	6	279	294	327	0.491	0.932
LOKIASV2_1322_ESMFold_hypothetical_protein	3oro-assembly1.cif.gz_A	3oro-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 4)	6.454E-13	1.000	414	176	471	621	3	262	272	308	0.477	0.956
LOKIASV2_1322_ESMFold_hypothetical_protein	4o38-assembly1.cif.gz_A	4o38-assembly1.cif.gz_A Crystal structure of the human cyclin G associated kinase (GAK)	1.141E-12	1.000	412	166	478	621	6	256	267	320	0.504	0.940
LOKIASV2_1322_ESMFold_hypothetical_protein	7rj8-assembly1.cif.gz_A	7rj8-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND (2R)-2-AMINO-N-[3-(DIFLUOROM ETHOXY)-4-(1,3-OXAZOL-5-YL)PHENYL]-4-METHYLPENTANAMIDE	2.819E-13	1.000	412	165	484	621	3	297	297	341	0.515	0.993
LOKIASV2_1322_ESMFold_hypothetical_protein	5m08-assembly2.cif.gz_B	5m08-assembly2.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A_R136A double mutant	3.751E-12	1.000	411	163	470	621	3	252	253	309	0.496	0.988
LOKIASV2_1322_ESMFold_hypothetical_protein	4c59-assembly1.cif.gz_A	4c59-assembly1.cif.gz_A Structure of GAK kinase in complex with nanobody (NbGAK_4)	7.158E-13	1.000	411	165	478	621	3	256	266	324	0.506	0.955
LOKIASV2_1322_ESMFold_hypothetical_protein	5y80-assembly1.cif.gz_A	5y80-assembly1.cif.gz_A Complex structure of cyclin G-associated kinase with gefitinib	2.414E-13	1.000	411	166	485	621	7	303	306	340	0.515	0.971
LOKIASV2_1322_ESMFold_hypothetical_protein	5ikw-assembly1.cif.gz_A	5ikw-assembly1.cif.gz_A Crystal Structure of BMP-2-inducible kinase in complex with an Indazole inhibitor	3.127E-13	1.000	408	167	468	621	1	277	297	323	0.486	0.933
LOKIASV2_1322_ESMFold_hypothetical_protein	5m06-assembly1.cif.gz_B	5m06-assembly1.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain	2.354E-12	1.000	405	163	468	621	2	246	248	308	0.493	0.988
LOKIASV2_1322_ESMFold_hypothetical_protein	4y8d-assembly2.cif.gz_B	4y8d-assembly2.cif.gz_B Crystal structure of Cyclin-G associated kinase (GAK) complexed with selective 12i inhibitor	3.212E-12	1.000	404	165	478	621	3	252	262	320	0.506	0.954
LOKIASV2_1322_ESMFold_hypothetical_protein	2fum-assembly3.cif.gz_C	2fum-assembly3.cif.gz_C Catalytic domain of protein kinase PknB from Mycobacterium tuberculosis in complex with mitoxantrone	1.369E-11	1.000	402	176	470	621	9	253	254	304	0.475	0.965
LOKIASV2_1322_ESMFold_hypothetical_protein	5l4q-assembly1.cif.gz_A	5l4q-assembly1.cif.gz_A Crystal Structure of Adaptor Protein 2 Associated Kinase 1 (AAK1) in Complex with LKB1 (AAK1 Dual Inhibitor)	1.265E-12	1.000	400	165	470	621	3	273	293	323	0.493	0.925
LOKIASV2_1322_ESMFold_hypothetical_protein	5te0-assembly1.cif.gz_A	5te0-assembly1.cif.gz_A Crystal Structure of Adaptor Protein 2 Associated Kinase (AAK1) in complex with BIBF 1120	9.765E-13	1.000	399	161	469	621	3	286	316	326	0.498	0.899
LOKIASV2_1322_ESMFold_hypothetical_protein	5m07-assembly1.cif.gz_A	5m07-assembly1.cif.gz_A Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A mutant	4.161E-12	1.000	396	163	468	621	3	245	248	307	0.493	0.980
LOKIASV2_1322_ESMFold_hypothetical_protein	4c57-assembly2.cif.gz_B	4c57-assembly2.cif.gz_B Structure of GAK kinase in complex with a nanobody	1.403E-12	1.000	395	166	478	621	4	297	308	337	0.504	0.955
LOKIASV2_1322_ESMFold_hypothetical_protein	3ori-assembly4.cif.gz_D	3ori-assembly4.cif.gz_D Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 1)	3.383E-12	1.000	393	176	471	621	2	255	267	308	0.477	0.951
LOKIASV2_1322_ESMFold_hypothetical_protein	6b2q-assembly2.cif.gz_B	6b2q-assembly2.cif.gz_B Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	5.676E-12	1.000	392	176	476	621	11	260	267	309	0.485	0.936
LOKIASV2_1322_ESMFold_hypothetical_protein	5m08-assembly1.cif.gz_A	5m08-assembly1.cif.gz_A Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A_R136A double mutant	1.113E-11	1.000	390	163	470	621	3	246	247	309	0.496	0.988
LOKIASV2_1322_ESMFold_hypothetical_protein	7rj7-assembly1.cif.gz_A	7rj7-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND 2-(1-AMINO-3-METHYLBUTYL)-6- (PYRIDIN-4-YL)QUINOLINE-4-CARBONITRILE	5.526E-13	1.000	386	165	469	621	10	289	304	329	0.491	0.921
LOKIASV2_1322_ESMFold_hypothetical_protein	5m09-assembly2.cif.gz_B	5m09-assembly2.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A_R136N double mutant	1.369E-11	1.000	385	163	468	621	2	242	245	307	0.493	0.984
LOKIASV2_1322_ESMFold_hypothetical_protein	6bl8-assembly1.cif.gz_A	6bl8-assembly1.cif.gz_A Predicting the Conformational Variability of Abl Tyrosine Kinase Using Molecular Dynamics Simulations and Markov State Models	2.750E-12	1.000	385	169	477	621	5	270	270	325	0.498	0.985
LOKIASV2_1322_ESMFold_hypothetical_protein	6l14-assembly1.cif.gz_A	6l14-assembly1.cif.gz_A Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivatives	8.588E-12	1.000	383	176	462	621	6	250	271	293	0.462	0.904
LOKIASV2_1322_ESMFold_hypothetical_protein	5m07-assembly2.cif.gz_B	5m07-assembly2.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain, C20A mutant	1.867E-11	1.000	382	163	468	621	3	244	247	308	0.493	0.980
LOKIASV2_1322_ESMFold_hypothetical_protein	6i2p-assembly2.cif.gz_B	6i2p-assembly2.cif.gz_B Crystal structure of the Mycobacterium tuberculosis PknB kinase domain (L33E mutant) in complex with its substrate GarA	5.390E-12	1.000	382	176	469	621	10	265	266	302	0.473	0.962
LOKIASV2_1322_ESMFold_hypothetical_protein	5toe-assembly1.cif.gz_A	5toe-assembly1.cif.gz_A Pim-1 kinase in complex with a 7-azaindole	8.155E-12	1.000	382	176	481	621	5	272	272	316	0.493	0.985
LOKIASV2_1322_ESMFold_hypothetical_protein	3f69-assembly1.cif.gz_A	3f69-assembly1.cif.gz_A Crystal structure of the Mycobacterium tuberculosis PknB mutant kinase domain in complex with KT5720	1.598E-11	1.000	381	164	471	621	1	261	270	320	0.496	0.967
LOKIASV2_1322_ESMFold_hypothetical_protein	2buj-assembly2.cif.gz_B	2buj-assembly2.cif.gz_B Crystal structure of the human Serine-threonine Kinase 16 in complex with staurosporine	5.978E-12	1.000	380	163	469	621	4	282	286	324	0.494	0.976
LOKIASV2_1322_ESMFold_hypothetical_protein	4c58-assembly1.cif.gz_A-2	4c58-assembly1.cif.gz_A-2 Structure of GAK kinase in complex with nanobody (NbGAK_4)	2.419E-11	1.000	379	165	478	621	3	257	267	319	0.506	0.955
LOKIASV2_1322_ESMFold_hypothetical_protein	3ork-assembly1.cif.gz_A	3ork-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 2)	5.978E-12	1.000	375	163	471	621	1	262	274	322	0.498	0.956
LOKIASV2_1322_ESMFold_hypothetical_protein	4lm5-assembly1.cif.gz_A	4lm5-assembly1.cif.gz_A Crystal structure of Pim1 in complex with 2-{4-[(3-aminopropyl)amino]quinazolin-2-yl}phenol (resulting from displacement of SKF86002)	1.773E-11	1.000	372	176	479	621	4	264	265	311	0.490	0.985
LOKIASV2_1322_ESMFold_hypothetical_protein	3ort-assembly1.cif.gz_A	3ort-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 6)	3.050E-12	1.000	372	171	471	621	7	260	271	314	0.485	0.937
LOKIASV2_1322_ESMFold_hypothetical_protein	4x3f-assembly2.cif.gz_B	4x3f-assembly2.cif.gz_B Crystal structure of the intracellular domain of the M. tuberculosis Ser/Thr kinase PknA	1.234E-11	1.000	372	162	476	621	1	268	280	325	0.507	0.957
LOKIASV2_1322_ESMFold_hypothetical_protein	5m06-assembly1.cif.gz_A	5m06-assembly1.cif.gz_A Crystal structure of Mycobacterium tuberculosis PknI kinase domain	4.059E-11	1.000	371	163	468	621	3	243	245	308	0.493	0.984
LOKIASV2_1322_ESMFold_hypothetical_protein	7oai-assembly1.cif.gz_A	7oai-assembly1.cif.gz_A Crystal structure of pseudokinase CASK in complex with PFE-PKIS12	7.744E-12	1.000	371	169	479	621	2	278	299	322	0.501	0.926
LOKIASV2_1322_ESMFold_hypothetical_protein	3f61-assembly1.cif.gz_A	3f61-assembly1.cif.gz_A Crystal Structure of M. tuberculosis PknB Leu33Asp/Val222Asp double mutant in complex with ADP	4.860E-12	1.000	369	166	471	621	2	259	271	320	0.493	0.952
LOKIASV2_1322_ESMFold_hypothetical_protein	4alu-assembly1.cif.gz_A	4alu-assembly1.cif.gz_A Benzofuropyrimidinone Inhibitors of Pim-1	1.966E-11	1.000	369	170	481	621	1	274	274	322	0.502	1.000
LOKIASV2_1322_ESMFold_hypothetical_protein	7t4j-assembly1.cif.gz_B	7t4j-assembly1.cif.gz_B Crystal Structure of EGFR_D770_N771insNPG/V948R in complex with TAK-788	1.598E-11	1.000	369	176	482	621	12	278	278	322	0.494	0.960
LOKIASV2_1322_ESMFold_hypothetical_protein	2buj-assembly1.cif.gz_A	2buj-assembly1.cif.gz_A Crystal structure of the human Serine-threonine Kinase 16 in complex with staurosporine	3.133E-11	1.000	369	163	469	621	3	285	291	326	0.494	0.973
LOKIASV2_1322_ESMFold_hypothetical_protein	2bil-assembly1.cif.gz_B	2bil-assembly1.cif.gz_B The human protein kinase Pim1 in complex with its consensus peptide Pimtide	9.525E-12	1.000	368	176	481	621	6	274	274	323	0.493	0.982
LOKIASV2_1322_ESMFold_hypothetical_protein	4wsq-assembly2.cif.gz_B	4wsq-assembly2.cif.gz_B Crystal Structure of Adaptor Protein 2 Associated Kinase (AAK1) in complex with small molecule inhibitor	3.951E-12	1.000	368	165	469	621	3	283	310	327	0.491	0.906
LOKIASV2_1322_ESMFold_hypothetical_protein	5xka-assembly1.cif.gz_B	5xka-assembly1.cif.gz_B Crystal structure of M.tuberculosis PknI kinase domain	6.141E-11	1.000	367	163	477	621	2	251	251	317	0.507	0.996
LOKIASV2_1322_ESMFold_hypothetical_protein	5n5l-assembly1.cif.gz_A	5n5l-assembly1.cif.gz_A Crystal structure of human Pim-1 kinase in complex with a consensuspeptide and [2-oxo-2-(1H-pyrrol-2-yl)ethyl] 5-bromo-1H-indole-3-carboxylate	1.598E-11	1.000	363	176	462	621	6	251	272	299	0.462	0.904
LOKIASV2_1322_ESMFold_hypothetical_protein	4x3f-assembly3.cif.gz_C	4x3f-assembly3.cif.gz_C Crystal structure of the intracellular domain of the M. tuberculosis Ser/Thr kinase PknA	2.181E-11	1.000	363	176	476	621	12	262	274	310	0.485	0.916
LOKIASV2_1322_ESMFold_hypothetical_protein	5hvj-assembly1.cif.gz_A	5hvj-assembly1.cif.gz_A Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	8.588E-12	1.000	363	176	477	621	11	265	283	318	0.486	0.901
LOKIASV2_1322_ESMFold_hypothetical_protein	6b2q-assembly1.cif.gz_D	6b2q-assembly1.cif.gz_D Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	8.823E-11	1.000	362	176	476	621	11	254	260	310	0.485	0.938
LOKIASV2_1322_ESMFold_hypothetical_protein	3vbt-assembly1.cif.gz_A	3vbt-assembly1.cif.gz_A Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in Pim-1 kinase needle screening and inhibitor design	2.825E-11	1.000	362	176	479	621	4	266	267	313	0.490	0.985
LOKIASV2_1322_ESMFold_hypothetical_protein	5nk3-assembly1.cif.gz_A	5nk3-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 1l	3.562E-12	1.000	362	163	475	621	2	273	281	329	0.504	0.968
LOKIASV2_1322_ESMFold_hypothetical_protein	1yxs-assembly1.cif.gz_A	1yxs-assembly1.cif.gz_A Crystal Structure of Kinase Pim1 with P123M mutation	3.133E-11	1.000	361	176	470	621	6	272	274	315	0.475	0.974
LOKIASV2_1322_ESMFold_hypothetical_protein	4enx-assembly1.cif.gz_A	4enx-assembly1.cif.gz_A Crystal Structure of Pim-1 Kinase in complex with inhibitor (2E,5Z)-2-(2-chlorophenylimino)-5-(4-hydroxy-3-nitrobenzylidene)thiazolidin-4-one	4.274E-11	1.000	360	176	479	621	2	265	266	313	0.490	0.992
LOKIASV2_1322_ESMFold_hypothetical_protein	4ow8-assembly1.cif.gz_A-2	4ow8-assembly1.cif.gz_A-2 Crystal structure of kinase domain of PknA from Mtb	4.059E-11	1.000	360	163	476	621	1	270	276	322	0.506	0.978
LOKIASV2_1322_ESMFold_hypothetical_protein	4xli-assembly1.cif.gz_A	4xli-assembly1.cif.gz_A Crystal structure of Abl2/Arg kinase in complex with dasatinib	6.141E-11	1.000	359	169	470	621	5	261	264	315	0.486	0.973
LOKIASV2_1322_ESMFold_hypothetical_protein	3umw-assembly1.cif.gz_A	3umw-assembly1.cif.gz_A Crystal structure of Pim1 kinase in complex with inhibitor (Z)-2-[(1H-indazol-3-yl)methylene]-6-methoxy-7-(piperazin-1-ylmethyl)benzofuran-3(2H)-one	2.547E-11	1.000	357	176	479	621	2	264	264	315	0.490	0.996
LOKIASV2_1322_ESMFold_hypothetical_protein	3cxw-assembly1.cif.gz_A	3cxw-assembly1.cif.gz_A Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and a beta carboline ligand I	2.547E-11	1.000	357	176	479	621	6	270	272	318	0.490	0.974
LOKIASV2_1322_ESMFold_hypothetical_protein	2iw8-assembly2.cif.gz_C	2iw8-assembly2.cif.gz_C STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR	3.299E-11	1.000	356	176	469	621	5	256	266	305	0.473	0.947
LOKIASV2_1322_ESMFold_hypothetical_protein	2c3i-assembly1.cif.gz_B	2c3i-assembly1.cif.gz_B CRYSTAL STRUCTURE OF HUMAN PIM1 IN COMPLEX WITH IMIDAZOPYRIDAZIN I	3.299E-11	1.000	355	176	462	621	2	245	266	299	0.462	0.917
LOKIASV2_1322_ESMFold_hypothetical_protein	4eqm-assembly3.cif.gz_C	4eqm-assembly3.cif.gz_C Structural analysis of Staphylococcus aureus serine/threonine kinase PknB	1.369E-11	1.000	353	168	469	621	4	257	269	312	0.486	0.944
LOKIASV2_1322_ESMFold_hypothetical_protein	5h9b-assembly1.cif.gz_A	5h9b-assembly1.cif.gz_A Drosophila CaMKII-wt in complex with a fragment of the Eag potassium channel and Mg2+/AMPPN	4.274E-11	1.000	353	176	470	621	8	265	269	312	0.475	0.959
LOKIASV2_1322_ESMFold_hypothetical_protein	2g2f-assembly1.cif.gz_A	2g2f-assembly1.cif.gz_A A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domain	1.867E-11	1.000	352	169	479	621	6	275	275	327	0.501	0.982
LOKIASV2_1322_ESMFold_hypothetical_protein	5n4x-assembly1.cif.gz_A	5n4x-assembly1.cif.gz_A Crystal structure of human Pim-1 kinase in complex with a consensuspeptide and fragment like molekule 4,5-dibromothiophene-2-carbohydrazide	3.854E-11	1.000	351	176	462	621	6	251	272	301	0.462	0.904
LOKIASV2_1322_ESMFold_hypothetical_protein	5ng0-assembly1.cif.gz_B	5ng0-assembly1.cif.gz_B Structure of RIP2K(L294F) with bound AMPPCP	3.659E-11	1.000	351	180	470	621	18	277	282	307	0.469	0.922
LOKIASV2_1322_ESMFold_hypothetical_protein	6t8x-assembly1.cif.gz_A	6t8x-assembly1.cif.gz_A Crystal structure of MAPKAPK2 (MK2) complexed with PF-3644022 and 5-(4-bromophenyl)-N-[4-(1-piperazinyl)phenyl]-N-(2-pyridinylmethyl)-2-furancarboxamide	3.475E-11	1.000	347	162	475	621	8	278	279	328	0.506	0.971
LOKIASV2_1322_ESMFold_hypothetical_protein	3orl-assembly1.cif.gz_A	3orl-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 3)	1.172E-11	1.000	345	176	471	621	9	257	268	310	0.477	0.929
LOKIASV2_1322_ESMFold_hypothetical_protein	2iw9-assembly1.cif.gz_C	2iw9-assembly1.cif.gz_C STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR	1.030E-10	1.000	345	176	467	621	5	255	269	303	0.470	0.933
LOKIASV2_1322_ESMFold_hypothetical_protein	4eor-assembly2.cif.gz_C	4eor-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 WT - human cyclin A3 complex with the inhibitor NU6102	3.299E-11	1.000	345	176	465	621	5	259	271	307	0.467	0.941
LOKIASV2_1322_ESMFold_hypothetical_protein	3mfu-assembly1.cif.gz_A	3mfu-assembly1.cif.gz_A CASK-4M CaM Kinase Domain, AMPPNP-Mn2+	3.659E-11	1.000	345	169	478	621	2	277	302	321	0.499	0.914
LOKIASV2_1322_ESMFold_hypothetical_protein	7xzr-assembly1.cif.gz_A	7xzr-assembly1.cif.gz_A Crystal structure of TNIK-AMPPNP-thiopeptide TP15 complex	2.547E-11	1.000	344	176	476	621	14	298	299	330	0.485	0.953
LOKIASV2_1322_ESMFold_hypothetical_protein	4cfm-assembly2.cif.gz_C	4cfm-assembly2.cif.gz_C Structure-based design of C8-substituted O6-cyclohexylmethoxyguanine CDK1 and 2 inhibitors.	7.554E-11	1.000	343	176	470	621	5	256	267	307	0.475	0.944
LOKIASV2_1322_ESMFold_hypothetical_protein	4eqm-assembly6.cif.gz_F	4eqm-assembly6.cif.gz_F Structural analysis of Staphylococcus aureus serine/threonine kinase PknB	1.559E-10	1.000	343	163	469	621	1	255	268	316	0.494	0.951
LOKIASV2_1322_ESMFold_hypothetical_protein	5tur-assembly1.cif.gz_A	5tur-assembly1.cif.gz_A Pim-1 kinase in complex with a 7-azaindole	8.823E-11	1.000	343	176	470	621	5	268	270	315	0.475	0.978
LOKIASV2_1322_ESMFold_hypothetical_protein	3kk9-assembly1.cif.gz_A	3kk9-assembly1.cif.gz_A CaMKII Substrate Complex B	1.030E-10	1.000	342	169	485	621	1	273	276	329	0.510	0.989
LOKIASV2_1322_ESMFold_hypothetical_protein	4o0s-assembly1.cif.gz_A	4o0s-assembly1.cif.gz_A Crystal structures of human kinase Aurora A	8.378E-11	1.000	341	167	468	621	1	259	265	314	0.486	0.977
LOKIASV2_1322_ESMFold_hypothetical_protein	3dj7-assembly1.cif.gz_A	3dj7-assembly1.cif.gz_A Crystal structure of the mouse Aurora-A catalytic domain (Asn186->Gly, Lys240->Arg, Met302->Leu) in complex with Compound 130.	1.642E-10	1.000	340	167	468	621	1	254	257	314	0.486	0.988
LOKIASV2_1322_ESMFold_hypothetical_protein	3orp-assembly1.cif.gz_A	3orp-assembly1.cif.gz_A Mycobacterium tuberculosis PknB kinase domain L33D mutant (crystal form 5)	2.682E-11	1.000	340	170	471	621	6	262	274	313	0.486	0.938
LOKIASV2_1322_ESMFold_hypothetical_protein	3bgz-assembly1.cif.gz_A	3bgz-assembly1.cif.gz_A Human Pim-1 kinase in complex with diphenyl indole inhibitor VX3	8.378E-11	1.000	339	176	479	621	6	267	268	315	0.490	0.978
LOKIASV2_1322_ESMFold_hypothetical_protein	7vsy-assembly1.cif.gz_A	7vsy-assembly1.cif.gz_A Pim1 with N82K mutation	1.143E-10	1.000	339	176	479	621	6	272	273	316	0.490	0.978
LOKIASV2_1322_ESMFold_hypothetical_protein	4x3f-assembly1.cif.gz_A	4x3f-assembly1.cif.gz_A Crystal structure of the intracellular domain of the M. tuberculosis Ser/Thr kinase PknA	7.955E-11	1.000	339	169	476	621	5	265	277	318	0.496	0.942
LOKIASV2_1322_ESMFold_hypothetical_protein	5x1s-assembly1.cif.gz_A	5x1s-assembly1.cif.gz_A PpkA-294 with Amppcp	2.240E-10	1.000	338	163	466	621	4	280	281	326	0.490	0.986
LOKIASV2_1322_ESMFold_hypothetical_protein	2owb-assembly1.cif.gz_A	2owb-assembly1.cif.gz_A Structure of the Catalytic Domain of Human Polo-like Kinase 1	9.785E-11	1.000	338	163	486	621	1	281	294	336	0.522	0.956
LOKIASV2_1322_ESMFold_hypothetical_protein	3q4t-assembly1.cif.gz_A	3q4t-assembly1.cif.gz_A Crystal structure of Activin receptor type-IIA (ACVR2A) kinase domain in complex with dorsomorphin	2.547E-11	1.000	337	164	469	621	1	303	305	353	0.493	0.993
LOKIASV2_1322_ESMFold_hypothetical_protein	5e8v-assembly1.cif.gz_A	5e8v-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431A,R433A,E485A,K488A,R493A,R495A)	2.547E-11	1.000	336	176	469	621	5	296	296	334	0.473	0.986
LOKIASV2_1322_ESMFold_hypothetical_protein	2euf-assembly1.cif.gz_B	2euf-assembly1.cif.gz_B X-ray structure of human CDK6-Vcyclin in complex with the inhibitor PD0332991	5.831E-11	1.000	335	176	467	621	4	273	282	312	0.470	0.957
LOKIASV2_1322_ESMFold_hypothetical_protein	4b4l-assembly1.cif.gz_A	4b4l-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AN ARD DAP-KINASE 1 MUTANT	1.729E-10	1.000	335	164	470	621	1	270	299	316	0.494	0.903
LOKIASV2_1322_ESMFold_hypothetical_protein	5qtz-assembly1.cif.gz_A	5qtz-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D) IN COMPLEX WITH 6-[1-(2,2-DIFLUOROETHYL)-4-(6-METHYLPYRIDIN-2-YL)-1H-IMIDAZOL-5-YL]IMIDAZO[1,2-A]PYRIDINE	1.867E-11	1.000	335	168	472	621	3	302	303	342	0.491	0.990
LOKIASV2_1322_ESMFold_hypothetical_protein	8d6d-assembly2.cif.gz_B	8d6d-assembly2.cif.gz_B Crystal Structure of Human Myt1 Kinase domain Bounded with compound 39	1.918E-10	1.000	334	161	466	621	14	266	274	314	0.493	0.923
LOKIASV2_1322_ESMFold_hypothetical_protein	7vds-assembly1.cif.gz_A	7vds-assembly1.cif.gz_A The structure of cyclin-dependent kinase 5 (CDK5) in complex with p25 and Compound 24	3.854E-11	1.000	334	176	470	621	3	284	290	331	0.475	0.972
LOKIASV2_1322_ESMFold_hypothetical_protein	5e91-assembly1.cif.gz_A	5e91-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431A,R433A,E485A,K488A,R493A,R495A) IN COMPLEX WITH 3-AMINO-6-[4-(2- HYDROXYETHYL)PHENYL]-N-[4-(MORPHOLIN-4-YL)PYRIDIN-3-YL] PYRAZINE-2-CARBOXAMIDE	3.133E-11	1.000	334	176	469	621	5	295	297	334	0.473	0.980
LOKIASV2_1322_ESMFold_hypothetical_protein	5e8y-assembly1.cif.gz_A	5e8y-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN (E431A,R433A,E485A,K488A,R493A,R495A) IN COMPLEX WITH STAUROSPORINE	3.854E-11	1.000	333	176	469	621	5	298	298	336	0.473	0.987
LOKIASV2_1322_ESMFold_hypothetical_protein	5e90-assembly1.cif.gz_A	5e90-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 1 KINASE DOMAIN (T204D,I211V,Y249F, S280T,Y282F,S287N,A350C,L352F) IN COMPLEX WITH 3-AMINO-6- [4-(2-HYDROXYETHYL)PHENYL]-N-[4-(MORPHOLIN-4-YL)PYRIDIN-3-YL]PYRAZINE-2-CARBOXAMIDE	1.172E-11	1.000	333	176	472	621	9	302	303	342	0.478	0.970
LOKIASV2_1322_ESMFold_hypothetical_protein	3fpm-assembly1.cif.gz_A	3fpm-assembly1.cif.gz_A Crystal Structure of a Squarate Inhibitor bound to MAPKAP Kinase-2	1.598E-11	1.000	332	163	484	621	6	272	283	329	0.519	0.943
LOKIASV2_1322_ESMFold_hypothetical_protein	3ckx-assembly1.cif.gz_A	3ckx-assembly1.cif.gz_A Crystal structure of sterile 20-like kinase 3 (MST3, STK24) in complex with staurosporine	2.419E-11	1.000	331	176	476	621	5	276	277	330	0.485	0.982
LOKIASV2_1322_ESMFold_hypothetical_protein	6qmo-assembly1.cif.gz_A	6qmo-assembly1.cif.gz_A Death-associated Protein Kinase 1 (DAPK1) catalytic and auto-regulatory domains with S289E and S308A mutations	4.169E-10	1.000	331	163	470	621	1	271	299	318	0.496	0.906
LOKIASV2_1322_ESMFold_hypothetical_protein	3dog-assembly1.cif.gz_C	3dog-assembly1.cif.gz_C Structure of Thr 160 phosphorylated CDK2/cyclin A in complex with the inhibitor N-&-N1	8.378E-11	1.000	330	176	467	621	5	253	268	303	0.470	0.929
LOKIASV2_1322_ESMFold_hypothetical_protein	8d6c-assembly2.cif.gz_B	8d6c-assembly2.cif.gz_B Crystal Structure of Human Myt1 Kinase domain Bounded with compound 28	1.642E-10	1.000	330	161	462	621	17	272	279	312	0.486	0.918
LOKIASV2_1322_ESMFold_hypothetical_protein	5qin-assembly1.cif.gz_A	5qin-assembly1.cif.gz_A TGF-BETA RECEPTOR TYPE 2 KINASE DOMAIN IN COMPLEX WITH N- {4-[3-(6-METHOXYPYRIDIN-3-YL)-1H-PYRROLO[3,2-B]PYRIDIN-2- YL]PYRIDIN-2-YL}ACETAMIDE	3.299E-11	1.000	330	176	469	621	5	295	295	334	0.473	0.986
LOKIASV2_1322_ESMFold_hypothetical_protein	4bco-assembly2.cif.gz_C	4bco-assembly2.cif.gz_C Structure of CDK2 in complex with cyclin A and a 2-amino-4-heteroaryl- pyrimidine inhibitor	1.143E-10	1.000	328	176	469	621	5	260	270	308	0.473	0.948
LOKIASV2_1322_ESMFold_hypothetical_protein	8d6c-assembly1.cif.gz_A	8d6c-assembly1.cif.gz_A Crystal Structure of Human Myt1 Kinase domain Bounded with compound 28	1.642E-10	1.000	328	161	462	621	13	267	276	311	0.486	0.924
LOKIASV2_1322_ESMFold_hypothetical_protein	3kk8-assembly1.cif.gz_A	3kk8-assembly1.cif.gz_A CaMKII Substrate Complex A	8.378E-11	1.000	328	171	484	621	4	276	284	327	0.506	0.961
LOKIASV2_1322_ESMFold_hypothetical_protein	5o21-assembly2.cif.gz_B	5o21-assembly2.cif.gz_B Crystal structure of WNK3 kinase domain in a monophosphorylated state with chloride bound in the active site	3.056E-10	1.000	327	166	462	621	2	265	274	310	0.478	0.964
LOKIASV2_1322_ESMFold_hypothetical_protein	2vz6-assembly2.cif.gz_B	2vz6-assembly2.cif.gz_B Structure of human calcium calmodulin dependent protein kinase type II alpha (CAMK2A) in complex with Indirubin E804	8.823E-11	1.000	326	176	476	621	7	270	294	316	0.485	0.898
LOKIASV2_1322_ESMFold_hypothetical_protein	1z9x-assembly1.cif.gz_A	1z9x-assembly1.cif.gz_A Human DRP-1 kinase, W305S S308A D40 mutant, crystal form with 3 monomers in the asymmetric unit	1.821E-10	1.000	326	164	470	621	1	273	303	318	0.494	0.901
LOKIASV2_1322_ESMFold_hypothetical_protein	4ysm-assembly2.cif.gz_B	4ysm-assembly2.cif.gz_B Calcium-Dependent Protein Kinase from Eimeria tenella	2.825E-11	1.000	326	165	482	621	12	288	475	330	0.512	0.583
LOKIASV2_1322_ESMFold_hypothetical_protein	6t8x-assembly1.cif.gz_F	6t8x-assembly1.cif.gz_F Crystal structure of MAPKAPK2 (MK2) complexed with PF-3644022 and 5-(4-bromophenyl)-N-[4-(1-piperazinyl)phenyl]-N-(2-pyridinylmethyl)-2-furancarboxamide	1.559E-10	1.000	325	162	468	621	7	274	276	324	0.494	0.971
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7u-assembly1.cif.gz_B-2	5s7u-assembly1.cif.gz_B-2 XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010938a	6.467E-11	1.000	325	176	468	621	4	277	279	332	0.472	0.982
LOKIASV2_1322_ESMFold_hypothetical_protein	4a4o-assembly1.cif.gz_A-2	4a4o-assembly1.cif.gz_A-2 CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1 IN COMPLEX WITH A 2-(2-AMINO- PYRIMIDIN-4-YL)-1,5,6,7-TETRAHYDRO-PYRROLOPYRIDIN-4-ONE INHIBITOR	2.755E-10	1.000	325	164	470	621	1	266	290	317	0.494	0.917
LOKIASV2_1322_ESMFold_hypothetical_protein	7dv6-assembly1.cif.gz_A	7dv6-assembly1.cif.gz_A Discovery of Functionally Selective Transforming Growth Factor beta Type II Receptor (TGF-beta RII) Inhibitors as Anti-Fibrosis Agents	4.059E-11	1.000	325	176	467	621	5	303	304	338	0.470	0.984
LOKIASV2_1322_ESMFold_hypothetical_protein	4k18-assembly1.cif.gz_A	4k18-assembly1.cif.gz_A Structure of PIM-1 kinase bound to 5-(4-cyanobenzyl)-N-(4-fluorophenyl)-7-hydroxypyrazolo[1,5-a]pyrimidine-3-carboxamide	1.030E-10	1.000	324	176	484	621	7	277	277	325	0.498	0.978
LOKIASV2_1322_ESMFold_hypothetical_protein	8d6e-assembly1.cif.gz_B	8d6e-assembly1.cif.gz_B Crystal Structure of Human Myt1 Kinase domain Bounded with RP-6306	4.624E-10	1.000	324	161	467	621	15	280	281	318	0.494	0.947
LOKIASV2_1322_ESMFold_hypothetical_protein	2iw8-assembly1.cif.gz_A	2iw8-assembly1.cif.gz_A STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR	1.268E-10	1.000	324	176	469	621	5	287	298	328	0.473	0.950
LOKIASV2_1322_ESMFold_hypothetical_protein	2a27-assembly4.cif.gz_H	2a27-assembly4.cif.gz_H Human DRP-1 kinase, W305S S308A D40 mutant, crystal form with 8 monomers in the asymmetric unit	4.169E-10	1.000	324	164	470	621	1	273	304	319	0.494	0.898
LOKIASV2_1322_ESMFold_hypothetical_protein	4u45-assembly2.cif.gz_A	4u45-assembly2.cif.gz_A MAP4K4 in complex with inhibitor (compound 25)	1.085E-10	1.000	323	176	477	621	14	288	289	333	0.486	0.952
LOKIASV2_1322_ESMFold_hypothetical_protein	2yaa-assembly1.cif.gz_B	2yaa-assembly1.cif.gz_B Crystal structure of the autoinhibited form of mouse DAPK2 in complex with ATP	3.759E-10	1.000	323	169	484	621	5	279	299	327	0.509	0.920
LOKIASV2_1322_ESMFold_hypothetical_protein	4asx-assembly1.cif.gz_A	4asx-assembly1.cif.gz_A Crystal structure of Activin receptor type-IIA (ACVR2A) kinase domain in complex with dihydro-Bauerine C	9.785E-11	1.000	323	163	470	621	4	307	310	347	0.496	0.981
LOKIASV2_1322_ESMFold_hypothetical_protein	6kmh-assembly2.cif.gz_B	6kmh-assembly2.cif.gz_B The crystal structure of CASK/Mint1 complex	1.406E-10	1.000	323	169	478	621	2	277	315	322	0.499	0.876
LOKIASV2_1322_ESMFold_hypothetical_protein	4dit-assembly1.cif.gz_A	4dit-assembly1.cif.gz_A Crystal Structure of GSK3beta in complex with a Imidazopyridine inhibitor	2.297E-11	1.000	323	174	486	621	20	301	329	338	0.504	0.857
LOKIASV2_1322_ESMFold_hypothetical_protein	8d6e-assembly2.cif.gz_A	8d6e-assembly2.cif.gz_A Crystal Structure of Human Myt1 Kinase domain Bounded with RP-6306	3.570E-10	1.000	322	160	466	621	14	270	278	316	0.494	0.924
LOKIASV2_1322_ESMFold_hypothetical_protein	6z36-assembly1.cif.gz_A	6z36-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2118	6.141E-11	1.000	322	176	467	621	7	283	286	332	0.470	0.969
LOKIASV2_1322_ESMFold_hypothetical_protein	4eok-assembly1.cif.gz_A	4eok-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor NU6102	7.955E-11	1.000	322	176	467	621	5	279	294	326	0.470	0.935
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7g-assembly2.cif.gz_B	5s7g-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035844b	2.975E-11	1.000	321	176	468	621	2	279	281	334	0.472	0.989
LOKIASV2_1322_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_C	2y7j-assembly1.cif.gz_C Structure of human phosphorylase kinase, gamma 2	3.056E-10	1.000	321	176	470	621	15	281	284	311	0.475	0.940
LOKIASV2_1322_ESMFold_hypothetical_protein	2iw6-assembly1.cif.gz_A	2iw6-assembly1.cif.gz_A STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR	1.918E-10	1.000	321	176	466	621	5	279	293	329	0.469	0.939
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7k-assembly1.cif.gz_B-2	5s7k-assembly1.cif.gz_B-2 XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010936a	1.598E-11	1.000	321	176	468	621	4	291	293	330	0.472	0.983
LOKIASV2_1322_ESMFold_hypothetical_protein	5li1-assembly1.cif.gz_A	5li1-assembly1.cif.gz_A Structure of a Par3-inhibitory peptide bound to PKCiota core kinase domain	2.020E-10	1.000	321	168	486	621	3	288	334	336	0.514	0.856
LOKIASV2_1322_ESMFold_hypothetical_protein	3a8x-assembly3.cif.gz_A	3a8x-assembly3.cif.gz_A Crystal Structure of PKCiota kinase domain	7.173E-11	1.000	321	167	486	621	2	291	336	340	0.515	0.863
LOKIASV2_1322_ESMFold_hypothetical_protein	2wtw-assembly1.cif.gz_A	2wtw-assembly1.cif.gz_A Aurora-A Inhibitor Structure (2nd crystal form)	5.990E-10	1.000	320	169	470	621	1	249	256	313	0.486	0.973
LOKIASV2_1322_ESMFold_hypothetical_protein	7f3g-assembly1.cif.gz_B	7f3g-assembly1.cif.gz_B Crystal structure of DCLK1 kinase domain in complex with ruxolitinib	4.391E-10	1.000	320	176	470	621	8	264	266	308	0.475	0.966
LOKIASV2_1322_ESMFold_hypothetical_protein	4eom-assembly2.cif.gz_C	4eom-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, Q131E - human cyclin A3 complex with ATP	5.128E-10	1.000	320	169	466	621	2	261	276	316	0.480	0.942
LOKIASV2_1322_ESMFold_hypothetical_protein	2y7j-assembly1.cif.gz_B	2y7j-assembly1.cif.gz_B Structure of human phosphorylase kinase, gamma 2	3.389E-10	1.000	320	176	470	621	15	278	281	310	0.475	0.940
LOKIASV2_1322_ESMFold_hypothetical_protein	4bid-assembly1.cif.gz_A	4bid-assembly1.cif.gz_A Crystal Structures of Ask1-inhibitor Complexes	1.729E-10	1.000	319	163	466	621	1	253	254	325	0.490	0.996
LOKIASV2_1322_ESMFold_hypothetical_protein	6t8x-assembly1.cif.gz_E	6t8x-assembly1.cif.gz_E Crystal structure of MAPKAPK2 (MK2) complexed with PF-3644022 and 5-(4-bromophenyl)-N-[4-(1-piperazinyl)phenyl]-N-(2-pyridinylmethyl)-2-furancarboxamide	1.481E-10	1.000	319	162	468	621	7	275	277	332	0.494	0.971
LOKIASV2_1322_ESMFold_hypothetical_protein	4bgg-assembly3.cif.gz_C	4bgg-assembly3.cif.gz_C Crystal structure of the ACVR1 kinase in complex with LDN-213844	6.467E-11	1.000	319	176	467	621	5	278	279	326	0.470	0.982
LOKIASV2_1322_ESMFold_hypothetical_protein	6ra5-assembly1.cif.gz_B	6ra5-assembly1.cif.gz_B Human tnik in complex with compound 9	2.484E-10	1.000	319	176	476	621	12	282	283	324	0.485	0.958
LOKIASV2_1322_ESMFold_hypothetical_protein	3r2y-assembly1.cif.gz_A	3r2y-assembly1.cif.gz_A MK2 kinase bound to Compound 1	1.005E-09	1.000	318	162	482	621	6	249	259	325	0.517	0.942
LOKIASV2_1322_ESMFold_hypothetical_protein	4i5p-assembly1.cif.gz_A	4i5p-assembly1.cif.gz_A Selective & Brain-Permeable Polo-like Kinase-2 (Plk-2) Inhibitors that Reduce -Synuclein Phosphorylation in Rat Brain	3.218E-10	1.000	318	167	462	621	1	258	284	308	0.477	0.908
LOKIASV2_1322_ESMFold_hypothetical_protein	3d5w-assembly1.cif.gz_A	3d5w-assembly1.cif.gz_A Crystal structure of a phosphorylated Polo-like kinase 1 (Plk1) catalytic domain in complex with ADP.	3.389E-10	1.000	318	163	462	621	1	260	285	314	0.483	0.912
LOKIASV2_1322_ESMFold_hypothetical_protein	3q3b-assembly2.cif.gz_B	3q3b-assembly2.cif.gz_B 6-Amino-4-(pyrimidin-4-yl)pyridones: Novel Glycogen Synthase Kinase-3 Inhibitors	6.141E-11	1.000	318	174	466	621	20	293	341	321	0.472	0.804
LOKIASV2_1322_ESMFold_hypothetical_protein	2x7g-assembly1.cif.gz_A	2x7g-assembly1.cif.gz_A Structure of human serine-arginine-rich protein-specific kinase 2 (SRPK2) bound to purvalanol B	7.955E-11	1.000	318	163	467	621	2	343	344	380	0.491	0.994
LOKIASV2_1322_ESMFold_hypothetical_protein	6cpe-assembly1.cif.gz_A	6cpe-assembly1.cif.gz_A Structure of apo, dephosphorylated Aurora A (122-403) in an active conformation	7.760E-10	1.000	317	169	468	621	2	252	256	308	0.483	0.980
LOKIASV2_1322_ESMFold_hypothetical_protein	2wot-assembly1.cif.gz_A	2wot-assembly1.cif.gz_A ALK5 IN COMPLEX WITH 4-((5,6-dimethyl-2-(2-pyridyl)-3-pyridyl)oxy)-N-(3,4,5-trimethoxyphenyl)pyridin-2-amine	2.297E-11	1.000	317	176	472	621	8	301	303	344	0.478	0.970
LOKIASV2_1322_ESMFold_hypothetical_protein	3d15-assembly1.cif.gz_A	3d15-assembly1.cif.gz_A Crystal structure of mouse Aurora A (Asn186->Gly, Lys240->Arg, Met302->Leu) in complex with 1-(3-chloro-phenyl)-3-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)- ethyl]-thiazol-2-yl}-urea [SNS-314]	4.169E-10	1.000	316	167	468	621	1	253	256	310	0.486	0.988
LOKIASV2_1322_ESMFold_hypothetical_protein	5a4e-assembly3.cif.gz_C	5a4e-assembly3.cif.gz_C DYRK1A in complex with methoxy benzothiazole fragment	2.902E-10	1.000	316	163	456	621	16	258	263	297	0.473	0.924
LOKIASV2_1322_ESMFold_hypothetical_protein	6bqq-assembly1.cif.gz_A	6bqq-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with BI2526	5.990E-10	1.000	316	169	467	621	2	270	271	316	0.481	0.993
LOKIASV2_1322_ESMFold_hypothetical_protein	4f0f-assembly1.cif.gz_A	4f0f-assembly1.cif.gz_A Crystal Structure of the Roco4 Kinase Domain bound to AppCp from D. discoideum	3.959E-10	1.000	316	176	469	621	10	276	276	308	0.473	0.967
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7g-assembly1.cif.gz_A	5s7g-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035844b	1.030E-10	1.000	316	176	468	621	7	283	284	334	0.472	0.975
LOKIASV2_1322_ESMFold_hypothetical_protein	3eid-assembly1.cif.gz_A	3eid-assembly1.cif.gz_A CDK2/CyclinA complexed with a pyrazolopyridazine inhibitor	1.821E-10	1.000	316	176	466	621	4	276	292	325	0.469	0.935
LOKIASV2_1322_ESMFold_hypothetical_protein	6ylc-assembly2.cif.gz_B	6ylc-assembly2.cif.gz_B Biochemical, Cellular and Structural Characterization of Novel ERK3 Inhibitors	9.291E-11	1.000	316	176	473	621	5	289	292	336	0.480	0.976
LOKIASV2_1322_ESMFold_hypothetical_protein	6t8x-assembly1.cif.gz_B	6t8x-assembly1.cif.gz_B Crystal structure of MAPKAPK2 (MK2) complexed with PF-3644022 and 5-(4-bromophenyl)-N-[4-(1-piperazinyl)phenyl]-N-(2-pyridinylmethyl)-2-furancarboxamide	1.406E-10	1.000	315	162	463	621	7	267	276	325	0.486	0.946
LOKIASV2_1322_ESMFold_hypothetical_protein	3l1s-assembly2.cif.gz_B	3l1s-assembly2.cif.gz_B 3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3	1.085E-10	1.000	315	174	463	621	19	283	330	313	0.467	0.803
LOKIASV2_1322_ESMFold_hypothetical_protein	8edh-assembly2.cif.gz_C	8edh-assembly2.cif.gz_C Identification of a class of WNK isoform-specific inhibitors through high-throughput screening	6.996E-10	1.000	314	176	465	621	11	256	261	302	0.467	0.943
LOKIASV2_1322_ESMFold_hypothetical_protein	6szm-assembly1.cif.gz_A	6szm-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2009	3.475E-11	1.000	314	176	467	621	7	285	288	331	0.470	0.969
LOKIASV2_1322_ESMFold_hypothetical_protein	2jbp-assembly9.cif.gz_I	2jbp-assembly9.cif.gz_I Protein kinase MK2 in complex with an inhibitor (crystal form-2, co- crystallization)	2.127E-10	1.000	314	162	484	621	7	273	289	332	0.520	0.924
LOKIASV2_1322_ESMFold_hypothetical_protein	6zgc-assembly1.cif.gz_A	6zgc-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Saracatinib (AZD0530)	3.299E-11	1.000	314	176	469	621	4	291	292	334	0.473	0.986
LOKIASV2_1322_ESMFold_hypothetical_protein	2jld-assembly1.cif.gz_B	2jld-assembly1.cif.gz_B Extremely Tight Binding of Ruthenium Complex to Glycogen Synthase Kinase 3	4.992E-11	1.000	314	174	463	621	20	300	349	327	0.467	0.805
LOKIASV2_1322_ESMFold_hypothetical_protein	4fg7-assembly1.cif.gz_A	4fg7-assembly1.cif.gz_A Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-293 in complex with ATP	2.075E-09	1.000	313	176	470	621	12	248	250	304	0.475	0.948
LOKIASV2_1322_ESMFold_hypothetical_protein	7m5z-assembly1.cif.gz_A	7m5z-assembly1.cif.gz_A Crystal Structure of the MerTK Kinase Domain in Complex with Inhibitor MIPS15692	1.030E-10	1.000	313	176	470	621	11	259	263	315	0.475	0.947
LOKIASV2_1322_ESMFold_hypothetical_protein	4eol-assembly1.cif.gz_A	4eol-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor RO3306	1.559E-10	1.000	313	176	469	621	5	284	295	328	0.473	0.949
LOKIASV2_1322_ESMFold_hypothetical_protein	3tzm-assembly1.cif.gz_A	3tzm-assembly1.cif.gz_A TGF-beta Receptor type 1 in complex with SB431542	4.740E-11	1.000	313	176	469	621	6	294	295	339	0.473	0.980
LOKIASV2_1322_ESMFold_hypothetical_protein	1pyx-assembly1.cif.gz_B	1pyx-assembly1.cif.gz_B GSK-3 Beta complexed with AMP-PNP	7.554E-11	1.000	313	174	469	621	20	298	338	327	0.477	0.825
LOKIASV2_1322_ESMFold_hypothetical_protein	6s73-assembly3.cif.gz_C	6s73-assembly3.cif.gz_C Crystal structure of Nek7 SRS mutant bound to compound 51	9.545E-10	1.000	312	176	470	621	9	255	259	307	0.475	0.954
LOKIASV2_1322_ESMFold_hypothetical_protein	6nzp-assembly3.cif.gz_B	6nzp-assembly3.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH COMPOUND-11 AKA 6-CYCLOPROPANEAMIDO-4-{[2-METHOXY-3-(1-METHYL-1H-1,2,4-TRI AZOL-3-YL)PHENYL]AMINO}-N-(?H?)METHYLPYRIDAZINE-3-CARBOXAMIDE	6.308E-10	1.000	312	176	467	621	10	259	260	312	0.470	0.962
LOKIASV2_1322_ESMFold_hypothetical_protein	3gok-assembly1.cif.gz_F	3gok-assembly1.cif.gz_F Binding site mapping of protein ligands	1.085E-10	1.000	312	162	484	621	6	281	284	345	0.520	0.972
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7v-assembly2.cif.gz_B	5s7v-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010942a	5.537E-11	1.000	312	176	467	621	4	288	291	333	0.470	0.979
LOKIASV2_1322_ESMFold_hypothetical_protein	2vgo-assembly2.cif.gz_B	2vgo-assembly2.cif.gz_B Crystal structure of Aurora B kinase in complex with Reversine inhibitor	9.785E-11	1.000	311	163	470	621	3	263	278	316	0.496	0.939
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7z-assembly1.cif.gz_A	5s7z-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with NU074488b	1.085E-10	1.000	311	176	467	621	7	284	287	331	0.470	0.969
LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_F	3kc3-assembly5.cif.gz_F MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine	9.291E-11	1.000	311	162	481	621	8	277	293	336	0.515	0.922
LOKIASV2_1322_ESMFold_hypothetical_protein	6v6a-assembly1.cif.gz_A	6v6a-assembly1.cif.gz_A Inhibitory scaffolding of the ancient MAPK, ERK7	6.630E-12	1.000	311	176	477	621	10	313	317	360	0.486	0.959
LOKIASV2_1322_ESMFold_hypothetical_protein	4mq1-assembly3.cif.gz_C	4mq1-assembly3.cif.gz_C The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	2.755E-10	1.000	311	163	467	621	15	325	329	362	0.491	0.945
LOKIASV2_1322_ESMFold_hypothetical_protein	4csv-assembly1.cif.gz_A	4csv-assembly1.cif.gz_A Tyrosine kinase AS - a common ancestor of Src and Abl bound to Gleevec	1.371E-09	1.000	310	176	467	621	9	240	244	302	0.470	0.951
LOKIASV2_1322_ESMFold_hypothetical_protein	5v19-assembly2.cif.gz_B	5v19-assembly2.cif.gz_B Structure-based drug design of novel ASK1 inhibitors using a fully integrated lead optimization strategy	5.990E-10	1.000	310	163	463	621	1	253	260	315	0.485	0.973
LOKIASV2_1322_ESMFold_hypothetical_protein	7ako-assembly1.cif.gz_A	7ako-assembly1.cif.gz_A Crystal structure of CHK1 kinase domain in complex with a CLASPIN phosphopeptide	4.624E-10	1.000	310	176	471	621	8	265	270	308	0.477	0.956
LOKIASV2_1322_ESMFold_hypothetical_protein	6lnm-assembly3.cif.gz_E	6lnm-assembly3.cif.gz_E Crystal structure of CASK-CaMK in complex with Mint1-CID	2.902E-10	1.000	310	169	477	621	1	277	322	317	0.498	0.860
LOKIASV2_1322_ESMFold_hypothetical_protein	3q3b-assembly1.cif.gz_A	3q3b-assembly1.cif.gz_A 6-Amino-4-(pyrimidin-4-yl)pyridones: Novel Glycogen Synthase Kinase-3 Inhibitors	1.085E-10	1.000	310	174	469	621	20	301	344	330	0.477	0.820
LOKIASV2_1322_ESMFold_hypothetical_protein	1how-assembly1.cif.gz_A	1how-assembly1.cif.gz_A THE X-RAY CRYSTAL STRUCTURE OF SKY1P, AN SR PROTEIN KINASE IN YEAST	2.359E-10	1.000	310	160	481	621	2	328	346	369	0.519	0.945
LOKIASV2_1322_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_F	3is5-assembly1.cif.gz_F Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	1.776E-09	1.000	309	167	467	621	1	264	266	318	0.485	0.992
LOKIASV2_1322_ESMFold_hypothetical_protein	2pzy-assembly2.cif.gz_B	2pzy-assembly2.cif.gz_B Structure of MK2 Complexed with Compound 76	6.308E-10	1.000	309	163	481	621	6	272	283	328	0.514	0.943
LOKIASV2_1322_ESMFold_hypothetical_protein	5vcw-assembly2.cif.gz_B	5vcw-assembly2.cif.gz_B CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH Pelitinib	5.990E-10	1.000	309	161	466	621	19	277	285	316	0.493	0.909
LOKIASV2_1322_ESMFold_hypothetical_protein	2x7f-assembly3.cif.gz_C	2x7f-assembly3.cif.gz_C Crystal structure of the kinase domain of human Traf2- and Nck- interacting Kinase with Wee1Chk1 inhibitor	1.481E-10	1.000	309	176	476	621	12	281	285	330	0.485	0.947
LOKIASV2_1322_ESMFold_hypothetical_protein	5vcz-assembly1.cif.gz_A	5vcz-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN MYT1 KINASE DOMAIN IN COMPLEX WITH Bosutinib isomer	4.391E-10	1.000	309	161	466	621	28	286	294	317	0.493	0.881
LOKIASV2_1322_ESMFold_hypothetical_protein	6zgc-assembly3.cif.gz_C	6zgc-assembly3.cif.gz_C Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Saracatinib (AZD0530)	4.501E-11	1.000	309	169	468	621	3	295	296	344	0.483	0.990
LOKIASV2_1322_ESMFold_hypothetical_protein	4krc-assembly1.cif.gz_A	4krc-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10-ATP-gamma-S Complex	6.141E-11	1.000	309	176	472	621	6	295	297	342	0.478	0.976
LOKIASV2_1322_ESMFold_hypothetical_protein	4ogr-assembly3.cif.gz_I	4ogr-assembly3.cif.gz_I crystal structure of P-TEFb complex with AFF4 and Tat	1.481E-10	1.000	309	176	470	621	12	303	319	333	0.475	0.915
LOKIASV2_1322_ESMFold_hypothetical_protein	6lnm-assembly1.cif.gz_A	6lnm-assembly1.cif.gz_A Crystal structure of CASK-CaMK in complex with Mint1-CID	3.218E-10	1.000	309	169	475	621	1	275	325	317	0.494	0.846
LOKIASV2_1322_ESMFold_hypothetical_protein	1q5k-assembly1.cif.gz_A	1q5k-assembly1.cif.gz_A crystal structure of Glycogen synthase kinase 3 in complexed with inhibitor	1.918E-10	1.000	309	174	463	621	20	296	345	322	0.467	0.803
LOKIASV2_1322_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_D	3is5-assembly1.cif.gz_D Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	6.825E-09	1.000	308	169	463	621	2	230	236	299	0.475	0.970
LOKIASV2_1322_ESMFold_hypothetical_protein	4yzn-assembly1.cif.gz_A	4yzn-assembly1.cif.gz_A Humanized Roco4 bound to Compound 19	6.643E-10	1.000	308	163	469	621	3	269	269	320	0.494	0.993
LOKIASV2_1322_ESMFold_hypothetical_protein	3she-assembly1.cif.gz_A	3she-assembly1.cif.gz_A Novel ATP-competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series	2.484E-10	1.000	308	165	479	621	1	232	270	319	0.507	0.859
LOKIASV2_1322_ESMFold_hypothetical_protein	8tuc-assembly1.cif.gz_A	8tuc-assembly1.cif.gz_A Unphosphorylated CaMKK2 in complex with CC-8977	7.760E-10	1.000	308	169	466	621	2	275	278	319	0.480	0.986
LOKIASV2_1322_ESMFold_hypothetical_protein	3db6-assembly1.cif.gz_A	3db6-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with Compound 902	6.308E-10	1.000	308	163	462	621	1	262	287	315	0.483	0.913
LOKIASV2_1322_ESMFold_hypothetical_protein	4bic-assembly1.cif.gz_A	4bic-assembly1.cif.gz_A Crystal Structures of Ask1-inhibitor Complexes	7.368E-10	1.000	307	163	467	621	1	259	260	324	0.491	0.996
LOKIASV2_1322_ESMFold_hypothetical_protein	6t6d-assembly4.cif.gz_D	6t6d-assembly4.cif.gz_D Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2149	1.918E-10	1.000	307	169	468	621	1	284	285	338	0.483	0.996
LOKIASV2_1322_ESMFold_hypothetical_protein	5s87-assembly2.cif.gz_B	5s87-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010953a	7.955E-11	1.000	307	176	468	621	4	288	290	328	0.472	0.983
LOKIASV2_1322_ESMFold_hypothetical_protein	2iw9-assembly2.cif.gz_A	2iw9-assembly2.cif.gz_A STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR	3.959E-10	1.000	307	176	466	621	5	278	294	325	0.469	0.932
LOKIASV2_1322_ESMFold_hypothetical_protein	1vjy-assembly1.cif.gz_A	1vjy-assembly1.cif.gz_A Crystal Structure of a Naphthyridine Inhibitor of Human TGF-beta Type I Receptor	1.030E-10	1.000	307	176	473	621	5	295	299	345	0.480	0.973
LOKIASV2_1322_ESMFold_hypothetical_protein	1ny3-assembly1.cif.gz_A	1ny3-assembly1.cif.gz_A Crystal structure of ADP bound to MAP KAP kinase 2	5.688E-10	1.000	306	176	470	621	18	260	277	305	0.475	0.877
LOKIASV2_1322_ESMFold_hypothetical_protein	6cmj-assembly2.cif.gz_B	6cmj-assembly2.cif.gz_B Human CAMKK2 with GSK650393	6.308E-10	1.000	306	176	468	621	5	273	287	318	0.472	0.937
LOKIASV2_1322_ESMFold_hypothetical_protein	3hmm-assembly1.cif.gz_A	3hmm-assembly1.cif.gz_A Structure of Alk5 + GW855857	1.143E-10	1.000	306	176	470	621	5	291	293	334	0.475	0.980
LOKIASV2_1322_ESMFold_hypothetical_protein	6xx8-assembly1.cif.gz_A	6xx8-assembly1.cif.gz_A Arabidopsis thaliana Casein Kinase 2 (CK2) alpha-1 crystal form II	5.537E-11	1.000	306	155	480	621	10	325	326	372	0.525	0.969
LOKIASV2_1322_ESMFold_hypothetical_protein	2jld-assembly1.cif.gz_A	2jld-assembly1.cif.gz_A Extremely Tight Binding of Ruthenium Complex to Glycogen Synthase Kinase 3	1.729E-10	1.000	306	174	463	621	20	299	349	326	0.467	0.802
LOKIASV2_1322_ESMFold_hypothetical_protein	3efl-assembly2.cif.gz_B	3efl-assembly2.cif.gz_B Crystal structure of the VEGFR2 kinase domain in complex with motesanib	1.005E-09	1.000	305	176	470	621	14	262	263	311	0.475	0.947
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7t-assembly1.cif.gz_A	5s7t-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010926a	1.559E-10	1.000	305	176	467	621	7	281	284	330	0.470	0.968
LOKIASV2_1322_ESMFold_hypothetical_protein	5s78-assembly1.cif.gz_A	5s78-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010934a	1.821E-10	1.000	305	176	467	621	7	282	285	333	0.470	0.968
LOKIASV2_1322_ESMFold_hypothetical_protein	5xvf-assembly1.cif.gz_A	5xvf-assembly1.cif.gz_A Crystal Structure of PAK4 in complex with inhibitor CZH062	4.391E-10	1.000	305	152	470	621	7	273	290	332	0.514	0.921
LOKIASV2_1322_ESMFold_hypothetical_protein	5s76-assembly2.cif.gz_B	5s76-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010916a	1.268E-10	1.000	305	176	467	621	4	289	292	329	0.470	0.979
LOKIASV2_1322_ESMFold_hypothetical_protein	6t6d-assembly1.cif.gz_A	6t6d-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2149	2.240E-10	1.000	305	176	467	621	5	289	292	332	0.470	0.976
LOKIASV2_1322_ESMFold_hypothetical_protein	4eos-assembly1.cif.gz_A	4eos-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 WT - human cyclin A3 complex with the inhibitor RO3306	3.218E-10	1.000	305	176	466	621	7	281	297	325	0.469	0.926
LOKIASV2_1322_ESMFold_hypothetical_protein	6s11-assembly2.cif.gz_B	6s11-assembly2.cif.gz_B Crystal Structure of DYRK1A with small molecule inhibitor	1.559E-10	1.000	305	163	467	621	14	325	330	365	0.491	0.945
LOKIASV2_1322_ESMFold_hypothetical_protein	2vx3-assembly3.cif.gz_C	2vx3-assembly3.cif.gz_C Crystal structure of the human dual specificity tyrosine- phosphorylation-regulated kinase 1A	1.642E-10	1.000	305	163	467	621	15	334	339	371	0.491	0.944
LOKIASV2_1322_ESMFold_hypothetical_protein	6cn9-assembly1.cif.gz_A	6cn9-assembly1.cif.gz_A Crystal structure of the Kinase domain of WNK1	4.169E-10	1.000	304	176	462	621	11	264	271	303	0.462	0.937
LOKIASV2_1322_ESMFold_hypothetical_protein	4j7b-assembly2.cif.gz_D	4j7b-assembly2.cif.gz_D Crystal structure of polo-like kinase 1	3.306E-09	1.000	304	163	466	621	5	260	281	315	0.490	0.911
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7l-assembly1.cif.gz_A	5s7l-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010943a	2.240E-10	1.000	304	169	467	621	1	283	286	335	0.481	0.990
LOKIASV2_1322_ESMFold_hypothetical_protein	8ak2-assembly1.cif.gz_A	8ak2-assembly1.cif.gz_A Drosophila melanogaster UNC89 Protein Kinase Domain 1 (apo)	1.115E-09	1.000	304	176	475	621	3	261	289	316	0.483	0.896
LOKIASV2_1322_ESMFold_hypothetical_protein	6gue-assembly2.cif.gz_C	6gue-assembly2.cif.gz_C CDK2/CyclinA in complex with AZD5438	5.688E-10	1.000	304	176	470	621	5	278	289	322	0.475	0.948
LOKIASV2_1322_ESMFold_hypothetical_protein	5oy6-assembly3.cif.gz_C	5oy6-assembly3.cif.gz_C Crystal structure of the ACVR1 (ALK2) kinase in complex with cyclical inhibitor OD36.	9.291E-11	1.000	304	176	468	621	5	290	291	335	0.472	0.983
LOKIASV2_1322_ESMFold_hypothetical_protein	5li9-assembly1.cif.gz_A	5li9-assembly1.cif.gz_A Structure of a nucleotide-bound form of PKCiota core kinase domain	1.642E-10	1.000	304	167	485	621	1	284	331	334	0.514	0.858
LOKIASV2_1322_ESMFold_hypothetical_protein	1pyx-assembly1.cif.gz_A	1pyx-assembly1.cif.gz_A GSK-3 Beta complexed with AMP-PNP	1.559E-10	1.000	304	174	463	621	20	292	343	321	0.467	0.796
LOKIASV2_1322_ESMFold_hypothetical_protein	1j1b-assembly1.cif.gz_B	1j1b-assembly1.cif.gz_B Binary complex structure of human tau protein kinase I with AMPPNP	6.141E-11	1.000	304	163	463	621	1	313	364	358	0.485	0.860
LOKIASV2_1322_ESMFold_hypothetical_protein	5s82-assembly1.cif.gz_B-2	5s82-assembly1.cif.gz_B-2 XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035128c	2.359E-10	1.000	303	176	468	621	4	282	284	328	0.472	0.982
LOKIASV2_1322_ESMFold_hypothetical_protein	7akb-assembly1.cif.gz_A	7akb-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 56	1.559E-10	1.000	303	161	467	621	6	327	333	383	0.494	0.967
LOKIASV2_1322_ESMFold_hypothetical_protein	6jkm-assembly1.cif.gz_A	6jkm-assembly1.cif.gz_A Crystal structure of BubR1 kinase domain	1.406E-10	1.000	303	152	480	621	17	323	334	347	0.530	0.919
LOKIASV2_1322_ESMFold_hypothetical_protein	3f7z-assembly2.cif.gz_B	3f7z-assembly2.cif.gz_B X-ray Co-Crystal Structure of Glycogen Synthase Kinase 3beta in Complex with an Inhibitor	2.127E-10	1.000	303	163	463	621	1	292	340	340	0.485	0.859
LOKIASV2_1322_ESMFold_hypothetical_protein	4nm0-assembly1.cif.gz_A	4nm0-assembly1.cif.gz_A Crystal structure of peptide inhibitor-free GSK-3/Axin complex	3.959E-10	1.000	303	174	463	621	26	307	356	326	0.467	0.792
LOKIASV2_1322_ESMFold_hypothetical_protein	5wdy-assembly2.cif.gz_B	5wdy-assembly2.cif.gz_B Crystal structure of WNK1 in complex with 1-cyclohexyl-N-({6-fluoro-1-[2-(3-methoxyphenyl)pyridin-4-yl]-1H-indol-3-yl}methyl)methanamine (compound 6)	4.624E-10	1.000	302	166	462	621	5	252	259	308	0.478	0.958
LOKIASV2_1322_ESMFold_hypothetical_protein	6t8x-assembly1.cif.gz_C	6t8x-assembly1.cif.gz_C Crystal structure of MAPKAPK2 (MK2) complexed with PF-3644022 and 5-(4-bromophenyl)-N-[4-(1-piperazinyl)phenyl]-N-(2-pyridinylmethyl)-2-furancarboxamide	7.368E-10	1.000	302	162	468	621	8	274	276	332	0.494	0.967
LOKIASV2_1322_ESMFold_hypothetical_protein	5uyj-assembly1.cif.gz_A	5uyj-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B	1.005E-09	1.000	302	169	466	621	2	278	281	321	0.480	0.986
LOKIASV2_1322_ESMFold_hypothetical_protein	2jbp-assembly6.cif.gz_F	2jbp-assembly6.cif.gz_F Protein kinase MK2 in complex with an inhibitor (crystal form-2, co- crystallization)	1.335E-10	1.000	302	162	485	621	7	272	287	342	0.522	0.927
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7i-assembly2.cif.gz_B	5s7i-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010928a	7.554E-11	1.000	302	176	467	621	4	291	294	339	0.470	0.980
LOKIASV2_1322_ESMFold_hypothetical_protein	7z5n-assembly8.cif.gz_H	7z5n-assembly8.cif.gz_H Crystal structure of DYRK1A in complex with CX-4945	4.624E-10	1.000	302	163	467	621	15	302	307	344	0.491	0.938
LOKIASV2_1322_ESMFold_hypothetical_protein	6l21-assembly1.cif.gz_A	6l21-assembly1.cif.gz_A Crystal structure of CK2a1 H160A with hematein	2.127E-10	1.000	302	152	476	621	10	330	331	375	0.523	0.970
LOKIASV2_1322_ESMFold_hypothetical_protein	4o0u-assembly1.cif.gz_A	4o0u-assembly1.cif.gz_A Crystal structures of human kinase Aurora A	9.063E-10	1.000	301	169	468	621	3	253	259	311	0.483	0.969
LOKIASV2_1322_ESMFold_hypothetical_protein	6cd6-assembly3.cif.gz_C	6cd6-assembly3.cif.gz_C Crystal Structure of the Human CAMKK1A in complex with GSK650394	2.423E-09	1.000	301	176	467	621	5	264	265	314	0.470	0.981
LOKIASV2_1322_ESMFold_hypothetical_protein	1dm2-assembly1.cif.gz_A	1dm2-assembly1.cif.gz_A HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR HYMENIALDISINE	8.172E-10	1.000	301	176	470	621	4	261	274	330	0.475	0.942
LOKIASV2_1322_ESMFold_hypothetical_protein	6bql-assembly1.cif.gz_A	6bql-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with TAE-226	5.401E-10	1.000	301	169	467	621	2	277	278	321	0.481	0.993
LOKIASV2_1322_ESMFold_hypothetical_protein	6t6d-assembly3.cif.gz_C	6t6d-assembly3.cif.gz_C Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2149	8.378E-11	1.000	301	167	468	621	3	277	278	341	0.486	0.989
LOKIASV2_1322_ESMFold_hypothetical_protein	4b6l-assembly1.cif.gz_A	4b6l-assembly1.cif.gz_A Discovery of Oral Polo-Like Kinase (PLK) Inhibitors with Enhanced Selectivity Profile using Residue Targeted Drug Design	1.059E-09	1.000	301	167	468	621	1	265	281	317	0.486	0.943
LOKIASV2_1322_ESMFold_hypothetical_protein	5uy6-assembly1.cif.gz_A	5uy6-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B	1.521E-09	1.000	301	169	467	621	2	281	282	324	0.481	0.993
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7w-assembly1.cif.gz_A	5s7w-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with HM000007h	1.729E-10	1.000	301	176	467	621	7	281	284	334	0.470	0.968
LOKIASV2_1322_ESMFold_hypothetical_protein	4krd-assembly1.cif.gz_A	4krd-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10 Complex	1.406E-10	1.000	301	176	472	621	6	293	294	337	0.478	0.980
LOKIASV2_1322_ESMFold_hypothetical_protein	6z1c-assembly1.cif.gz_A	6z1c-assembly1.cif.gz_A Crystal structure of Arabidopsis thaliana CK2-alpha-1 in complex with TTP-22	1.481E-10	1.000	301	176	476	621	31	328	331	347	0.485	0.900
LOKIASV2_1322_ESMFold_hypothetical_protein	3anr-assembly2.cif.gz_B	3anr-assembly2.cif.gz_B human DYRK1A/harmine complex	1.335E-10	1.000	301	163	470	621	17	340	343	374	0.496	0.945
LOKIASV2_1322_ESMFold_hypothetical_protein	6c83-assembly1.cif.gz_B	6c83-assembly1.cif.gz_B Structure of Aurora A (122-403) bound to inhibitory Monobody Mb2 and AMPPCP	6.643E-10	1.000	300	169	470	621	2	241	247	311	0.486	0.972
LOKIASV2_1322_ESMFold_hypothetical_protein	6brc-assembly1.cif.gz_A	6brc-assembly1.cif.gz_A Crystal Structure of the Human CAMKK2B in complex with AP26113-analog (ALK-IN-1)	1.236E-09	1.000	300	169	467	621	2	264	265	314	0.481	0.992
LOKIASV2_1322_ESMFold_hypothetical_protein	4j7b-assembly1.cif.gz_A	4j7b-assembly1.cif.gz_A Crystal structure of polo-like kinase 1	2.688E-09	1.000	300	161	476	621	5	266	284	326	0.509	0.923
LOKIASV2_1322_ESMFold_hypothetical_protein	4c0t-assembly1.cif.gz_A	4c0t-assembly1.cif.gz_A Candida albicans PKh Kinase Domain	2.981E-09	1.000	300	169	462	621	1	264	291	306	0.473	0.907
LOKIASV2_1322_ESMFold_hypothetical_protein	4eop-assembly2.cif.gz_C	4eop-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 Q131E - human cyclin A3 complex with the inhibitor RO3306	6.308E-10	1.000	300	176	467	621	5	283	297	327	0.470	0.939
LOKIASV2_1322_ESMFold_hypothetical_protein	7aj8-assembly1.cif.gz_A	7aj8-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 25	2.359E-10	1.000	300	163	470	621	2	327	330	376	0.496	0.988
LOKIASV2_1322_ESMFold_hypothetical_protein	3zrm-assembly1.cif.gz_A	3zrm-assembly1.cif.gz_A Identification of 2-(4-pyridyl)thienopyridinones as GSK-3beta inhibitors	1.143E-10	1.000	300	174	473	621	19	306	346	335	0.483	0.832
LOKIASV2_1322_ESMFold_hypothetical_protein	3say-assembly1.cif.gz_A	3say-assembly1.cif.gz_A Crystal structure of human glycogen synthase kinase 3 beta (GSK3b) in complex with inhibitor 142	2.240E-10	1.000	300	174	463	621	20	299	348	326	0.467	0.805
LOKIASV2_1322_ESMFold_hypothetical_protein	1q97-assembly2.cif.gz_B	1q97-assembly2.cif.gz_B The structure of the Saccharomyces cerevisiae SR protein kinase, Sky1p, with bound ATP	2.902E-10	1.000	300	163	484	621	3	345	361	384	0.519	0.950
LOKIASV2_1322_ESMFold_hypothetical_protein	6s73-assembly4.cif.gz_D	6s73-assembly4.cif.gz_D Crystal structure of Nek7 SRS mutant bound to compound 51	1.970E-09	1.000	299	176	470	621	12	255	259	305	0.475	0.942
LOKIASV2_1322_ESMFold_hypothetical_protein	3orz-assembly3.cif.gz_C	3orz-assembly3.cif.gz_C PDK1 mutant bound to allosteric disulfide fragment activator 2A2	1.444E-09	1.000	299	163	475	621	1	270	277	335	0.504	0.975
LOKIASV2_1322_ESMFold_hypothetical_protein	4hjo-assembly1.cif.gz_A	4hjo-assembly1.cif.gz_A Crystal structure of the inactive EGFR tyrosine kinase domain with erlotinib	1.970E-09	1.000	299	169	482	621	5	278	278	326	0.506	0.986
LOKIASV2_1322_ESMFold_hypothetical_protein	1ql6-assembly1.cif.gz_A	1ql6-assembly1.cif.gz_A THE CATALYTIC MECHANISM OF PHOSPHORYLASE KINASE PROBED BY MUTATIONAL STUDIES	8.172E-10	1.000	299	176	470	621	9	276	281	314	0.475	0.954
LOKIASV2_1322_ESMFold_hypothetical_protein	5s85-assembly1.cif.gz_A	5s85-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000884c	2.902E-10	1.000	299	176	468	621	7	280	282	330	0.472	0.972
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7k-assembly1.cif.gz_A	5s7k-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010936a	2.127E-10	1.000	299	176	467	621	7	282	285	330	0.470	0.968
LOKIASV2_1322_ESMFold_hypothetical_protein	8u2o-assembly1.cif.gz_A	8u2o-assembly1.cif.gz_A Crystal Structure of Cdk-related protein kinase 6 (PK6) from Plasmodium falciparum in complex with inhibitor TCMDC-123995	5.990E-10	1.000	299	169	467	621	5	280	289	328	0.481	0.955
LOKIASV2_1322_ESMFold_hypothetical_protein	6zgc-assembly4.cif.gz_D	6zgc-assembly4.cif.gz_D Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Saracatinib (AZD0530)	1.030E-10	1.000	299	176	468	621	6	290	291	337	0.472	0.979
LOKIASV2_1322_ESMFold_hypothetical_protein	4eol-assembly2.cif.gz_C	4eol-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor RO3306	1.918E-10	1.000	299	169	467	621	2	285	300	333	0.481	0.947
LOKIASV2_1322_ESMFold_hypothetical_protein	5oxg-assembly3.cif.gz_C	5oxg-assembly3.cif.gz_C Crystal structure of the ACVR1 (ALK2) kinase in complex with LDN-212854	1.204E-10	1.000	299	176	469	621	10	300	301	331	0.473	0.967
LOKIASV2_1322_ESMFold_hypothetical_protein	7a4w-assembly1.cif.gz_A	7a4w-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 3	1.642E-10	1.000	299	163	470	621	14	337	340	379	0.496	0.953
LOKIASV2_1322_ESMFold_hypothetical_protein	6b8j-assembly1.cif.gz_A	6b8j-assembly1.cif.gz_A Co-structure of human glycogen synthase kinase beta with a selective (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine inhibitor	1.918E-10	1.000	299	174	470	621	18	300	345	333	0.478	0.820
LOKIASV2_1322_ESMFold_hypothetical_protein	1o9u-assembly1.cif.gz_A-2	1o9u-assembly1.cif.gz_A-2 GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH AXIN PEPTIDE	1.406E-10	1.000	299	174	466	621	20	301	350	330	0.472	0.806
LOKIASV2_1322_ESMFold_hypothetical_protein	5air-assembly1.cif.gz_A	5air-assembly1.cif.gz_A Structural analysis of mouse GSK3beta fused with LRP6 peptide.	4.391E-10	1.000	299	174	463	621	26	305	353	323	0.467	0.793
LOKIASV2_1322_ESMFold_hypothetical_protein	1q99-assembly1.cif.gz_A	1q99-assembly1.cif.gz_A Crystal structure of the Saccharomyces cerevisiae SR protein kinsae, Sky1p, complexed with the non-hydrolyzable ATP analogue, AMP-PNP	2.484E-10	1.000	299	163	467	621	5	324	354	364	0.491	0.904
LOKIASV2_1322_ESMFold_hypothetical_protein	8jmx-assembly1.cif.gz_A	8jmx-assembly1.cif.gz_A The crystal structure of human aurka kinase domain in complex with AURKA-A2	3.306E-09	1.000	298	169	470	621	2	243	250	312	0.486	0.968
LOKIASV2_1322_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_A	3is5-assembly1.cif.gz_A Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	4.750E-09	1.000	298	169	467	621	2	259	260	317	0.481	0.992
LOKIASV2_1322_ESMFold_hypothetical_protein	3r30-assembly1.cif.gz_A	3r30-assembly1.cif.gz_A MK2 kinase bound to Compound 2	2.075E-09	1.000	298	162	482	621	6	254	264	329	0.517	0.943
LOKIASV2_1322_ESMFold_hypothetical_protein	2jbp-assembly7.cif.gz_G	2jbp-assembly7.cif.gz_G Protein kinase MK2 in complex with an inhibitor (crystal form-2, co- crystallization)	2.616E-10	1.000	298	162	481	621	7	272	287	339	0.515	0.927
LOKIASV2_1322_ESMFold_hypothetical_protein	4mq2-assembly4.cif.gz_D	4mq2-assembly4.cif.gz_D The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	2.359E-10	1.000	298	163	467	621	15	325	330	361	0.491	0.942
LOKIASV2_1322_ESMFold_hypothetical_protein	3anq-assembly4.cif.gz_D	3anq-assembly4.cif.gz_D human DYRK1A/inhibitor complex	1.406E-10	1.000	298	163	467	621	14	331	335	372	0.491	0.949
LOKIASV2_1322_ESMFold_hypothetical_protein	4mq2-assembly2.cif.gz_B	4mq2-assembly2.cif.gz_B The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	1.729E-10	1.000	298	163	467	621	15	334	339	370	0.491	0.944
LOKIASV2_1322_ESMFold_hypothetical_protein	6eis-assembly3.cif.gz_C	6eis-assembly3.cif.gz_C DYRK1A in complex with JWC-055	1.481E-10	1.000	298	163	467	621	15	337	341	373	0.491	0.947
LOKIASV2_1322_ESMFold_hypothetical_protein	1q5k-assembly1.cif.gz_B	1q5k-assembly1.cif.gz_B crystal structure of Glycogen synthase kinase 3 in complexed with inhibitor	1.268E-10	1.000	298	174	469	621	20	303	344	330	0.477	0.826
LOKIASV2_1322_ESMFold_hypothetical_protein	4j1r-assembly6.cif.gz_C	4j1r-assembly6.cif.gz_C Crystal Structure of GSK3b in complex with inhibitor 15R	2.902E-10	1.000	298	174	463	621	19	296	345	324	0.467	0.806
LOKIASV2_1322_ESMFold_hypothetical_protein	4bid-assembly2.cif.gz_B	4bid-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	2.616E-10	1.000	297	163	466	621	1	256	258	325	0.490	0.992
LOKIASV2_1322_ESMFold_hypothetical_protein	6e2n-assembly1.cif.gz_A	6e2n-assembly1.cif.gz_A ASK1 kinase domain complex with inhibitor	9.545E-10	1.000	297	163	466	621	1	258	264	316	0.490	0.977
LOKIASV2_1322_ESMFold_hypothetical_protein	1zys-assembly1.cif.gz_A	1zys-assembly1.cif.gz_A Co-crystal structure of Checkpoint Kinase Chk1 with a pyrrolo-pyridine inhibitor	1.236E-09	1.000	297	176	462	621	7	257	271	298	0.462	0.926
LOKIASV2_1322_ESMFold_hypothetical_protein	5ax9-assembly2.cif.gz_B	5ax9-assembly2.cif.gz_B Crystal structure of the kinase domain of human TRAF2 and NCK-interacting protein kinase in complex with compund 9	1.821E-10	1.000	297	176	473	621	13	273	274	328	0.480	0.953
LOKIASV2_1322_ESMFold_hypothetical_protein	1y91-assembly1.cif.gz_A	1y91-assembly1.cif.gz_A Crystal structure of human CDK2 complexed with a pyrazolo[1,5-a]pyrimidine inhibitor	6.643E-10	1.000	297	176	469	621	4	274	286	328	0.473	0.948
LOKIASV2_1322_ESMFold_hypothetical_protein	8ahi-assembly1.cif.gz_A	8ahi-assembly1.cif.gz_A PAC-FragmentDEL: Photoactivated covalent capture of DNA encoded fragments for hit discovery	2.552E-09	1.000	297	180	467	621	26	274	292	298	0.464	0.853
LOKIASV2_1322_ESMFold_hypothetical_protein	7a52-assembly2.cif.gz_B	7a52-assembly2.cif.gz_B Structure of DYRK1A in complex with compound 6	6.996E-10	1.000	297	163	467	621	8	328	333	372	0.491	0.964
LOKIASV2_1322_ESMFold_hypothetical_protein	4f1o-assembly1.cif.gz_A	4f1o-assembly1.cif.gz_A Crystal Structure of the L1180T mutant Roco4 Kinase Domain from D. discoideum bound to AppCp	1.687E-09	1.000	296	176	469	621	10	276	276	309	0.473	0.967
LOKIASV2_1322_ESMFold_hypothetical_protein	5s8b-assembly1.cif.gz_A	5s8b-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010960a	1.821E-10	1.000	296	169	467	621	1	281	284	344	0.481	0.989
LOKIASV2_1322_ESMFold_hypothetical_protein	5s7o-assembly1.cif.gz_A	5s7o-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM007391c	2.755E-10	1.000	296	169	467	621	1	284	287	339	0.481	0.990
LOKIASV2_1322_ESMFold_hypothetical_protein	6srh-assembly1.cif.gz_A	6srh-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2117	1.642E-10	1.000	296	169	467	621	1	285	288	336	0.481	0.990
LOKIASV2_1322_ESMFold_hypothetical_protein	1oi9-assembly1.cif.gz_A	1oi9-assembly1.cif.gz_A Structure of human Thr160-phospho CDK2/cyclin A complexed with a 6-cyclohexylmethyloxy-2-anilino-purine inhibitor	9.063E-10	1.000	296	176	463	621	5	281	296	323	0.464	0.936
LOKIASV2_1322_ESMFold_hypothetical_protein	6qy8-assembly4.cif.gz_D	6qy8-assembly4.cif.gz_D Human CSNK2A2 bound to ERB-041	3.218E-10	1.000	296	176	476	621	33	321	323	343	0.485	0.895
LOKIASV2_1322_ESMFold_hypothetical_protein	6ej4-assembly3.cif.gz_C	6ej4-assembly3.cif.gz_C DYRK1A in complex with XMD7-112	1.406E-10	1.000	296	163	470	621	15	331	332	370	0.496	0.955
LOKIASV2_1322_ESMFold_hypothetical_protein	5a54-assembly4.cif.gz_D	5a54-assembly4.cif.gz_D DYRK1A IN COMPLEX WITH NITRO BENZOTHIAZOLE FRAGMENT	9.291E-11	1.000	296	163	467	621	16	331	335	366	0.491	0.943
LOKIASV2_1322_ESMFold_hypothetical_protein	1h8f-assembly1.cif.gz_B	1h8f-assembly1.cif.gz_B Glycogen Synthase Kinase 3 beta.	5.990E-10	1.000	296	174	466	621	20	301	350	329	0.472	0.806
LOKIASV2_1322_ESMFold_hypothetical_protein	4yzb-assembly1.cif.gz_A	4yzb-assembly1.cif.gz_A CDPK1 from Eimeria tenella in complex with inhibitor UW1521	6.996E-10	1.000	296	167	467	621	13	276	466	313	0.485	0.567
LOKIASV2_1322_ESMFold_hypothetical_protein	5fp6-assembly1.cif.gz_A	5fp6-assembly1.cif.gz_A Structure of cyclin-dependent kinase 2 with small-molecule ligand 3-(4,7-dichloro-1H-indol-3-yl)prop-2-yn-1-ol (AT17833) in an alternate binding site.	6.308E-10	1.000	295	176	469	621	4	270	278	334	0.473	0.960
LOKIASV2_1322_ESMFold_hypothetical_protein	3gxl-assembly1.cif.gz_A	3gxl-assembly1.cif.gz_A ALK-5 kinase complex with GW857175	2.616E-10	1.000	295	176	470	621	5	283	285	335	0.475	0.979
LOKIASV2_1322_ESMFold_hypothetical_protein	3d5u-assembly1.cif.gz_A	3d5u-assembly1.cif.gz_A Crystal structure of a wildtype Polo-like kinase 1 (Plk1) catalytic domain.	1.236E-09	1.000	295	163	462	621	1	263	288	317	0.483	0.913
LOKIASV2_1322_ESMFold_hypothetical_protein	4mq1-assembly4.cif.gz_D	4mq1-assembly4.cif.gz_D The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	2.359E-10	1.000	295	163	467	621	15	333	337	369	0.491	0.947
LOKIASV2_1322_ESMFold_hypothetical_protein	6s1i-assembly4.cif.gz_D	6s1i-assembly4.cif.gz_D Crystal Structure of DYRK1A with small molecule inhibitor	2.240E-10	1.000	295	163	467	621	15	340	346	378	0.491	0.942
LOKIASV2_1322_ESMFold_hypothetical_protein	6ae3-assembly1.cif.gz_A	6ae3-assembly1.cif.gz_A Crystal structure of GSK3beta complexed with Morin	4.624E-10	1.000	295	174	470	621	19	300	348	331	0.478	0.810
LOKIASV2_1322_ESMFold_hypothetical_protein	5myv-assembly2.cif.gz_B	5myv-assembly2.cif.gz_B Crystal structure of SRPK2 in complex with compound 1	1.918E-10	1.000	295	163	469	621	4	342	349	383	0.494	0.971
LOKIASV2_1322_ESMFold_hypothetical_protein	5eyk-assembly1.cif.gz_A	5eyk-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AURORA B IN COMPLEX WITH BI 847325	1.918E-10	1.000	294	176	470	621	6	251	264	308	0.475	0.932
LOKIASV2_1322_ESMFold_hypothetical_protein	4m66-assembly2.cif.gz_B	4m66-assembly2.cif.gz_B Crystal structure of the mouse RIP3 kinase domain	5.843E-09	1.000	294	176	477	621	9	251	265	310	0.486	0.917
LOKIASV2_1322_ESMFold_hypothetical_protein	2btr-assembly1.cif.gz_A	2btr-assembly1.cif.gz_A STRUCTURE OF CDK2 COMPLEXED WITH PNU-198873	1.776E-09	1.000	294	176	467	621	4	259	275	326	0.470	0.931
LOKIASV2_1322_ESMFold_hypothetical_protein	2pvl-assembly1.cif.gz_A	2pvl-assembly1.cif.gz_A Structure-Based Design of Pyrazolo[1,5-a][1,3,5]triazine Derivatives as Potent Inhibitors of Protein Kinase CK2	4.624E-10	1.000	294	163	476	621	26	325	328	359	0.506	0.915
LOKIASV2_1322_ESMFold_hypothetical_protein	7z5n-assembly5.cif.gz_E	7z5n-assembly5.cif.gz_E Crystal structure of DYRK1A in complex with CX-4945	3.389E-10	1.000	294	163	467	621	15	335	340	371	0.491	0.944
LOKIASV2_1322_ESMFold_hypothetical_protein	7sxh-assembly1.cif.gz_A	7sxh-assembly1.cif.gz_A BIO-8546 bound GSK3beta-axin complex	2.484E-10	1.000	294	174	463	621	18	293	341	325	0.467	0.809
LOKIASV2_1322_ESMFold_hypothetical_protein	6s1i-assembly3.cif.gz_C	6s1i-assembly3.cif.gz_C Crystal Structure of DYRK1A with small molecule inhibitor	3.389E-10	1.000	294	163	467	621	15	339	345	382	0.491	0.942
LOKIASV2_1322_ESMFold_hypothetical_protein	5myv-assembly3.cif.gz_C	5myv-assembly3.cif.gz_C Crystal structure of SRPK2 in complex with compound 1	1.335E-10	1.000	294	163	469	621	4	341	348	384	0.494	0.971
LOKIASV2_1322_ESMFold_hypothetical_protein	1uv5-assembly1.cif.gz_A-2	1uv5-assembly1.cif.gz_A-2 GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 6-BROMOINDIRUBIN-3'-OXIME	5.128E-10	1.000	294	174	463	621	20	301	348	326	0.467	0.810
LOKIASV2_1322_ESMFold_hypothetical_protein	4nm5-assembly1.cif.gz_A	4nm5-assembly1.cif.gz_A Crystal structure of GSK-3/Axin complex bound to phosphorylated Wnt receptor LRP6 c-motif	6.467E-11	1.000	294	167	469	621	4	320	361	362	0.488	0.878
LOKIASV2_1322_ESMFold_hypothetical_protein	5tf9-assembly2.cif.gz_B	5tf9-assembly2.cif.gz_B Crystal structure of WNK1 in complex with Mn2+AMPPNP and WNK476	1.687E-09	1.000	293	166	462	621	5	259	266	307	0.478	0.959
LOKIASV2_1322_ESMFold_hypothetical_protein	1r1w-assembly1.cif.gz_A	1r1w-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET	9.545E-10	1.000	293	176	470	621	27	268	287	301	0.475	0.843
LOKIASV2_1322_ESMFold_hypothetical_protein	6ra5-assembly1.cif.gz_A	6ra5-assembly1.cif.gz_A Human tnik in complex with compound 9	1.236E-09	1.000	293	176	473	621	14	292	295	325	0.480	0.946
LOKIASV2_1322_ESMFold_hypothetical_protein	5acb-assembly2.cif.gz_D	5acb-assembly2.cif.gz_D Crystal Structure of the Human Cdk12-Cyclink Complex	2.755E-10	1.000	293	176	467	621	10	297	320	330	0.470	0.900
LOKIASV2_1322_ESMFold_hypothetical_protein	6eiq-assembly3.cif.gz_C	6eiq-assembly3.cif.gz_C DYRK1A in complex with XMD14-124	1.481E-10	1.000	293	163	467	621	15	329	333	370	0.491	0.946
LOKIASV2_1322_ESMFold_hypothetical_protein	6ae3-assembly1.cif.gz_B	6ae3-assembly1.cif.gz_B Crystal structure of GSK3beta complexed with Morin	3.570E-10	1.000	293	174	479	621	19	308	344	339	0.493	0.843
LOKIASV2_1322_ESMFold_hypothetical_protein	6cd6-assembly1.cif.gz_A	6cd6-assembly1.cif.gz_A Crystal Structure of the Human CAMKK1A in complex with GSK650394	3.667E-09	1.000	292	176	466	621	4	262	264	309	0.469	0.981
LOKIASV2_1322_ESMFold_hypothetical_protein	2jbp-assembly11.cif.gz_K	2jbp-assembly11.cif.gz_K Protein kinase MK2 in complex with an inhibitor (crystal form-2, co- crystallization)	1.115E-09	1.000	292	162	477	621	5	250	264	334	0.509	0.932
LOKIASV2_1322_ESMFold_hypothetical_protein	4agu-assembly3.cif.gz_C	4agu-assembly3.cif.gz_C CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	1.236E-09	1.000	292	176	463	621	3	269	278	327	0.464	0.960
LOKIASV2_1322_ESMFold_hypothetical_protein	5kbq-assembly1.cif.gz_A	5kbq-assembly1.cif.gz_A Pak1 in complex with bis-anilino pyrimidine inhibitor	5.128E-10	1.000	292	162	481	621	11	289	289	341	0.515	0.965
LOKIASV2_1322_ESMFold_hypothetical_protein	3u87-assembly1.cif.gz_A	3u87-assembly1.cif.gz_A Structure of a chimeric construct of human CK2alpha and human CK2alpha' in complex with a non-hydrolysable ATP-analogue	6.308E-10	1.000	292	176	476	621	38	328	329	345	0.485	0.884
LOKIASV2_1322_ESMFold_hypothetical_protein	7ake-assembly1.cif.gz_A	7ake-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 58	2.020E-10	1.000	292	163	467	621	9	327	333	369	0.491	0.958
LOKIASV2_1322_ESMFold_hypothetical_protein	4mq2-assembly1.cif.gz_A	4mq2-assembly1.cif.gz_A The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	2.240E-10	1.000	292	163	467	621	14	338	344	375	0.491	0.945
LOKIASV2_1322_ESMFold_hypothetical_protein	3m1s-assembly1.cif.gz_A	3m1s-assembly1.cif.gz_A Structure of Ruthenium Half-Sandwich Complex Bound to Glycogen Synthase Kinase 3	1.642E-10	1.000	292	174	469	621	20	306	348	333	0.477	0.825
LOKIASV2_1322_ESMFold_hypothetical_protein	2c6e-assembly1.cif.gz_A	2c6e-assembly1.cif.gz_A Aurora A kinase activated mutant (T287D) in complex with a 5- aminopyrimidinyl quinazoline inhibitor	3.139E-09	1.000	291	169	468	621	2	247	251	315	0.483	0.980
LOKIASV2_1322_ESMFold_hypothetical_protein	6s73-assembly2.cif.gz_B	6s73-assembly2.cif.gz_B Crystal structure of Nek7 SRS mutant bound to compound 51	1.776E-09	1.000	291	176	470	621	15	264	268	308	0.475	0.933
LOKIASV2_1322_ESMFold_hypothetical_protein	3f3z-assembly1.cif.gz_A-2	3f3z-assembly1.cif.gz_A-2 Crystal structure of Cryptosporidium parvum calcium dependent protein kinase cgd7_1840 in presence of indirubin E804	3.482E-09	1.000	291	176	477	621	6	268	272	314	0.486	0.967
LOKIASV2_1322_ESMFold_hypothetical_protein	1ckp-assembly1.cif.gz_A	1ckp-assembly1.cif.gz_A HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR PURVALANOL B	1.302E-09	1.000	291	176	467	621	4	263	279	326	0.470	0.932
LOKIASV2_1322_ESMFold_hypothetical_protein	3f5x-assembly1.cif.gz_A-3	3f5x-assembly1.cif.gz_A-3 CDK-2-Cyclin complex with indazole inhibitor 9 bound at its active site	1.005E-09	1.000	291	176	466	621	4	280	297	329	0.469	0.933
LOKIASV2_1322_ESMFold_hypothetical_protein	4eop-assembly1.cif.gz_A	4eop-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 Q131E - human cyclin A3 complex with the inhibitor RO3306	4.391E-10	1.000	291	176	469	621	7	287	298	329	0.473	0.943
LOKIASV2_1322_ESMFold_hypothetical_protein	1q41-assembly1.cif.gz_A	1q41-assembly1.cif.gz_A GSK-3 Beta complexed with Indirubin-3'-monoxime	4.870E-10	1.000	291	174	469	621	20	296	339	326	0.477	0.817
LOKIASV2_1322_ESMFold_hypothetical_protein	2jd5-assembly1.cif.gz_A	2jd5-assembly1.cif.gz_A Sky1p bound to Npl3p-derived substrate peptide	9.545E-10	1.000	291	160	467	621	2	322	353	365	0.496	0.909
LOKIASV2_1322_ESMFold_hypothetical_protein	4uzh-assembly1.cif.gz_A	4uzh-assembly1.cif.gz_A SAR156497 an exquisitely selective inhibitor of Aurora kinases	3.139E-09	1.000	290	163	468	621	1	245	251	320	0.493	0.976
LOKIASV2_1322_ESMFold_hypothetical_protein	6s75-assembly2.cif.gz_B	6s75-assembly2.cif.gz_B Crystal structure of Nek7 bound to compound 51	4.067E-09	1.000	290	176	470	621	15	263	267	310	0.475	0.933
LOKIASV2_1322_ESMFold_hypothetical_protein	4agu-assembly2.cif.gz_B	4agu-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	1.174E-09	1.000	290	176	463	621	2	266	276	329	0.464	0.960
LOKIASV2_1322_ESMFold_hypothetical_protein	2x7f-assembly1.cif.gz_A	2x7f-assembly1.cif.gz_A Crystal structure of the kinase domain of human Traf2- and Nck- interacting Kinase with Wee1Chk1 inhibitor	9.063E-10	1.000	290	176	476	621	11	272	276	325	0.485	0.949
LOKIASV2_1322_ESMFold_hypothetical_protein	5dh3-assembly1.cif.gz_B	5dh3-assembly1.cif.gz_B Crystal structure of MST2 in complex with XMU-MP-1	1.559E-10	1.000	290	176	478	621	10	285	285	334	0.488	0.968
LOKIASV2_1322_ESMFold_hypothetical_protein	7jxy-assembly2.cif.gz_B	7jxy-assembly2.cif.gz_B Structure of TTBK1 kinase domain in complex with Compound 18	2.075E-09	1.000	290	163	477	621	5	278	288	330	0.507	0.951
LOKIASV2_1322_ESMFold_hypothetical_protein	5dew-assembly1.cif.gz_A	5dew-assembly1.cif.gz_A Crystal structure of PAK1 in complex with an inhibitor compound 5	7.760E-10	1.000	290	151	480	621	3	292	295	355	0.531	0.983
LOKIASV2_1322_ESMFold_hypothetical_protein	4eon-assembly2.cif.gz_C	4eon-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, Q131E - human cyclin A3 complex with the inhibitor RO3306	6.643E-10	1.000	290	176	466	621	6	283	299	324	0.469	0.930
LOKIASV2_1322_ESMFold_hypothetical_protein	6isj-assembly1.cif.gz_A	6isj-assembly1.cif.gz_A Crystal structure of CX-4945 bound CK2 alpha from C. neoformans	2.020E-10	1.000	290	150	476	621	3	321	324	378	0.527	0.985
LOKIASV2_1322_ESMFold_hypothetical_protein	8bgc-assembly2.cif.gz_B	8bgc-assembly2.cif.gz_B Crystal structure of human Casein Kinase II subunit alpha (CK2a1) in complex with compound 2 (AA-CS-9-003)	8.606E-10	1.000	290	152	476	621	9	326	327	375	0.523	0.972
LOKIASV2_1322_ESMFold_hypothetical_protein	1q97-assembly1.cif.gz_A	1q97-assembly1.cif.gz_A The structure of the Saccharomyces cerevisiae SR protein kinase, Sky1p, with bound ATP	4.624E-10	1.000	290	163	467	621	4	321	351	363	0.491	0.906
LOKIASV2_1322_ESMFold_hypothetical_protein	3i4b-assembly1.cif.gz_A	3i4b-assembly1.cif.gz_A Crystal structure of GSK3b in complex with a pyrimidylpyrrole inhibitor	3.056E-10	1.000	290	174	469	621	28	317	359	336	0.477	0.808
LOKIASV2_1322_ESMFold_hypothetical_protein	2c6e-assembly2.cif.gz_B	2c6e-assembly2.cif.gz_B Aurora A kinase activated mutant (T287D) in complex with a 5- aminopyrimidinyl quinazoline inhibitor	2.831E-09	1.000	289	169	470	621	2	240	246	313	0.486	0.972
LOKIASV2_1322_ESMFold_hypothetical_protein	6gra-assembly1.cif.gz_A	6gra-assembly1.cif.gz_A Human AURKA bound to BRD-7880	1.776E-09	1.000	289	169	470	621	3	243	250	312	0.486	0.964
LOKIASV2_1322_ESMFold_hypothetical_protein	2bmc-assembly4.cif.gz_D	2bmc-assembly4.cif.gz_D Aurora-2 T287D T288D complexed with PHA-680632	8.172E-10	1.000	289	169	468	621	2	247	256	314	0.483	0.961
LOKIASV2_1322_ESMFold_hypothetical_protein	4x7h-assembly1.cif.gz_A	4x7h-assembly1.cif.gz_A Co-crystal Structure of PERK bound to N-{5-[(6,7-dimethoxyquinolin-4-yl)oxy]pyridin-2-yl}-1-methyl-3-oxo-2-phenyl-5-(pyridin-4-yl)-2,3-dihydro-1H-pyrazole-4-carboxamide inhibitor	1.236E-09	1.000	289	167	463	621	1	242	256	311	0.478	0.945
LOKIASV2_1322_ESMFold_hypothetical_protein	4x7j-assembly1.cif.gz_A	4x7j-assembly1.cif.gz_A Co-crystal Structure of PERK with 2-amino-N-[4-methoxy-3-(trifluoromethyl)phenyl]-4-methyl-3-[2-(methylamino)quinazolin-6-yl]benzamide inhibitor	2.301E-09	1.000	289	167	467	621	1	249	257	314	0.485	0.969
LOKIASV2_1322_ESMFold_hypothetical_protein	2cgu-assembly1.cif.gz_A	2cgu-assembly1.cif.gz_A Identification of chemically diverse Chk1 inhibitors by receptor- based virtual screening	5.268E-09	1.000	289	171	462	621	1	251	263	306	0.470	0.954
LOKIASV2_1322_ESMFold_hypothetical_protein	2jbp-assembly8.cif.gz_H	2jbp-assembly8.cif.gz_H Protein kinase MK2 in complex with an inhibitor (crystal form-2, co- crystallization)	1.174E-09	1.000	289	162	484	621	6	270	282	335	0.520	0.940
LOKIASV2_1322_ESMFold_hypothetical_protein	3mdy-assembly1.cif.gz_A	3mdy-assembly1.cif.gz_A Crystal structure of the cytoplasmic domain of the bone morphogenetic protein receptor type-1B (BMPR1B) in complex with FKBP12 and LDN-193189	4.391E-10	1.000	289	176	477	621	31	317	320	343	0.486	0.897
LOKIASV2_1322_ESMFold_hypothetical_protein	5zn1-assembly1.cif.gz_A	5zn1-assembly1.cif.gz_A X-ray structure of protein kinase ck2 alpha subunit in D2O	1.302E-09	1.000	289	176	470	621	37	321	327	337	0.475	0.872
LOKIASV2_1322_ESMFold_hypothetical_protein	6uip-assembly1.cif.gz_A	6uip-assembly1.cif.gz_A DYRK1A Kinase Domain in Complex with a 6-azaindole Derivative, GNF2133.	3.959E-10	1.000	289	163	467	621	19	341	345	373	0.491	0.936
LOKIASV2_1322_ESMFold_hypothetical_protein	4afj-assembly2.cif.gz_B	4afj-assembly2.cif.gz_B 5-aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors	1.005E-09	1.000	289	174	463	621	21	298	347	327	0.467	0.801
LOKIASV2_1322_ESMFold_hypothetical_protein	3beg-assembly1.cif.gz_A	3beg-assembly1.cif.gz_A Crystal structure of SR protein kinase 1 complexed to its substrate ASF/SF2	1.559E-10	1.000	289	163	470	621	2	345	348	386	0.496	0.989
LOKIASV2_1322_ESMFold_hypothetical_protein	7dd1-assembly1.cif.gz_A	7dd1-assembly1.cif.gz_A Crystal structure of SRPK1 in complex with a peptide inhibitor	6.996E-10	1.000	289	163	470	621	4	348	351	388	0.496	0.983
LOKIASV2_1322_ESMFold_hypothetical_protein	5oy4-assembly2.cif.gz_B	5oy4-assembly2.cif.gz_B GSK3beta complex with N-(6-(3,4-dihydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)acetamide	3.759E-10	1.000	289	174	463	621	25	305	354	328	0.467	0.794
LOKIASV2_1322_ESMFold_hypothetical_protein	7ncf-assembly1.cif.gz_A	7ncf-assembly1.cif.gz_A Crystal structure of HIPK2 in complex with MU135 (compound 21e)	1.143E-10	1.000	289	163	482	621	6	355	355	401	0.515	0.986
LOKIASV2_1322_ESMFold_hypothetical_protein	6fad-assembly4.cif.gz_D	6fad-assembly4.cif.gz_D SR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27	2.902E-10	1.000	289	163	470	621	16	353	356	382	0.496	0.949
LOKIASV2_1322_ESMFold_hypothetical_protein	5air-assembly1.cif.gz_B	5air-assembly1.cif.gz_B Structural analysis of mouse GSK3beta fused with LRP6 peptide.	4.169E-10	1.000	289	174	463	621	33	312	361	325	0.467	0.776
LOKIASV2_1322_ESMFold_hypothetical_protein	4yzb-assembly2.cif.gz_B	4yzb-assembly2.cif.gz_B CDPK1 from Eimeria tenella in complex with inhibitor UW1521	4.391E-10	1.000	289	167	467	621	13	271	464	311	0.485	0.558
LOKIASV2_1322_ESMFold_hypothetical_protein	4ztr-assembly1.cif.gz_A	4ztr-assembly1.cif.gz_A Human Aurora A catalytic domain bound to FK1141	4.510E-09	1.000	288	169	470	621	2	243	249	311	0.486	0.972
LOKIASV2_1322_ESMFold_hypothetical_protein	7bjr-assembly1.cif.gz_A	7bjr-assembly1.cif.gz_A Crystal structure of CHK1-10pt-mutant complex with compound 18	2.185E-09	1.000	288	176	471	621	5	253	257	307	0.477	0.969
LOKIASV2_1322_ESMFold_hypothetical_protein	6brc-assembly2.cif.gz_B	6brc-assembly2.cif.gz_B Crystal Structure of the Human CAMKK2B in complex with AP26113-analog (ALK-IN-1)	4.067E-09	1.000	288	176	466	621	5	258	260	305	0.469	0.977
LOKIASV2_1322_ESMFold_hypothetical_protein	2x8i-assembly1.cif.gz_A	2x8i-assembly1.cif.gz_A Discovery of a Novel Class of triazolones as Checkpoint Kinase Inhibitors - Hit to Lead Exploration	2.688E-09	1.000	288	176	471	621	8	258	261	307	0.477	0.962
LOKIASV2_1322_ESMFold_hypothetical_protein	4ks8-assembly1.cif.gz_A	4ks8-assembly1.cif.gz_A PAK6 kinase domain in complex with sunitinib	1.206E-08	1.000	288	176	467	621	23	275	287	303	0.470	0.882
LOKIASV2_1322_ESMFold_hypothetical_protein	7aj5-assembly1.cif.gz_A	7aj5-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 10	4.391E-10	1.000	288	163	470	621	1	327	330	382	0.496	0.991
LOKIASV2_1322_ESMFold_hypothetical_protein	5kpl-assembly2.cif.gz_B	5kpl-assembly2.cif.gz_B Glycogen Synthase Kinase 3 beta Complexed with BRD0705	1.174E-09	1.000	288	174	463	621	19	292	340	319	0.467	0.806
LOKIASV2_1322_ESMFold_hypothetical_protein	7jov-assembly3.cif.gz_F	7jov-assembly3.cif.gz_F CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	1.174E-09	1.000	288	151	475	621	49	338	385	343	0.523	0.753
LOKIASV2_1322_ESMFold_hypothetical_protein	2clq-assembly1.cif.gz_A-2	2clq-assembly1.cif.gz_A-2 Structure of mitogen-activated protein kinase kinase kinase 5	2.552E-09	1.000	287	163	466	621	1	256	263	324	0.490	0.973
LOKIASV2_1322_ESMFold_hypothetical_protein	3ma6-assembly1.cif.gz_A	3ma6-assembly1.cif.gz_A Crystal structure of kinase domain of TgCDPK1 in presence of 3BrB-PP1	3.667E-09	1.000	287	170	470	621	1	265	267	321	0.485	0.993
LOKIASV2_1322_ESMFold_hypothetical_protein	2duv-assembly1.cif.gz_A	2duv-assembly1.cif.gz_A Structure of CDK2 with a 3-hydroxychromones	2.831E-09	1.000	287	176	473	621	4	262	272	332	0.480	0.952
LOKIASV2_1322_ESMFold_hypothetical_protein	4agu-assembly1.cif.gz_A	4agu-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDKL1 KINASE DOMAIN	1.371E-09	1.000	287	176	463	621	3	268	277	326	0.464	0.960
LOKIASV2_1322_ESMFold_hypothetical_protein	3gok-assembly1.cif.gz_A	3gok-assembly1.cif.gz_A Binding site mapping of protein ligands	7.368E-10	1.000	287	162	484	621	6	282	285	351	0.520	0.972
LOKIASV2_1322_ESMFold_hypothetical_protein	3gok-assembly1.cif.gz_G	3gok-assembly1.cif.gz_G Binding site mapping of protein ligands	7.760E-10	1.000	287	162	484	621	6	283	286	349	0.520	0.972
LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly3.cif.gz_L	3kc3-assembly3.cif.gz_L MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine	3.056E-10	1.000	287	159	485	621	4	277	291	342	0.527	0.942
LOKIASV2_1322_ESMFold_hypothetical_protein	4twc-assembly2.cif.gz_B	4twc-assembly2.cif.gz_B 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4- carboxamide derivatives as potent inhibitors of CK1d/e	5.268E-09	1.000	287	167	474	621	1	278	292	320	0.496	0.952
LOKIASV2_1322_ESMFold_hypothetical_protein	8c12-assembly1.cif.gz_AAA	8c12-assembly1.cif.gz_AAA Identification of an intermediate activation state of PAK5 reveals a novel mechanism of kinase inhibition.	3.139E-09	1.000	287	152	470	621	8	275	293	330	0.514	0.915
LOKIASV2_1322_ESMFold_hypothetical_protein	2xmy-assembly1.cif.gz_A	2xmy-assembly1.cif.gz_A Discovery and Characterisation of 2-Anilino-4-(thiazol-5-yl) pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents	1.302E-09	1.000	287	176	469	621	4	283	295	328	0.473	0.949
LOKIASV2_1322_ESMFold_hypothetical_protein	2qlu-assembly1.cif.gz_A	2qlu-assembly1.cif.gz_A Crystal structure of Activin receptor type II kinase domain from human	1.602E-09	1.000	287	176	469	621	3	294	297	335	0.473	0.983
LOKIASV2_1322_ESMFold_hypothetical_protein	6qy8-assembly1.cif.gz_A	6qy8-assembly1.cif.gz_A Human CSNK2A2 bound to ERB-041	4.391E-10	1.000	287	176	470	621	33	315	321	339	0.475	0.882
LOKIASV2_1322_ESMFold_hypothetical_protein	6s1i-assembly2.cif.gz_B	6s1i-assembly2.cif.gz_B Crystal Structure of DYRK1A with small molecule inhibitor	6.643E-10	1.000	287	163	467	621	15	340	346	377	0.491	0.942
LOKIASV2_1322_ESMFold_hypothetical_protein	4jrn-assembly1.cif.gz_A	4jrn-assembly1.cif.gz_A ROP18 kinase domain in complex with AMP-PNP and sucrose	9.291E-11	1.000	287	154	484	621	35	349	349	362	0.533	0.903
LOKIASV2_1322_ESMFold_hypothetical_protein	6sgd-assembly1.cif.gz_A	6sgd-assembly1.cif.gz_A Nek2 kinase covalently bound to 2-arylamino-6-ethynylpurine inhibitor 24	1.776E-09	1.000	286	176	461	621	6	236	248	299	0.461	0.931
LOKIASV2_1322_ESMFold_hypothetical_protein	6bwk-assembly1.cif.gz_A	6bwk-assembly1.cif.gz_A Crystal structure of the human MLKL pseudokinase domain T357E/S358E mutant	1.236E-09	1.000	286	180	469	621	16	262	263	303	0.467	0.939
LOKIASV2_1322_ESMFold_hypothetical_protein	3d5x-assembly1.cif.gz_A	3d5x-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with wortmannin.	3.482E-09	1.000	286	163	486	621	1	273	279	338	0.522	0.978
LOKIASV2_1322_ESMFold_hypothetical_protein	2x7f-assembly2.cif.gz_B	2x7f-assembly2.cif.gz_B Crystal structure of the kinase domain of human Traf2- and Nck- interacting Kinase with Wee1Chk1 inhibitor	4.391E-10	1.000	286	169	476	621	1	284	288	341	0.496	0.986
LOKIASV2_1322_ESMFold_hypothetical_protein	6s1f-assembly1.cif.gz_A	6s1f-assembly1.cif.gz_A Structure of the kinase domain of human RIPK2 in complex with the inhibitor CSLP3	8.172E-10	1.000	286	173	481	621	16	276	291	332	0.498	0.897
LOKIASV2_1322_ESMFold_hypothetical_protein	4dgm-assembly1.cif.gz_A	4dgm-assembly1.cif.gz_A Crystal Structure of maize CK2 in complex with the inhibitor apigenin	3.218E-10	1.000	286	150	476	621	3	324	326	380	0.527	0.988
LOKIASV2_1322_ESMFold_hypothetical_protein	3anr-assembly3.cif.gz_C	3anr-assembly3.cif.gz_C human DYRK1A/harmine complex	3.389E-10	1.000	286	163	467	621	16	332	338	371	0.491	0.938
LOKIASV2_1322_ESMFold_hypothetical_protein	2wei-assembly1.cif.gz_A	2wei-assembly1.cif.gz_A Crystal structure of the kinase domain of Cryptosporidium parvum calcium dependent protein kinase in complex with 3-MB-PP1	2.831E-09	1.000	285	176	470	621	16	271	278	306	0.475	0.921
LOKIASV2_1322_ESMFold_hypothetical_protein	7nry-assembly1.cif.gz_X	7nry-assembly1.cif.gz_X Re-refinement of MAPKAP kinase-2/inhibitor complex 3fyj	1.776E-09	1.000	285	176	477	621	19	247	283	303	0.486	0.809
LOKIASV2_1322_ESMFold_hypothetical_protein	6unq-assembly1.cif.gz_A	6unq-assembly1.cif.gz_A Kinase domain of ALK2-K493A with AMPPNP	5.990E-10	1.000	285	176	466	621	3	288	289	330	0.469	0.990
LOKIASV2_1322_ESMFold_hypothetical_protein	8buq-assembly1.cif.gz_B	8buq-assembly1.cif.gz_B Structure of DDB1 bound to DS43-engaged CDK12-cyclin K	5.128E-10	1.000	285	176	467	621	13	298	321	328	0.470	0.891
LOKIASV2_1322_ESMFold_hypothetical_protein	3l1s-assembly1.cif.gz_A	3l1s-assembly1.cif.gz_A 3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3	5.401E-10	1.000	285	174	469	621	27	295	336	323	0.477	0.801
LOKIASV2_1322_ESMFold_hypothetical_protein	1wbp-assembly1.cif.gz_A	1wbp-assembly1.cif.gz_A SRPK1 bound to 9mer docking motif peptide	3.056E-10	1.000	285	160	470	621	1	347	350	391	0.501	0.991
LOKIASV2_1322_ESMFold_hypothetical_protein	4uzd-assembly1.cif.gz_A	4uzd-assembly1.cif.gz_A SAR156497 an exquisitely selective inhibitor of Aurora kinases	2.423E-09	1.000	284	169	470	621	2	248	254	313	0.486	0.972
LOKIASV2_1322_ESMFold_hypothetical_protein	4fkj-assembly1.cif.gz_A	4fkj-assembly1.cif.gz_A Crystal structure of the cdk2 in complex with aminopyrazole inhibitor	2.301E-09	1.000	284	176	467	621	4	262	278	325	0.470	0.932
LOKIASV2_1322_ESMFold_hypothetical_protein	5k3y-assembly2.cif.gz_B	5k3y-assembly2.cif.gz_B Crystal structure of AuroraB/INCENP in complex with BI 811283	9.545E-10	1.000	284	161	470	621	2	264	278	318	0.499	0.946
LOKIASV2_1322_ESMFold_hypothetical_protein	1csn-assembly1.cif.gz_A	1csn-assembly1.cif.gz_A BINARY COMPLEX OF CASEIN KINASE-1 WITH MGATP	1.302E-09	1.000	284	169	484	621	1	287	293	334	0.509	0.980
LOKIASV2_1322_ESMFold_hypothetical_protein	6gu2-assembly1.cif.gz_A	6gu2-assembly1.cif.gz_A CDK1/CyclinB/Cks2 in complex with Flavopiridol	1.236E-09	1.000	284	176	484	621	7	294	294	343	0.498	0.980
LOKIASV2_1322_ESMFold_hypothetical_protein	2jbo-assembly1.cif.gz_A	2jbo-assembly1.cif.gz_A Protein kinase MK2 in complex with an inhibitor (crystal form-1, soaking)	5.401E-10	1.000	284	162	484	621	8	283	295	343	0.520	0.936
LOKIASV2_1322_ESMFold_hypothetical_protein	7a4s-assembly1.cif.gz_A	7a4s-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 2	4.870E-10	1.000	284	163	467	621	1	325	331	376	0.491	0.982
LOKIASV2_1322_ESMFold_hypothetical_protein	6l24-assembly1.cif.gz_A	6l24-assembly1.cif.gz_A Crystal structure of CK2a1 H115Y/V116I with hematein	8.606E-10	1.000	284	163	479	621	30	333	334	361	0.510	0.910
LOKIASV2_1322_ESMFold_hypothetical_protein	6eir-assembly2.cif.gz_B	6eir-assembly2.cif.gz_B DYRK1A in complex with XMD15-27-2	4.870E-10	1.000	284	163	467	621	17	330	335	364	0.491	0.937
LOKIASV2_1322_ESMFold_hypothetical_protein	6y9s-assembly2.cif.gz_B	6y9s-assembly2.cif.gz_B Crystal structure of GSK-3b in complex with the imidazo[1,5-a]pyridine-3-carboxamide inhibitor 16	7.368E-10	1.000	284	167	461	621	4	290	340	338	0.475	0.844
LOKIASV2_1322_ESMFold_hypothetical_protein	5a3x-assembly1.cif.gz_A	5a3x-assembly1.cif.gz_A DYRK1A in complex with hydroxy benzothiazole fragment	6.643E-10	1.000	284	163	470	621	16	340	343	376	0.496	0.948
LOKIASV2_1322_ESMFold_hypothetical_protein	5mxx-assembly1.cif.gz_A	5mxx-assembly1.cif.gz_A Crystal structure of human SR protein kinase 1 (SRPK1) in complex with compound 1	7.368E-10	1.000	284	163	470	621	15	358	361	387	0.496	0.953
LOKIASV2_1322_ESMFold_hypothetical_protein	5odt-assembly1.cif.gz_A	5odt-assembly1.cif.gz_A Aurora-A in complex with TACC3	3.862E-09	1.000	283	167	470	621	1	248	258	314	0.490	0.961
LOKIASV2_1322_ESMFold_hypothetical_protein	8bzi-assembly1.cif.gz_A	8bzi-assembly1.cif.gz_A Human MST3 (STK24) kinase in complex with inhibitor MR39	8.606E-10	1.000	283	176	478	621	11	265	267	328	0.488	0.955
LOKIASV2_1322_ESMFold_hypothetical_protein	7s85-assembly1.cif.gz_A	7s85-assembly1.cif.gz_A Crystal structure of CDK2 liganded with compound WN316	2.981E-09	1.000	283	176	469	621	2	269	281	335	0.473	0.954
LOKIASV2_1322_ESMFold_hypothetical_protein	3a7f-assembly1.cif.gz_A	3a7f-assembly1.cif.gz_A Human MST3 kinase	2.688E-09	1.000	283	176	483	621	16	284	284	329	0.496	0.947
LOKIASV2_1322_ESMFold_hypothetical_protein	6fd3-assembly1.cif.gz_A	6fd3-assembly1.cif.gz_A Thiophosphorylated PAK3 kinase domain	6.643E-10	1.000	283	152	482	621	7	296	296	354	0.533	0.980
LOKIASV2_1322_ESMFold_hypothetical_protein	6o6q-assembly1.cif.gz_B-2	6o6q-assembly1.cif.gz_B-2 Crystal structure of Cka1p, a casein kinase 2 alpha ortholog from Candida albicans	5.401E-10	1.000	283	150	479	621	9	324	325	380	0.531	0.972
LOKIASV2_1322_ESMFold_hypothetical_protein	4afj-assembly1.cif.gz_A	4afj-assembly1.cif.gz_A 5-aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors	2.755E-10	1.000	283	174	470	621	19	299	344	333	0.478	0.817
LOKIASV2_1322_ESMFold_hypothetical_protein	6v6l-assembly1.cif.gz_A	6v6l-assembly1.cif.gz_A Co-structure of human glycogen synthase kinase beta with 1-(6-((2-((6-amino-5-nitropyridin-2-yl)amino)ethyl)amino)-2-(2,4-dichlorophenyl)pyridin-3-yl)-4-methylpiperazin-2-one	3.056E-10	1.000	283	167	463	621	3	295	344	345	0.478	0.852
LOKIASV2_1322_ESMFold_hypothetical_protein	6yzh-assembly1.cif.gz_A	6yzh-assembly1.cif.gz_A Crystal structure of P8C9 bound to CK2alpha	1.236E-09	1.000	283	170	475	621	47	343	344	351	0.493	0.863
LOKIASV2_1322_ESMFold_hypothetical_protein	6cd6-assembly4.cif.gz_D	6cd6-assembly4.cif.gz_D Crystal Structure of the Human CAMKK1A in complex with GSK650394	1.033E-08	1.000	282	169	467	621	1	266	267	319	0.481	0.996
LOKIASV2_1322_ESMFold_hypothetical_protein	2fvd-assembly1.cif.gz_A	2fvd-assembly1.cif.gz_A Cyclin Dependent Kinase 2 (CDK2) with diaminopyrimidine inhibitor	2.075E-09	1.000	282	176	469	621	4	272	284	329	0.473	0.947
LOKIASV2_1322_ESMFold_hypothetical_protein	7psu-assembly2.cif.gz_B	7psu-assembly2.cif.gz_B Structure of protein kinase CK2alpha mutant K198R associated with the Okur-Chung Neurodevelopmental Syndrome	2.301E-09	1.000	282	158	476	621	26	330	332	364	0.514	0.919
LOKIASV2_1322_ESMFold_hypothetical_protein	3anq-assembly1.cif.gz_A	3anq-assembly1.cif.gz_A human DYRK1A/inhibitor complex	2.359E-10	1.000	282	163	470	621	16	340	343	380	0.496	0.948
LOKIASV2_1322_ESMFold_hypothetical_protein	7s6v-assembly1.cif.gz_A	7s6v-assembly1.cif.gz_A Leishmania infantum Glycogen Synthase Kinase 3 beta bound to CGP60474	5.990E-10	1.000	282	176	470	621	20	304	345	328	0.475	0.826
LOKIASV2_1322_ESMFold_hypothetical_protein	7o7i-assembly1.cif.gz_A	7o7i-assembly1.cif.gz_A Crystal structure of the human HIPK3 kinase domain	5.128E-10	1.000	282	163	478	621	2	361	367	403	0.509	0.981
LOKIASV2_1322_ESMFold_hypothetical_protein	2wqn-assembly1.cif.gz_A	2wqn-assembly1.cif.gz_A Structure of ADP-bound human Nek7	1.033E-08	1.000	281	176	470	621	14	255	259	306	0.475	0.934
LOKIASV2_1322_ESMFold_hypothetical_protein	4f0g-assembly1.cif.gz_A	4f0g-assembly1.cif.gz_A Crystal Structure of the Roco4 Kinase Domain from D. discoideum	7.187E-09	1.000	281	176	469	621	11	263	263	307	0.473	0.962
LOKIASV2_1322_ESMFold_hypothetical_protein	5h8g-assembly1.cif.gz_A	5h8g-assembly1.cif.gz_A Crystal structure of CK2 with compound 7b	7.368E-10	1.000	281	152	474	621	9	323	324	374	0.520	0.972
LOKIASV2_1322_ESMFold_hypothetical_protein	1q4l-assembly1.cif.gz_B	1q4l-assembly1.cif.gz_B GSK-3 Beta complexed with Inhibitor I-5	8.172E-10	1.000	281	174	479	621	20	302	337	333	0.493	0.840
LOKIASV2_1322_ESMFold_hypothetical_protein	6uip-assembly2.cif.gz_B	6uip-assembly2.cif.gz_B DYRK1A Kinase Domain in Complex with a 6-azaindole Derivative, GNF2133.	4.870E-10	1.000	281	163	467	621	14	335	338	374	0.491	0.953
LOKIASV2_1322_ESMFold_hypothetical_protein	5aik-assembly4.cif.gz_D	5aik-assembly4.cif.gz_D Human DYRK1A in complex with LDN-211898	3.056E-10	1.000	281	163	467	621	16	338	343	376	0.491	0.942
LOKIASV2_1322_ESMFold_hypothetical_protein	7o7k-assembly1.cif.gz_A	7o7k-assembly1.cif.gz_A Crystal structure of the human DYRK1A kinase domain bound to abemaciclib	6.308E-10	1.000	281	163	467	621	16	340	345	375	0.491	0.942
LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_D	3kc3-assembly5.cif.gz_D MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine	2.831E-09	1.000	280	162	485	621	6	264	269	335	0.522	0.963
LOKIASV2_1322_ESMFold_hypothetical_protein	3sw7-assembly1.cif.gz_A	3sw7-assembly1.cif.gz_A Crystal Structure of the CDK2 in complex with thiazolylpyrimidine inhibitor	3.306E-09	1.000	280	176	467	621	4	262	278	325	0.470	0.932
LOKIASV2_1322_ESMFold_hypothetical_protein	6hmr-assembly2.cif.gz_B	6hmr-assembly2.cif.gz_B Crystal structure of human Casein Kinase I delta in complex with a photoswitchable 2-Azothiazole-based inhibitor (compound 2)	5.268E-09	1.000	280	169	474	621	4	268	280	310	0.493	0.946
LOKIASV2_1322_ESMFold_hypothetical_protein	4fkq-assembly1.cif.gz_A	4fkq-assembly1.cif.gz_A Crystal structure of the cdk2 in complex with oxindole inhibitor	1.687E-09	1.000	280	176	469	621	4	271	283	328	0.473	0.947
LOKIASV2_1322_ESMFold_hypothetical_protein	5zn2-assembly1.cif.gz_A	5zn2-assembly1.cif.gz_A X-ray structure of protein kinase ck2 alpha subunit H148A mutant	2.423E-09	1.000	280	176	470	621	37	318	324	337	0.475	0.870
LOKIASV2_1322_ESMFold_hypothetical_protein	5kpl-assembly1.cif.gz_A	5kpl-assembly1.cif.gz_A Glycogen Synthase Kinase 3 beta Complexed with BRD0705	1.236E-09	1.000	280	174	463	621	19	291	340	318	0.467	0.803
LOKIASV2_1322_ESMFold_hypothetical_protein	1q41-assembly1.cif.gz_B	1q41-assembly1.cif.gz_B GSK-3 Beta complexed with Indirubin-3'-monoxime	9.063E-10	1.000	280	174	469	621	20	303	343	334	0.477	0.828
LOKIASV2_1322_ESMFold_hypothetical_protein	7zks-assembly1.cif.gz_A	7zks-assembly1.cif.gz_A SRPK1 IN COMPLEX WITH INHIBITOR	1.005E-09	1.000	280	163	470	621	4	345	348	385	0.496	0.983
LOKIASV2_1322_ESMFold_hypothetical_protein	8ahp-assembly1.cif.gz_A	8ahp-assembly1.cif.gz_A The crystal structure of the truncated form of Lotus japonicus kinase 1	2.359E-10	1.000	280	161	463	621	2	311	358	356	0.488	0.866
LOKIASV2_1322_ESMFold_hypothetical_protein	6ccf-assembly2.cif.gz_B	6ccf-assembly2.cif.gz_B Crystal Structure of the Human CAMKK1A in complex with Hesperadin	1.033E-08	1.000	279	169	467	621	1	261	262	320	0.481	0.996
LOKIASV2_1322_ESMFold_hypothetical_protein	2w5h-assembly1.cif.gz_A	2w5h-assembly1.cif.gz_A Human Nek2 kinase Apo	1.871E-09	1.000	279	176	461	621	6	253	265	294	0.461	0.936
LOKIASV2_1322_ESMFold_hypothetical_protein	1uu9-assembly1.cif.gz_A	1uu9-assembly1.cif.gz_A Structure of human PDK1 kinase domain in complex with BIM-3	4.750E-09	1.000	279	164	485	621	1	274	277	336	0.519	0.989
LOKIASV2_1322_ESMFold_hypothetical_protein	2f2c-assembly1.cif.gz_B	2f2c-assembly1.cif.gz_B X-ray structure of human CDK6-Vcyclinwith the inhibitor aminopurvalanol	6.643E-10	1.000	279	189	470	621	13	274	280	304	0.454	0.936
LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_J	3kc3-assembly5.cif.gz_J MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine	1.335E-10	1.000	279	159	484	621	3	274	288	348	0.525	0.944
LOKIASV2_1322_ESMFold_hypothetical_protein	5xv7-assembly1.cif.gz_A	5xv7-assembly1.cif.gz_A SRPK1 in complex with Alectinib	4.391E-10	1.000	279	163	470	621	4	347	350	388	0.496	0.983
LOKIASV2_1322_ESMFold_hypothetical_protein	3daj-assembly1.cif.gz_A	3daj-assembly1.cif.gz_A Crystal structure of Aurora A complexed with an inhibitor discovered through site-directed dynamic tethering	5.843E-09	1.000	278	169	470	621	2	239	245	312	0.486	0.971
LOKIASV2_1322_ESMFold_hypothetical_protein	6ccf-assembly1.cif.gz_A	6ccf-assembly1.cif.gz_A Crystal Structure of the Human CAMKK1A in complex with Hesperadin	3.306E-09	1.000	278	169	467	621	1	259	260	319	0.481	0.996
LOKIASV2_1322_ESMFold_hypothetical_protein	1ke8-assembly1.cif.gz_A	1ke8-assembly1.cif.gz_A CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE	2.831E-09	1.000	278	176	469	621	4	270	282	329	0.473	0.947
LOKIASV2_1322_ESMFold_hypothetical_protein	2jbp-assembly4.cif.gz_D	2jbp-assembly4.cif.gz_D Protein kinase MK2 in complex with an inhibitor (crystal form-2, co- crystallization)	7.760E-10	1.000	278	162	484	621	5	270	286	344	0.520	0.930
LOKIASV2_1322_ESMFold_hypothetical_protein	6yat-assembly1.cif.gz_A	6yat-assembly1.cif.gz_A Crystal structure of STK4 (MST1) in complex with compound 6	3.056E-10	1.000	278	176	478	621	13	291	291	334	0.488	0.959
LOKIASV2_1322_ESMFold_hypothetical_protein	5osm-assembly1.cif.gz_A	5osm-assembly1.cif.gz_A Cdk2(F80C, C177A) with covalent adduct at C80	8.606E-10	1.000	278	162	467	621	3	278	292	345	0.493	0.945
LOKIASV2_1322_ESMFold_hypothetical_protein	8edh-assembly1.cif.gz_A	8edh-assembly1.cif.gz_A Identification of a class of WNK isoform-specific inhibitors through high-throughput screening	6.480E-09	1.000	277	168	462	621	10	248	255	304	0.475	0.937
LOKIASV2_1322_ESMFold_hypothetical_protein	2w5b-assembly1.cif.gz_A	2w5b-assembly1.cif.gz_A Human Nek2 kinase ATPgammaS-bound	3.667E-09	1.000	277	176	461	621	6	259	271	297	0.461	0.937
LOKIASV2_1322_ESMFold_hypothetical_protein	8qlq-assembly1.cif.gz_A	8qlq-assembly1.cif.gz_A Human MST3 (STK24) kinase in complex with macrocyclic inhibitor JA310	1.371E-09	1.000	277	176	478	621	10	277	280	330	0.488	0.957
LOKIASV2_1322_ESMFold_hypothetical_protein	2rgp-assembly1.cif.gz_A	2rgp-assembly1.cif.gz_A Structure of EGFR in complex with hydrazone, a potent dual inhibitor	5.002E-09	1.000	277	168	484	621	5	268	284	330	0.510	0.930
LOKIASV2_1322_ESMFold_hypothetical_protein	2vwi-assembly1.cif.gz_D	2vwi-assembly1.cif.gz_D Structure of the OSR1 kinase, a hypertension drug target	1.174E-09	1.000	277	176	467	621	12	278	284	314	0.470	0.940
LOKIASV2_1322_ESMFold_hypothetical_protein	5d7a-assembly2.cif.gz_B	5d7a-assembly2.cif.gz_B Crystal structure of the kinase domain of TRAF2 and NCK-interacting protein kinase with NCB-0846	1.059E-09	1.000	277	176	473	621	15	285	286	330	0.480	0.948
LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_E	3kc3-assembly5.cif.gz_E MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine	1.174E-09	1.000	277	156	485	621	2	276	287	349	0.531	0.958
LOKIASV2_1322_ESMFold_hypothetical_protein	5zn3-assembly1.cif.gz_A	5zn3-assembly1.cif.gz_A X-ray structure of protein kinase ck2 alpha subunit H148S mutant	3.482E-09	1.000	277	163	470	621	29	318	324	351	0.496	0.895
LOKIASV2_1322_ESMFold_hypothetical_protein	3w8l-assembly2.cif.gz_B	3w8l-assembly2.cif.gz_B Crystal structure of human CK2 in complex with inositol hexakisphosphate	3.482E-09	1.000	277	176	475	621	36	325	326	342	0.483	0.890
LOKIASV2_1322_ESMFold_hypothetical_protein	4md9-assembly1.cif.gz_E	4md9-assembly1.cif.gz_E Crystal Structure of symmetric CK2 holoenzyme with mutated alpha subunit (F121E truncated at aa 336)	3.667E-09	1.000	277	159	482	621	24	329	329	367	0.522	0.930
LOKIASV2_1322_ESMFold_hypothetical_protein	1ias-assembly1.cif.gz_A	1ias-assembly1.cif.gz_A CYTOPLASMIC DOMAIN OF UNPHOSPHORYLATED TYPE I TGF-BETA RECEPTOR CRYSTALLIZED WITHOUT FKBP12	2.902E-10	1.000	277	176	470	621	35	326	330	339	0.475	0.885
LOKIASV2_1322_ESMFold_hypothetical_protein	5myv-assembly4.cif.gz_D	5myv-assembly4.cif.gz_D Crystal structure of SRPK2 in complex with compound 1	6.643E-10	1.000	277	163	470	621	4	348	351	387	0.496	0.983
LOKIASV2_1322_ESMFold_hypothetical_protein	3h10-assembly3.cif.gz_D	3h10-assembly3.cif.gz_D Aurora A inhibitor complex	1.871E-09	1.000	276	169	470	621	3	249	255	313	0.486	0.969
LOKIASV2_1322_ESMFold_hypothetical_protein	2phk-assembly1.cif.gz_A-2	2phk-assembly1.cif.gz_A-2 THE CRYSTAL STRUCTURE OF A PHOSPHORYLASE KINASE PEPTIDE SUBSTRATE COMPLEX: KINASE SUBSTRATE RECOGNITION	3.306E-09	1.000	276	170	460	621	1	269	277	314	0.469	0.971
LOKIASV2_1322_ESMFold_hypothetical_protein	3lfn-assembly1.cif.gz_A	3lfn-assembly1.cif.gz_A Crystal structure of CDK2 with SAR57, an aminoindazole type inhibitor	1.059E-09	1.000	276	176	467	621	4	269	285	325	0.470	0.933
LOKIASV2_1322_ESMFold_hypothetical_protein	6nfy-assembly1.cif.gz_B	6nfy-assembly1.cif.gz_B Crystal structure of nonphosphorylated, HPK1 kinase domain in complex with sunitinib in the inactive state.	4.067E-09	1.000	276	176	467	621	10	268	285	308	0.470	0.909
LOKIASV2_1322_ESMFold_hypothetical_protein	5x18-assembly2.cif.gz_B	5x18-assembly2.cif.gz_B Crystal structure of Casein kinase I homolog 1	1.521E-09	1.000	276	169	474	621	2	282	294	331	0.493	0.956
LOKIASV2_1322_ESMFold_hypothetical_protein	7akb-assembly2.cif.gz_B	7akb-assembly2.cif.gz_B Structure of DYRK1A in complex with compound 56	2.981E-09	1.000	276	163	467	621	8	329	335	371	0.491	0.961
LOKIASV2_1322_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_B	3is5-assembly1.cif.gz_B Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	1.562E-08	1.000	275	169	467	621	5	258	260	315	0.481	0.977
LOKIASV2_1322_ESMFold_hypothetical_protein	6vre-assembly2.cif.gz_B	6vre-assembly2.cif.gz_B Structure of ASK1 bound to BIO-1772961	1.059E-09	1.000	275	163	463	621	2	253	260	319	0.485	0.969
LOKIASV2_1322_ESMFold_hypothetical_protein	2bts-assembly1.cif.gz_A	2bts-assembly1.cif.gz_A STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032	3.667E-09	1.000	275	176	470	621	4	261	274	328	0.475	0.942
LOKIASV2_1322_ESMFold_hypothetical_protein	7nzy-assembly2.cif.gz_B	7nzy-assembly2.cif.gz_B Crystal structure of human Casein Kinase I delta in complex with CGS-15943	2.831E-09	1.000	275	169	474	621	2	273	286	321	0.493	0.951
LOKIASV2_1322_ESMFold_hypothetical_protein	3pj8-assembly1.cif.gz_A	3pj8-assembly1.cif.gz_A Structure of CDK2 in complex with a Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine.	2.552E-09	1.000	275	176	469	621	5	276	288	327	0.473	0.944
LOKIASV2_1322_ESMFold_hypothetical_protein	2xik-assembly1.cif.gz_A	2xik-assembly1.cif.gz_A Structure of Human YSK1 (Yeast Sps1-Ste20-related Kinase 1)	2.359E-10	1.000	275	176	474	621	18	288	289	330	0.481	0.938
LOKIASV2_1322_ESMFold_hypothetical_protein	6eiv-assembly2.cif.gz_B	6eiv-assembly2.cif.gz_B DYRK1A in complex with JWD-065	5.401E-10	1.000	275	163	467	621	17	335	340	374	0.491	0.938
LOKIASV2_1322_ESMFold_hypothetical_protein	6fad-assembly3.cif.gz_C	6fad-assembly3.cif.gz_C SR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27	4.624E-10	1.000	275	163	470	621	16	356	359	385	0.496	0.950
LOKIASV2_1322_ESMFold_hypothetical_protein	7jov-assembly4.cif.gz_G	7jov-assembly4.cif.gz_G CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	1.871E-09	1.000	275	151	475	621	51	341	388	347	0.523	0.750
LOKIASV2_1322_ESMFold_hypothetical_protein	4wot-assembly2.cif.gz_B	4wot-assembly2.cif.gz_B ROCK2 IN COMPLEX WITH 1426382-07-1	1.302E-09	1.000	275	151	485	621	52	355	394	357	0.539	0.772
LOKIASV2_1322_ESMFold_hypothetical_protein	3igo-assembly1.cif.gz_A	3igo-assembly1.cif.gz_A Crystal structure of Cryptosporidium parvum CDPK1, cgd3_920	3.482E-09	1.000	275	169	471	621	2	260	446	317	0.488	0.581
LOKIASV2_1322_ESMFold_hypothetical_protein	2w5a-assembly1.cif.gz_A	2w5a-assembly1.cif.gz_A Human Nek2 kinase ADP-bound	1.236E-09	1.000	274	176	461	621	6	255	267	296	0.461	0.936
LOKIASV2_1322_ESMFold_hypothetical_protein	4fki-assembly1.cif.gz_A	4fki-assembly1.cif.gz_A Crystal Structure of the Cdk2 in Complex with Aminopyrazole Inhibitor	1.602E-09	1.000	274	176	467	621	4	271	287	328	0.470	0.934
LOKIASV2_1322_ESMFold_hypothetical_protein	3ocb-assembly1.cif.gz_A	3ocb-assembly1.cif.gz_A Akt1 kinase domain with pyrrolopyrimidine inhibitor	2.688E-09	1.000	274	169	485	621	2	285	316	334	0.510	0.899
LOKIASV2_1322_ESMFold_hypothetical_protein	1tki-assembly1.cif.gz_A	1tki-assembly1.cif.gz_A AUTOINHIBITED SERINE KINASE DOMAIN OF THE GIANT MUSCLE PROTEIN TITIN	6.825E-09	1.000	274	176	470	621	7	260	321	311	0.475	0.791
LOKIASV2_1322_ESMFold_hypothetical_protein	3qkk-assembly1.cif.gz_A	3qkk-assembly1.cif.gz_A Spirochromane Akt Inhibitors	2.301E-09	1.000	274	176	485	621	7	285	327	326	0.499	0.853
LOKIASV2_1322_ESMFold_hypothetical_protein	4cxa-assembly2.cif.gz_A	4cxa-assembly2.cif.gz_A Crystal structure of the human CDK12-cyclin K complex bound to AMPPNP	5.401E-10	1.000	274	176	482	621	10	308	330	345	0.494	0.906
LOKIASV2_1322_ESMFold_hypothetical_protein	1q4l-assembly1.cif.gz_A	1q4l-assembly1.cif.gz_A GSK-3 Beta complexed with Inhibitor I-5	1.302E-09	1.000	274	174	479	621	20	304	342	335	0.493	0.833
LOKIASV2_1322_ESMFold_hypothetical_protein	7cga-assembly3.cif.gz_C	7cga-assembly3.cif.gz_C Crystal structure of human unphosphorylated p38gamma	1.559E-10	1.000	274	167	484	621	6	316	347	364	0.512	0.896
LOKIASV2_1322_ESMFold_hypothetical_protein	5uvc-assembly1.cif.gz_A	5uvc-assembly1.cif.gz_A Design, Synthesis, and Evaluation of the First Selective and Potent G-protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	8.172E-10	1.000	274	153	482	621	121	414	457	350	0.531	0.643
LOKIASV2_1322_ESMFold_hypothetical_protein	7wj7-assembly1.cif.gz_A	7wj7-assembly1.cif.gz_A Crystal Structure of the Kinase Domain with Adenosine of a Class III Lanthipeptide Synthetase CurKC	1.562E-08	1.000	273	176	448	621	3	237	242	287	0.440	0.971
LOKIASV2_1322_ESMFold_hypothetical_protein	7qwk-assembly1.cif.gz_A	7qwk-assembly1.cif.gz_A GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	2.981E-09	1.000	273	176	462	621	8	242	245	298	0.462	0.959
LOKIASV2_1322_ESMFold_hypothetical_protein	4bie-assembly2.cif.gz_B	4bie-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	1.871E-09	1.000	273	163	466	621	1	249	257	321	0.490	0.969
LOKIASV2_1322_ESMFold_hypothetical_protein	5jq5-assembly1.cif.gz_A	5jq5-assembly1.cif.gz_A Crystal structure of CDK2 in complex with inhibitor ICEC0942	2.981E-09	1.000	273	176	469	621	2	275	287	334	0.473	0.955
LOKIASV2_1322_ESMFold_hypothetical_protein	4ekk-assembly1.cif.gz_A	4ekk-assembly1.cif.gz_A Akt1 with AMP-PNP	2.075E-09	1.000	273	169	485	621	2	292	319	345	0.510	0.912
LOKIASV2_1322_ESMFold_hypothetical_protein	3mdy-assembly2.cif.gz_C	3mdy-assembly2.cif.gz_C Crystal structure of the cytoplasmic domain of the bone morphogenetic protein receptor type-1B (BMPR1B) in complex with FKBP12 and LDN-193189	1.059E-09	1.000	273	176	477	621	31	319	320	342	0.486	0.903
LOKIASV2_1322_ESMFold_hypothetical_protein	5zn4-assembly1.cif.gz_A	5zn4-assembly1.cif.gz_A X-ray structure of protein kinase ck2 alpha subunit H148N mutant	3.139E-09	1.000	273	163	470	621	29	321	327	352	0.496	0.896
LOKIASV2_1322_ESMFold_hypothetical_protein	7a53-assembly2.cif.gz_B	7a53-assembly2.cif.gz_B Structure of DYRK1A in complex with compound 7	4.391E-10	1.000	273	163	467	621	7	328	334	376	0.491	0.964
LOKIASV2_1322_ESMFold_hypothetical_protein	5t31-assembly1.cif.gz_A	5t31-assembly1.cif.gz_A Exploiting an Asp-Glu switch in Glycogen Synthase Kinase 3 to design paralog selective inhibitors for use in acute myeloid leukemia	2.552E-09	1.000	273	174	485	621	20	310	335	338	0.502	0.869
LOKIASV2_1322_ESMFold_hypothetical_protein	5z33-assembly1.cif.gz_A	5z33-assembly1.cif.gz_A Crystal structure of Mitogen-activated Protein Kinase Mps1 in Magnaporthe oryzae	7.955E-11	1.000	273	164	473	621	1	312	375	361	0.499	0.832
LOKIASV2_1322_ESMFold_hypothetical_protein	7jov-assembly2.cif.gz_C	7jov-assembly2.cif.gz_C CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	1.871E-09	1.000	273	151	485	621	51	352	389	357	0.539	0.776
LOKIASV2_1322_ESMFold_hypothetical_protein	5u7q-assembly3.cif.gz_C	5u7q-assembly3.cif.gz_C Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-Dihydrothieno[3,2-d]pyrimidin-4(1H)-ones	1.302E-09	1.000	273	151	485	621	51	355	390	357	0.539	0.782
LOKIASV2_1322_ESMFold_hypothetical_protein	5ezr-assembly1.cif.gz_A	5ezr-assembly1.cif.gz_A Crystal Structure of PVX_084705 bound to compound	1.970E-09	1.000	273	165	477	621	513	791	803	330	0.504	0.347
LOKIASV2_1322_ESMFold_hypothetical_protein	5knj-assembly2.cif.gz_B	5knj-assembly2.cif.gz_B Pseudokinase Domain of MLKL bound to Compound 1.	7.971E-09	1.000	272	180	468	621	16	258	259	299	0.465	0.938
LOKIASV2_1322_ESMFold_hypothetical_protein	5oop-assembly1.cif.gz_A	5oop-assembly1.cif.gz_A Structure of CHK1 10-pt. mutant complex with AMP-PNP	9.310E-09	1.000	272	176	462	621	5	249	261	298	0.462	0.939
LOKIASV2_1322_ESMFold_hypothetical_protein	7b31-assembly1.cif.gz_A	7b31-assembly1.cif.gz_A MST3 in complex with compound MRIA9	2.423E-09	1.000	272	176	478	621	11	264	265	327	0.488	0.958
LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_G	3kc3-assembly5.cif.gz_G MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine	6.153E-09	1.000	272	156	477	621	3	264	276	331	0.519	0.949
LOKIASV2_1322_ESMFold_hypothetical_protein	1ke9-assembly1.cif.gz_A	1ke9-assembly1.cif.gz_A CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4-({[AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE	4.067E-09	1.000	272	176	467	621	4	265	281	327	0.470	0.932
LOKIASV2_1322_ESMFold_hypothetical_protein	3r9o-assembly1.cif.gz_A	3r9o-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-2-143	3.667E-09	1.000	272	176	467	621	4	266	282	329	0.470	0.933
LOKIASV2_1322_ESMFold_hypothetical_protein	7sxj-assembly1.cif.gz_A	7sxj-assembly1.cif.gz_A BIO-2895 (BRD0705) bound GSK3beta-axin complex	3.862E-09	1.000	272	174	463	621	22	299	347	326	0.467	0.801
LOKIASV2_1322_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_A	7wj6-assembly1.cif.gz_A Crystal Structure of the Kinase Domain of a Class III Lanthipeptide Synthetase CurKC	2.908E-08	1.000	271	176	448	621	3	240	244	284	0.440	0.975
LOKIASV2_1322_ESMFold_hypothetical_protein	4c3p-assembly1.cif.gz_D	4c3p-assembly1.cif.gz_D Structure of dephosphorylated Aurora A (122-403) bound to TPX2 and AMPPCP	1.409E-08	1.000	271	169	468	621	4	255	260	314	0.483	0.969
LOKIASV2_1322_ESMFold_hypothetical_protein	7b32-assembly1.cif.gz_A	7b32-assembly1.cif.gz_A MST3 in complex with MRIA7	2.981E-09	1.000	271	176	478	621	11	263	264	327	0.488	0.958
LOKIASV2_1322_ESMFold_hypothetical_protein	2wma-assembly2.cif.gz_C	2wma-assembly2.cif.gz_C Structural and thermodynamic consequences of cyclization of peptide ligands for the recruitment site of cyclin A	8.841E-09	1.000	271	176	466	621	5	251	266	299	0.469	0.929
LOKIASV2_1322_ESMFold_hypothetical_protein	1v1k-assembly1.cif.gz_A	1v1k-assembly1.cif.gz_A CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR	8.841E-09	1.000	271	176	469	621	4	265	277	327	0.473	0.946
LOKIASV2_1322_ESMFold_hypothetical_protein	6q3b-assembly1.cif.gz_A	6q3b-assembly1.cif.gz_A CDK2 in complex with FragLite2	2.981E-09	1.000	271	176	469	621	4	271	283	329	0.473	0.947
LOKIASV2_1322_ESMFold_hypothetical_protein	3dak-assembly2.cif.gz_D	3dak-assembly2.cif.gz_D Crystal Structure of Domain-Swapped OSR1 kinase domain	2.075E-09	1.000	271	163	467	621	1	281	284	336	0.491	0.989
LOKIASV2_1322_ESMFold_hypothetical_protein	4btj-assembly2.cif.gz_B	4btj-assembly2.cif.gz_B TTBK1 in complex with ATP	1.825E-08	1.000	271	163	477	621	4	282	293	326	0.507	0.952
LOKIASV2_1322_ESMFold_hypothetical_protein	6ylk-assembly1.cif.gz_A	6ylk-assembly1.cif.gz_A Cdk2(F80C) with Covalent Adduct TK22 at F80C	2.981E-09	1.000	271	167	469	621	1	283	295	340	0.488	0.959
LOKIASV2_1322_ESMFold_hypothetical_protein	4cqg-assembly1.cif.gz_A	4cqg-assembly1.cif.gz_A The crystal structure of MPK38 in complex with OTSSP167, an orally- administrative MELK selective inhibitor	4.283E-09	1.000	271	176	474	621	10	248	313	309	0.481	0.764
LOKIASV2_1322_ESMFold_hypothetical_protein	6fvg-assembly1.cif.gz_A	6fvg-assembly1.cif.gz_A The Structure of CK2alpha with CCh507 bound	3.139E-09	1.000	271	170	470	621	32	321	327	346	0.485	0.887
LOKIASV2_1322_ESMFold_hypothetical_protein	6ae3-assembly2.cif.gz_D	6ae3-assembly2.cif.gz_D Crystal structure of GSK3beta complexed with Morin	1.687E-09	1.000	271	174	469	621	19	295	333	334	0.477	0.832
LOKIASV2_1322_ESMFold_hypothetical_protein	4b99-assembly1.cif.gz_A	4b99-assembly1.cif.gz_A Crystal Structure of MAPK7 (ERK5) with inhibitor	3.389E-10	1.000	271	176	484	621	9	299	335	342	0.498	0.869
LOKIASV2_1322_ESMFold_hypothetical_protein	3llt-assembly1.cif.gz_A	3llt-assembly1.cif.gz_A Crystal structure of PF14_0431, kinase domain.	3.570E-10	1.000	271	163	462	621	8	334	341	377	0.483	0.959
LOKIASV2_1322_ESMFold_hypothetical_protein	3is5-assembly1.cif.gz_E	3is5-assembly1.cif.gz_E Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	2.761E-08	1.000	270	169	463	621	5	248	252	302	0.475	0.968
LOKIASV2_1322_ESMFold_hypothetical_protein	5de2-assembly2.cif.gz_B	5de2-assembly2.cif.gz_B Structural mechanism of Nek7 activation by Nek9-induced dimerisation	7.569E-09	1.000	270	176	470	621	15	258	262	307	0.475	0.931
LOKIASV2_1322_ESMFold_hypothetical_protein	3a2c-assembly1.cif.gz_G	3a2c-assembly1.cif.gz_G Crystal structure of a pyrazolopyrimidine inhibitor complex bound to MAPKAP Kinase-2 (MK2)	4.283E-09	1.000	270	163	478	621	2	262	273	334	0.509	0.956
LOKIASV2_1322_ESMFold_hypothetical_protein	2r3m-assembly1.cif.gz_A	2r3m-assembly1.cif.gz_A Crystal Structure of Cyclin-Dependent Kinase 2 with inhibitor	5.843E-09	1.000	270	176	467	621	4	263	279	326	0.470	0.932
LOKIASV2_1322_ESMFold_hypothetical_protein	2wtk-assembly2.cif.gz_C	2wtk-assembly2.cif.gz_C Structure of the heterotrimeric LKB1-STRADalpha-MO25alpha complex	8.395E-09	1.000	270	176	462	621	3	254	285	304	0.462	0.884
LOKIASV2_1322_ESMFold_hypothetical_protein	3d0e-assembly1.cif.gz_A	3d0e-assembly1.cif.gz_A Crystal structure of human Akt2 in complex with GSK690693	2.831E-09	1.000	270	169	485	621	2	284	324	338	0.510	0.873
LOKIASV2_1322_ESMFold_hypothetical_protein	6tca-assembly2.cif.gz_C	6tca-assembly2.cif.gz_C Phosphorylated p38 and MAPKAPK2 complex with inhibitor	1.059E-09	1.000	270	162	480	621	1	282	326	343	0.514	0.865
LOKIASV2_1322_ESMFold_hypothetical_protein	7jov-assembly4.cif.gz_H	7jov-assembly4.cif.gz_H CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	2.075E-09	1.000	270	151	474	621	49	337	386	345	0.522	0.749
LOKIASV2_1322_ESMFold_hypothetical_protein	3h0z-assembly3.cif.gz_C	3h0z-assembly3.cif.gz_C Aurora A in complex with a bisanilinopyrimidine	1.733E-08	1.000	269	167	468	621	1	243	246	313	0.486	0.988
LOKIASV2_1322_ESMFold_hypothetical_protein	4kb8-assembly5.cif.gz_A	4kb8-assembly5.cif.gz_A CK1d in complex with 1-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4-YL]PYRIDIN-2-YL}-N-METHYLMETHANAMINE ligand	2.761E-08	1.000	269	169	474	621	1	253	265	309	0.493	0.955
LOKIASV2_1322_ESMFold_hypothetical_protein	1zyd-assembly1.cif.gz_A	1zyd-assembly1.cif.gz_A Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type Complexed with ATP.	1.270E-08	1.000	269	169	465	621	2	252	270	311	0.478	0.930
LOKIASV2_1322_ESMFold_hypothetical_protein	1gii-assembly1.cif.gz_A	1gii-assembly1.cif.gz_A HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR	9.805E-09	1.000	269	176	468	621	4	266	279	327	0.472	0.943
LOKIASV2_1322_ESMFold_hypothetical_protein	3sv0-assembly1.cif.gz_A	3sv0-assembly1.cif.gz_A Crystal structure of casein kinase-1 like protein in plant	1.145E-08	1.000	269	169	478	621	2	282	294	333	0.499	0.956
LOKIASV2_1322_ESMFold_hypothetical_protein	6bu6-assembly4.cif.gz_D	6bu6-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a bis-difluorophenol-aminopyridine inhibitor	1.115E-09	1.000	269	163	466	621	2	301	318	346	0.490	0.943
LOKIASV2_1322_ESMFold_hypothetical_protein	5cyz-assembly1.cif.gz_A	5cyz-assembly1.cif.gz_A Structure of S. cerevisiae Hrr25:Mam1 complex, form 1	8.841E-09	1.000	269	168	479	621	3	285	369	326	0.502	0.767
LOKIASV2_1322_ESMFold_hypothetical_protein	2j50-assembly2.cif.gz_B	2j50-assembly2.cif.gz_B Structure of Aurora-2 in complex with PHA-739358	6.153E-09	1.000	268	169	470	621	1	243	249	313	0.486	0.976
LOKIASV2_1322_ESMFold_hypothetical_protein	5knj-assembly1.cif.gz_A	5knj-assembly1.cif.gz_A Pseudokinase Domain of MLKL bound to Compound 1.	1.733E-08	1.000	268	180	467	621	15	251	252	298	0.464	0.940
LOKIASV2_1322_ESMFold_hypothetical_protein	5one-assembly1.cif.gz_A	5one-assembly1.cif.gz_A Crystal structure of Aurora-A in complex with FMF-03-145-1 (compound 2)	9.310E-09	1.000	268	169	468	621	2	251	257	315	0.483	0.973
LOKIASV2_1322_ESMFold_hypothetical_protein	5oq5-assembly1.cif.gz_A	5oq5-assembly1.cif.gz_A Structure of CHK1 8-pt. mutant complex with aminopyrimido-benzodiazepinone LRRK2 inhibitor	1.338E-08	1.000	268	176	462	621	7	254	265	297	0.462	0.936
LOKIASV2_1322_ESMFold_hypothetical_protein	2w05-assembly1.cif.gz_A	2w05-assembly1.cif.gz_A Structure of CDK2 in complex with an imidazolyl pyrimidine, compound 5b	7.971E-09	1.000	268	176	470	621	4	263	276	328	0.475	0.942
LOKIASV2_1322_ESMFold_hypothetical_protein	5uu1-assembly1.cif.gz_A	5uu1-assembly1.cif.gz_A Crystal Structure of Human Vaccinia-related kinase 2 (VRK-2) bound to BI-D1870	9.063E-10	1.000	268	164	467	621	3	301	315	343	0.490	0.949
LOKIASV2_1322_ESMFold_hypothetical_protein	1j91-assembly1.cif.gz_A	1j91-assembly1.cif.gz_A Crystal structure of Z. mays CK2 kinase alpha subunit in complex with the ATP-competitive inhibitor 4,5,6,7-tetrabromobenzotriazole	5.843E-09	1.000	268	152	478	621	5	326	327	379	0.527	0.985
LOKIASV2_1322_ESMFold_hypothetical_protein	2b9f-assembly1.cif.gz_A	2b9f-assembly1.cif.gz_A Crystal structure of non-phosphorylated Fus3	1.918E-10	1.000	268	163	483	621	1	302	337	367	0.517	0.896
LOKIASV2_1322_ESMFold_hypothetical_protein	7zkx-assembly1.cif.gz_A	7zkx-assembly1.cif.gz_A SRPK2 IN COMPLEX WITH INHIBITOR	9.805E-09	1.000	268	163	466	621	2	338	339	380	0.490	0.994
LOKIASV2_1322_ESMFold_hypothetical_protein	2xnm-assembly1.cif.gz_A	2xnm-assembly1.cif.gz_A Structure of NEK2 bound to CCT	4.067E-09	1.000	267	176	461	621	6	246	258	296	0.461	0.934
LOKIASV2_1322_ESMFold_hypothetical_protein	4bic-assembly2.cif.gz_B	4bic-assembly2.cif.gz_B Crystal Structures of Ask1-inhibitor Complexes	5.843E-09	1.000	267	163	470	621	1	255	259	326	0.496	0.985
LOKIASV2_1322_ESMFold_hypothetical_protein	2vwi-assembly1.cif.gz_C	2vwi-assembly1.cif.gz_C Structure of the OSR1 kinase, a hypertension drug target	3.667E-09	1.000	267	176	463	621	9	265	270	301	0.464	0.952
LOKIASV2_1322_ESMFold_hypothetical_protein	1h08-assembly1.cif.gz_A	1h08-assembly1.cif.gz_A CDK2 in complex with a disubstituted 2, 4-bis anilino pyrimidine CDK4 inhibitor	3.862E-09	1.000	267	176	467	621	4	267	283	325	0.470	0.933
LOKIASV2_1322_ESMFold_hypothetical_protein	3unk-assembly1.cif.gz_A	3unk-assembly1.cif.gz_A CDK2 in complex with inhibitor YL5-083	2.981E-09	1.000	267	176	469	621	4	283	295	329	0.473	0.949
LOKIASV2_1322_ESMFold_hypothetical_protein	6s1b-assembly1.cif.gz_A	6s1b-assembly1.cif.gz_A Crystal Structure of DYRK1A with small molecule inhibitor	7.760E-10	1.000	267	163	467	621	15	332	338	373	0.491	0.941
LOKIASV2_1322_ESMFold_hypothetical_protein	4fr4-assembly3.cif.gz_C	4fr4-assembly3.cif.gz_C Crystal structure of human serine/threonine-protein kinase 32A (YANK1)	6.996E-10	1.000	267	165	486	621	1	289	344	343	0.519	0.840
LOKIASV2_1322_ESMFold_hypothetical_protein	3vud-assembly1.cif.gz_A	3vud-assembly1.cif.gz_A Crystal structure of a cysteine-deficient mutant M1 in MAP kinase JNK1	2.755E-10	1.000	267	164	474	621	1	320	355	370	0.501	0.901
LOKIASV2_1322_ESMFold_hypothetical_protein	1gij-assembly1.cif.gz_A	1gij-assembly1.cif.gz_A HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR	5.268E-09	1.000	266	176	468	621	4	260	273	328	0.472	0.941
LOKIASV2_1322_ESMFold_hypothetical_protein	5fqd-assembly1.cif.gz_C	5fqd-assembly1.cif.gz_C Structural basis of Lenalidomide induced CK1a degradation by the crl4crbn ubiquitin ligase	4.067E-09	1.000	266	169	474	621	2	280	294	326	0.493	0.949
LOKIASV2_1322_ESMFold_hypothetical_protein	3rpv-assembly1.cif.gz_A	3rpv-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-2-88	6.153E-09	1.000	266	176	467	621	4	278	294	333	0.470	0.935
LOKIASV2_1322_ESMFold_hypothetical_protein	4tyh-assembly1.cif.gz_A	4tyh-assembly1.cif.gz_A Ternary complex of P38 and MK2 with a P38 inhibitor	9.545E-10	1.000	266	162	476	621	1	268	339	331	0.507	0.791
LOKIASV2_1322_ESMFold_hypothetical_protein	7z5n-assembly2.cif.gz_B	7z5n-assembly2.cif.gz_B Crystal structure of DYRK1A in complex with CX-4945	3.306E-09	1.000	266	163	467	621	15	338	343	379	0.491	0.945
LOKIASV2_1322_ESMFold_hypothetical_protein	6tca-assembly1.cif.gz_A	6tca-assembly1.cif.gz_A Phosphorylated p38 and MAPKAPK2 complex with inhibitor	2.359E-10	1.000	266	162	485	621	1	280	345	344	0.522	0.812
LOKIASV2_1322_ESMFold_hypothetical_protein	5myv-assembly1.cif.gz_A	5myv-assembly1.cif.gz_A Crystal structure of SRPK2 in complex with compound 1	1.115E-09	1.000	266	163	469	621	4	345	352	387	0.494	0.972
LOKIASV2_1322_ESMFold_hypothetical_protein	4b0g-assembly1.cif.gz_A	4b0g-assembly1.cif.gz_A Complex of Aurora-A bound to an Imidazopyridine-based inhibitor	3.396E-08	1.000	265	169	468	621	3	241	247	313	0.483	0.968
LOKIASV2_1322_ESMFold_hypothetical_protein	2cn5-assembly1.cif.gz_A-2	2cn5-assembly1.cif.gz_A-2 Crystal structure of human Chk2 in complex with ADP	3.139E-09	1.000	265	176	482	621	13	283	283	328	0.494	0.958
LOKIASV2_1322_ESMFold_hypothetical_protein	6yl6-assembly1.cif.gz_A	6yl6-assembly1.cif.gz_A Cdk2(F80C)	2.075E-09	1.000	265	176	466	621	9	286	303	331	0.469	0.917
LOKIASV2_1322_ESMFold_hypothetical_protein	8buc-assembly1.cif.gz_B	8buc-assembly1.cif.gz_B Structure of DDB1 bound to dCeMM3-engaged CDK12-cyclin K	3.306E-09	1.000	265	176	467	621	13	302	327	336	0.470	0.887
LOKIASV2_1322_ESMFold_hypothetical_protein	5vhb-assembly1.cif.gz_A	5vhb-assembly1.cif.gz_A Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based inhibitor	1.871E-09	1.000	265	154	473	621	7	292	328	346	0.515	0.872
LOKIASV2_1322_ESMFold_hypothetical_protein	6l23-assembly1.cif.gz_A	6l23-assembly1.cif.gz_A Crystal structure of CK2a1 V116I with hematein	6.480E-09	1.000	265	176	479	621	38	333	334	350	0.490	0.886
LOKIASV2_1322_ESMFold_hypothetical_protein	7jnt-assembly2.cif.gz_C	7jnt-assembly2.cif.gz_C CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	6.480E-09	1.000	265	151	475	621	51	338	386	343	0.523	0.746
LOKIASV2_1322_ESMFold_hypothetical_protein	4wot-assembly2.cif.gz_D	4wot-assembly2.cif.gz_D ROCK2 IN COMPLEX WITH 1426382-07-1	3.862E-09	1.000	265	151	475	621	51	342	389	350	0.523	0.751
LOKIASV2_1322_ESMFold_hypothetical_protein	3ma6-assembly2.cif.gz_B	3ma6-assembly2.cif.gz_B Crystal structure of kinase domain of TgCDPK1 in presence of 3BrB-PP1	6.825E-09	1.000	264	176	470	621	6	265	266	321	0.475	0.977
LOKIASV2_1322_ESMFold_hypothetical_protein	7m2f-assembly1.cif.gz_A	7m2f-assembly1.cif.gz_A CDK2 with compound 14 inhibitor with carboxylate	3.862E-09	1.000	264	176	469	621	4	269	281	331	0.473	0.947
LOKIASV2_1322_ESMFold_hypothetical_protein	1di8-assembly1.cif.gz_A	1di8-assembly1.cif.gz_A THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4-[3-HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE	2.831E-09	1.000	264	176	469	621	4	271	283	333	0.473	0.947
LOKIASV2_1322_ESMFold_hypothetical_protein	5iey-assembly1.cif.gz_A	5iey-assembly1.cif.gz_A Crystal structure of a CDK inhibitor bound to CDK2	5.843E-09	1.000	264	176	470	621	4	273	286	333	0.475	0.944
LOKIASV2_1322_ESMFold_hypothetical_protein	6b3e-assembly2.cif.gz_C	6b3e-assembly2.cif.gz_C Crystal structure of human CDK12/CyclinK in complex with an inhibitor	4.283E-09	1.000	264	176	469	621	9	287	308	328	0.473	0.906
LOKIASV2_1322_ESMFold_hypothetical_protein	6dd4-assembly4.cif.gz_D	6dd4-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropyl-dihydropteridine inhibitor	5.268E-09	1.000	264	163	466	621	2	294	311	335	0.490	0.942
LOKIASV2_1322_ESMFold_hypothetical_protein	6gih-assembly1.cif.gz_A	6gih-assembly1.cif.gz_A Crystal Structure of CK2alpha with CAM187 bound	3.139E-09	1.000	264	163	470	621	29	318	324	354	0.496	0.895
LOKIASV2_1322_ESMFold_hypothetical_protein	5n3b-assembly1.cif.gz_A	5n3b-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 2-(pyridin-3-yl)ethanamine	1.970E-09	1.000	264	164	476	621	30	304	346	336	0.504	0.795
LOKIASV2_1322_ESMFold_hypothetical_protein	7p7g-assembly2.cif.gz_B	7p7g-assembly2.cif.gz_B Crystal structure of phosphorylated pT220 Casein Kinase I delta (CK1d), conformation 2 and 3	1.825E-08	1.000	263	176	474	621	3	273	283	316	0.481	0.958
LOKIASV2_1322_ESMFold_hypothetical_protein	5okt-assembly1.cif.gz_A	5okt-assembly1.cif.gz_A Crystal structure of human Casein Kinase I delta in complex with IWP-2	8.395E-09	1.000	263	176	474	621	6	273	286	318	0.481	0.937
LOKIASV2_1322_ESMFold_hypothetical_protein	1xkk-assembly1.cif.gz_A	1xkk-assembly1.cif.gz_A EGFR kinase domain complexed with a quinazoline inhibitor- GW572016	3.225E-08	1.000	263	168	470	621	5	255	289	319	0.488	0.869
LOKIASV2_1322_ESMFold_hypothetical_protein	1g3n-assembly1.cif.gz_A	1g3n-assembly1.cif.gz_A STRUCTURE OF A P18(INK4C)-CDK6-K-CYCLIN TERNARY COMPLEX	1.871E-09	1.000	263	176	467	621	5	288	293	331	0.470	0.969
LOKIASV2_1322_ESMFold_hypothetical_protein	6una-assembly2.cif.gz_B	6una-assembly2.cif.gz_B Crystal structure of inactive p38gamma	5.128E-10	1.000	263	162	485	621	2	302	331	365	0.522	0.909
LOKIASV2_1322_ESMFold_hypothetical_protein	2oza-assembly1.cif.gz_A	2oza-assembly1.cif.gz_A Structure of p38alpha complex	2.688E-09	1.000	263	162	476	621	1	271	332	331	0.507	0.816
LOKIASV2_1322_ESMFold_hypothetical_protein	6a1c-assembly1.cif.gz_A	6a1c-assembly1.cif.gz_A Crystal structure of the CK2a1-go289 complex	5.548E-09	1.000	263	176	479	621	38	333	334	350	0.490	0.886
LOKIASV2_1322_ESMFold_hypothetical_protein	7pqs-assembly2.cif.gz_B	7pqs-assembly2.cif.gz_B SRPK1 in complex with MSC2711186	1.005E-09	1.000	263	163	470	621	5	348	351	388	0.496	0.980
LOKIASV2_1322_ESMFold_hypothetical_protein	1q8y-assembly2.cif.gz_B	1q8y-assembly2.cif.gz_B The structure of the yeast SR protein kinase, Sky1p, with bound ADP	3.306E-09	1.000	263	163	461	621	2	262	357	314	0.481	0.731
LOKIASV2_1322_ESMFold_hypothetical_protein	5u7q-assembly6.cif.gz_D-3	5u7q-assembly6.cif.gz_D-3 Identification of A New Class of Potent Cdc7 Inhibitors Designed by Putative Pharmacophore Model: Synthesis and Biological Evaluation of 2,3-Dihydrothieno[3,2-d]pyrimidin-4(1H)-ones	4.510E-09	1.000	263	151	485	621	47	348	383	358	0.539	0.789
LOKIASV2_1322_ESMFold_hypothetical_protein	4uyn-assembly1.cif.gz_A	4uyn-assembly1.cif.gz_A SAR156497 an exquisitely selective inhibitor of Aurora kinases	2.364E-08	1.000	262	163	468	621	1	243	249	322	0.493	0.976
LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_C	3kc3-assembly5.cif.gz_C MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine	2.552E-09	1.000	262	160	485	621	5	270	281	341	0.525	0.947
LOKIASV2_1322_ESMFold_hypothetical_protein	5oo3-assembly1.cif.gz_A	5oo3-assembly1.cif.gz_A Cdk2(F80C, C177A) with covalent ligand at F80C	3.306E-09	1.000	262	176	469	621	3	278	286	330	0.473	0.965
LOKIASV2_1322_ESMFold_hypothetical_protein	1bl6-assembly1.cif.gz_A	1bl6-assembly1.cif.gz_A THE COMPLEX STRUCTURE OF THE MAP KINASE P38/SB216995	7.554E-11	1.000	262	163	484	621	2	315	351	365	0.519	0.895
LOKIASV2_1322_ESMFold_hypothetical_protein	6sgk-assembly1.cif.gz_A	6sgk-assembly1.cif.gz_A Nek2 kinase bound to inhibitor 102	7.971E-09	1.000	261	176	461	621	6	235	247	297	0.461	0.931
LOKIASV2_1322_ESMFold_hypothetical_protein	6c2t-assembly1.cif.gz_A-2	6c2t-assembly1.cif.gz_A-2 Aurora A ligand complex	5.548E-09	1.000	261	169	468	621	1	250	253	312	0.483	0.988
LOKIASV2_1322_ESMFold_hypothetical_protein	6vc0-assembly1.cif.gz_A	6vc0-assembly1.cif.gz_A Crystal structure of the horse MLKL pseudokinase domain	2.024E-08	1.000	261	176	467	621	10	270	272	305	0.470	0.960
LOKIASV2_1322_ESMFold_hypothetical_protein	8p7j-assembly2.cif.gz_B	8p7j-assembly2.cif.gz_B Crystal structure of MAP2K6 with a covalent compound GCL96	6.825E-09	1.000	261	169	469	621	4	274	279	327	0.485	0.971
LOKIASV2_1322_ESMFold_hypothetical_protein	1buh-assembly1.cif.gz_A	1buh-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITH CELL CYCLE-REGULATORY PROTEIN CKSHS1	5.548E-09	1.000	261	171	467	621	4	275	287	333	0.478	0.948
LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_H	3kc3-assembly5.cif.gz_H MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine	1.871E-09	1.000	261	162	485	621	4	274	290	347	0.522	0.934
LOKIASV2_1322_ESMFold_hypothetical_protein	4dgl-assembly1.cif.gz_D	4dgl-assembly1.cif.gz_D Crystal Structure of the CK2 Tetrameric Holoenzyme	6.825E-09	1.000	261	158	482	621	25	328	328	369	0.523	0.927
LOKIASV2_1322_ESMFold_hypothetical_protein	3f88-assembly2.cif.gz_B	3f88-assembly2.cif.gz_B glycogen synthase Kinase 3beta inhibitor complex	7.569E-09	1.000	261	174	463	621	20	293	341	325	0.467	0.804
LOKIASV2_1322_ESMFold_hypothetical_protein	4xhg-assembly1.cif.gz_A	4xhg-assembly1.cif.gz_A Structure of C. glabrata Hrr25 bound to ADP (formate condition)	8.395E-09	1.000	261	169	478	621	2	282	357	332	0.499	0.787
LOKIASV2_1322_ESMFold_hypothetical_protein	7jov-assembly3.cif.gz_E	7jov-assembly3.cif.gz_E CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	4.510E-09	1.000	261	151	485	621	51	351	385	356	0.539	0.782
LOKIASV2_1322_ESMFold_hypothetical_protein	4yuq-assembly1.cif.gz_A	4yuq-assembly1.cif.gz_A CDPK1 from Eimeria tenella in complex with inhibitor UW1354	4.067E-09	1.000	261	169	467	621	15	271	462	309	0.481	0.556
LOKIASV2_1322_ESMFold_hypothetical_protein	6oyt-assembly1.cif.gz_A	6oyt-assembly1.cif.gz_A ASK1 kinase domain in complex with GS-4997	2.622E-08	1.000	260	160	463	621	2	216	222	309	0.490	0.968
LOKIASV2_1322_ESMFold_hypothetical_protein	7qwk-assembly4.cif.gz_D	7qwk-assembly4.cif.gz_D GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	7.569E-09	1.000	260	176	462	621	8	246	254	302	0.462	0.941
LOKIASV2_1322_ESMFold_hypothetical_protein	2wtv-assembly2.cif.gz_B	2wtv-assembly2.cif.gz_B Aurora-A Inhibitor Structure	7.569E-09	1.000	260	169	470	621	3	257	264	314	0.486	0.966
LOKIASV2_1322_ESMFold_hypothetical_protein	3le6-assembly1.cif.gz_A	3le6-assembly1.cif.gz_A The structure of cyclin dependent kinase 2 (CKD2) with a pyrazolobenzodiazepine inhibitor	7.569E-09	1.000	260	176	470	621	4	274	283	329	0.475	0.958
LOKIASV2_1322_ESMFold_hypothetical_protein	2ycf-assembly1.cif.gz_A	2ycf-assembly1.cif.gz_A Crystal Structure of Checkpoint Kinase 2 in complex with Inhibitor PV1531	1.115E-09	1.000	260	176	485	621	11	282	286	334	0.499	0.951
LOKIASV2_1322_ESMFold_hypothetical_protein	3g33-assembly1.cif.gz_C	3g33-assembly1.cif.gz_C Crystal structure of CDK4/cyclin D3	1.087E-08	1.000	260	176	470	621	2	290	291	332	0.475	0.993
LOKIASV2_1322_ESMFold_hypothetical_protein	6rcg-assembly1.cif.gz_A	6rcg-assembly1.cif.gz_A Crystal structure of Casein kinase 1 delta (CK1 delta) complexed with SR3029 inhibitor	1.645E-08	1.000	260	163	474	621	2	283	295	331	0.502	0.956
LOKIASV2_1322_ESMFold_hypothetical_protein	5clp-assembly1.cif.gz_A	5clp-assembly1.cif.gz_A Crystal Structure of CK2alpha with 3,4-dichlorophenethylamine bound	7.569E-09	1.000	260	176	470	621	37	316	322	339	0.475	0.870
LOKIASV2_1322_ESMFold_hypothetical_protein	5my8-assembly1.cif.gz_A	5my8-assembly1.cif.gz_A Crystal structure of SRPK1 in complex with SPHINX31	1.005E-09	1.000	260	163	470	621	7	352	355	397	0.496	0.975
LOKIASV2_1322_ESMFold_hypothetical_protein	5o2c-assembly1.cif.gz_A	5o2c-assembly1.cif.gz_A Crystal structure of WNK3 kinase and CCT1 didomain in a unphosphorylated state	1.776E-09	1.000	260	176	491	621	18	287	368	327	0.509	0.734
LOKIASV2_1322_ESMFold_hypothetical_protein	5uzj-assembly1.cif.gz_B	5uzj-assembly1.cif.gz_B Crystal Structure of ROCK1 bound to an aminopyridine inhibitor	4.283E-09	1.000	260	151	485	621	53	351	386	355	0.539	0.775
LOKIASV2_1322_ESMFold_hypothetical_protein	1zyc-assembly2.cif.gz_C	1zyc-assembly2.cif.gz_C Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type in Apo Form.	2.024E-08	1.000	259	169	465	621	2	254	271	312	0.478	0.934
LOKIASV2_1322_ESMFold_hypothetical_protein	3a2c-assembly1.cif.gz_C	3a2c-assembly1.cif.gz_C Crystal structure of a pyrazolopyrimidine inhibitor complex bound to MAPKAP Kinase-2 (MK2)	8.841E-09	1.000	259	163	484	621	2	265	273	334	0.519	0.967
LOKIASV2_1322_ESMFold_hypothetical_protein	3dak-assembly3.cif.gz_C	3dak-assembly3.cif.gz_C Crystal Structure of Domain-Swapped OSR1 kinase domain	3.862E-09	1.000	259	176	467	621	11	278	281	317	0.470	0.954
LOKIASV2_1322_ESMFold_hypothetical_protein	7nzy-assembly4.cif.gz_D	7nzy-assembly4.cif.gz_D Crystal structure of human Casein Kinase I delta in complex with CGS-15943	1.562E-08	1.000	259	169	474	621	1	272	285	317	0.493	0.954
LOKIASV2_1322_ESMFold_hypothetical_protein	7p7f-assembly3.cif.gz_C	7p7f-assembly3.cif.gz_C Crystal structure of phosphorylated pT220 Casein Kinase I delta (CK1d), conformation 1	2.131E-08	1.000	259	176	474	621	6	272	285	314	0.481	0.937
LOKIASV2_1322_ESMFold_hypothetical_protein	2wnt-assembly1.cif.gz_B	2wnt-assembly1.cif.gz_B Crystal Structure of the Human Ribosomal protein S6 kinase	5.548E-09	1.000	259	176	470	621	4	250	285	320	0.475	0.867
LOKIASV2_1322_ESMFold_hypothetical_protein	3kc3-assembly5.cif.gz_I	3kc3-assembly5.cif.gz_I MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine	4.510E-09	1.000	259	163	485	621	5	273	295	338	0.520	0.912
LOKIASV2_1322_ESMFold_hypothetical_protein	5n1m-assembly1.cif.gz_A	5n1m-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule (5-chloro-2-methoxyphenyl)methanamine	2.075E-09	1.000	259	151	476	621	17	309	351	356	0.525	0.835
LOKIASV2_1322_ESMFold_hypothetical_protein	4l6q-assembly1.cif.gz_A	4l6q-assembly1.cif.gz_A ROCK2 in complex with benzoxaborole	5.002E-09	1.000	259	151	485	621	47	351	388	363	0.539	0.786
LOKIASV2_1322_ESMFold_hypothetical_protein	5bml-assembly1.cif.gz_B	5bml-assembly1.cif.gz_B ROCK 1 bound to a pyridine thiazole inhibitor	6.480E-09	1.000	259	151	485	621	53	357	395	356	0.539	0.772
LOKIASV2_1322_ESMFold_hypothetical_protein	3dbe-assembly1.cif.gz_A	3dbe-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with Compound 557	1.145E-08	1.000	258	163	486	621	1	277	284	342	0.522	0.975
LOKIASV2_1322_ESMFold_hypothetical_protein	5ouu-assembly1.cif.gz_A	5ouu-assembly1.cif.gz_A The crystal structure of CK2alpha in complex with compound 22	6.825E-09	1.000	258	150	470	621	8	319	324	372	0.517	0.963
LOKIASV2_1322_ESMFold_hypothetical_protein	4wbo-assembly2.cif.gz_B	4wbo-assembly2.cif.gz_B Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	3.862E-09	1.000	258	176	482	621	158	440	495	327	0.494	0.572
LOKIASV2_1322_ESMFold_hypothetical_protein	7wj6-assembly1.cif.gz_B	7wj6-assembly1.cif.gz_B Crystal Structure of the Kinase Domain of a Class III Lanthipeptide Synthetase CurKC	4.633E-08	1.000	257	176	448	621	5	237	241	285	0.440	0.967
LOKIASV2_1322_ESMFold_hypothetical_protein	4kb8-assembly3.cif.gz_C	4kb8-assembly3.cif.gz_C CK1d in complex with 1-{4-[3-(4-FLUOROPHENYL)-1-METHYL-1H-PYRAZOL-4-YL]PYRIDIN-2-YL}-N-METHYLMETHANAMINE ligand	1.145E-08	1.000	257	176	474	621	3	265	277	317	0.481	0.949
LOKIASV2_1322_ESMFold_hypothetical_protein	1oir-assembly1.cif.gz_A	1oir-assembly1.cif.gz_A Imidazopyridines: a potent and selective class of Cyclin-dependent Kinase inhibitors identified through Structure-based hybridisation	2.423E-09	1.000	257	176	467	621	4	273	287	331	0.470	0.941
LOKIASV2_1322_ESMFold_hypothetical_protein	3v04-assembly1.cif.gz_A	3v04-assembly1.cif.gz_A Discovery of Novel Allosteric MEK Inhibitors Possessing Classical and Non-classical Bidentate Ser212 Interactions.	2.423E-09	1.000	257	169	479	621	3	288	289	344	0.501	0.990
LOKIASV2_1322_ESMFold_hypothetical_protein	3s0o-assembly1.cif.gz_A	3s0o-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-1-138	7.971E-09	1.000	257	176	469	621	4	281	293	333	0.473	0.949
LOKIASV2_1322_ESMFold_hypothetical_protein	6tca-assembly3.cif.gz_E	6tca-assembly3.cif.gz_E Phosphorylated p38 and MAPKAPK2 complex with inhibitor	2.185E-09	1.000	257	162	479	621	1	264	327	333	0.512	0.807
LOKIASV2_1322_ESMFold_hypothetical_protein	1rdq-assembly1.cif.gz_E	1rdq-assembly1.cif.gz_E Hydrolysis of ATP in the crystal of Y204A mutant of cAMP-dependent protein kinase	3.482E-09	1.000	257	154	482	621	16	293	342	349	0.530	0.813
LOKIASV2_1322_ESMFold_hypothetical_protein	2vo0-assembly1.cif.gz_A	2vo0-assembly1.cif.gz_A Structure of PKA-PKB chimera complexed with C-(4-(4-Chlorophenyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidin-4-yl)methylamine	4.283E-09	1.000	257	146	470	621	4	302	343	355	0.523	0.872
LOKIASV2_1322_ESMFold_hypothetical_protein	3nie-assembly3.cif.gz_A	3nie-assembly3.cif.gz_A Crystal Structure of PF11_0147	5.990E-10	1.000	257	154	470	621	5	315	369	379	0.510	0.843
LOKIASV2_1322_ESMFold_hypothetical_protein	7jnt-assembly1.cif.gz_B	7jnt-assembly1.cif.gz_B CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	5.002E-09	1.000	257	151	485	621	51	341	376	355	0.539	0.774
LOKIASV2_1322_ESMFold_hypothetical_protein	3mwu-assembly1.cif.gz_A	3mwu-assembly1.cif.gz_A Activated Calcium-Dependent Protein Kinase 1 from Cryptosporidium parvum (CpCDPK1) in complex with bumped kinase inhibitor RM-1-95	3.862E-09	1.000	257	176	481	621	11	284	447	328	0.493	0.613
LOKIASV2_1322_ESMFold_hypothetical_protein	1muo-assembly1.cif.gz_A	1muo-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AURORA-2, AN ONCOGENIC SERINE-THREONINE KINASE	1.645E-08	1.000	256	169	461	621	1	242	251	301	0.472	0.964
LOKIASV2_1322_ESMFold_hypothetical_protein	6vpm-assembly1.cif.gz_B	6vpm-assembly1.cif.gz_B TPX2 residues 7-20 fused to Aurora A residues 116-389 with C290 disulfide bonded to compound 8-34, and in complex with AMP-PNP	5.548E-09	1.000	256	169	469	621	20	271	277	314	0.485	0.910
LOKIASV2_1322_ESMFold_hypothetical_protein	7vto-assembly2.cif.gz_B	7vto-assembly2.cif.gz_B The crystal structure of PAK1 with the inhibitor GW8510	7.569E-09	1.000	256	180	481	621	20	278	278	322	0.486	0.932
LOKIASV2_1322_ESMFold_hypothetical_protein	7egb-assembly1.cif.gz_8	7egb-assembly1.cif.gz_8 TFIID-based holo PIC on SCP promoter	6.480E-09	1.000	256	176	467	621	3	277	298	326	0.470	0.923
LOKIASV2_1322_ESMFold_hypothetical_protein	2xh5-assembly1.cif.gz_A	2xh5-assembly1.cif.gz_A Structure of 4-(4-tert-Butylbenzyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4- yl)piperidin-4-amine bound to PKB	1.922E-08	1.000	256	169	470	621	2	263	317	312	0.486	0.826
LOKIASV2_1322_ESMFold_hypothetical_protein	4wua-assembly1.cif.gz_A	4wua-assembly1.cif.gz_A Crystal structure of human SRPK1 complexed to an inhibitor SRPIN340	3.139E-09	1.000	256	163	470	621	2	341	344	390	0.496	0.988
LOKIASV2_1322_ESMFold_hypothetical_protein	6ed6-assembly2.cif.gz_B	6ed6-assembly2.cif.gz_B Crystal structure of Rock2 with a pyridinylbenzamide based inhibitor	6.153E-09	1.000	256	151	485	621	46	331	364	351	0.539	0.786
LOKIASV2_1322_ESMFold_hypothetical_protein	4yga-assembly4.cif.gz_G	4yga-assembly4.cif.gz_G CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	6.480E-09	1.000	256	169	484	621	1	283	447	336	0.509	0.633
LOKIASV2_1322_ESMFold_hypothetical_protein	2w96-assembly1.cif.gz_B	2w96-assembly1.cif.gz_B Crystal Structure of CDK4 in complex with a D-type cyclin	3.767E-08	1.000	255	176	470	621	3	266	267	311	0.475	0.989
LOKIASV2_1322_ESMFold_hypothetical_protein	5mqv-assembly6.cif.gz_F	5mqv-assembly6.cif.gz_F Crystal structure of human Casein Kinase I delta in complex with 4-(2,5-Dimethoxyphenyl)-N-(4-(5-(4-fluorphenyl)-2-(methylthio)-1H-imidazol-4-yl)-pyridin-2-yl)-1-methyl-1H-pyrrole-2-carboxamide	1.338E-08	1.000	255	176	482	621	3	277	286	323	0.494	0.962
LOKIASV2_1322_ESMFold_hypothetical_protein	3uyt-assembly6.cif.gz_C	3uyt-assembly6.cif.gz_C crystal structure of ck1d with PF670462 from P1 crystal form	8.841E-09	1.000	255	176	482	621	6	277	286	328	0.494	0.951
LOKIASV2_1322_ESMFold_hypothetical_protein	2yir-assembly1.cif.gz_A	2yir-assembly1.cif.gz_A Structural analysis of checkpoint kinase 2 in complex with inhibitor PV1352	1.521E-09	1.000	255	176	485	621	11	283	286	335	0.499	0.955
LOKIASV2_1322_ESMFold_hypothetical_protein	7b3m-assembly2.cif.gz_B	7b3m-assembly2.cif.gz_B MEK1 in complex with compound 6	6.825E-09	1.000	255	151	474	621	12	297	299	350	0.522	0.957
LOKIASV2_1322_ESMFold_hypothetical_protein	5es1-assembly1.cif.gz_A	5es1-assembly1.cif.gz_A CRYSTAL STRUCTURE OF MICROTUBULE AFFINITY-REGULATING KINASE 4 CATALYTIC DOMAIN IN COMPLEX WITH A PYRAZOLOPYRIMIDINE INHIBITOR	1.825E-08	1.000	255	176	468	621	6	248	304	307	0.472	0.799
LOKIASV2_1322_ESMFold_hypothetical_protein	6buu-assembly1.cif.gz_A	6buu-assembly1.cif.gz_A Crystal structure of AKT1 (aa 144-480) with a bisubstrate	1.825E-08	1.000	255	176	485	621	7	285	323	326	0.499	0.864
LOKIASV2_1322_ESMFold_hypothetical_protein	5czo-assembly1.cif.gz_A	5czo-assembly1.cif.gz_A Structure of S. cerevisiae Hrr25:Mam1 complex, form 2	3.862E-09	1.000	255	168	479	621	3	283	374	328	0.502	0.751
LOKIASV2_1322_ESMFold_hypothetical_protein	3tv7-assembly1.cif.gz_A	3tv7-assembly1.cif.gz_A Human Rho-associated protein kinase 1 (ROCK 1) in COMPLEX WITH RKI1342	5.002E-09	1.000	255	151	485	621	49	353	394	360	0.539	0.774
LOKIASV2_1322_ESMFold_hypothetical_protein	4mvf-assembly1.cif.gz_A	4mvf-assembly1.cif.gz_A Crystal Structure of Plasmodium falciparum CDPK2 complexed with inhibitor staurosporine	6.825E-09	1.000	255	163	483	621	1	240	408	323	0.517	0.588
LOKIASV2_1322_ESMFold_hypothetical_protein	3efw-assembly1.cif.gz_A	3efw-assembly1.cif.gz_A Structure of AuroraA with pyridyl-pyrimidine urea inhibitor	5.412E-08	1.000	254	169	468	621	3	237	240	311	0.483	0.979
LOKIASV2_1322_ESMFold_hypothetical_protein	7wj7-assembly1.cif.gz_B	7wj7-assembly1.cif.gz_B Crystal Structure of the Kinase Domain with Adenosine of a Class III Lanthipeptide Synthetase CurKC	6.002E-08	1.000	254	176	451	621	4	246	246	297	0.444	0.988
LOKIASV2_1322_ESMFold_hypothetical_protein	4kbk-assembly5.cif.gz_B-2	4kbk-assembly5.cif.gz_B-2 CK1d in complex with (3S)-3-{4-[3-(4-fluorophenyl)-1-methyl-1H-pyrazol-4-yl]pyridin-2-yl}morpholine inhibitor	2.245E-08	1.000	254	169	474	621	1	277	289	322	0.493	0.958
LOKIASV2_1322_ESMFold_hypothetical_protein	6cfm-assembly4.cif.gz_D	6cfm-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a propynyl-pteridinone inhibitor	1.409E-08	1.000	254	163	466	621	2	296	313	336	0.490	0.942
LOKIASV2_1322_ESMFold_hypothetical_protein	2h6d-assembly1.cif.gz_A	2h6d-assembly1.cif.gz_A Protein Kinase Domain of the Human 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK alpha-2 chain)	3.577E-08	1.000	253	169	467	621	2	247	256	310	0.481	0.961
LOKIASV2_1322_ESMFold_hypothetical_protein	3d5v-assembly1.cif.gz_A	3d5v-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain.	6.657E-08	1.000	253	164	462	621	1	233	260	319	0.481	0.896
LOKIASV2_1322_ESMFold_hypothetical_protein	2b55-assembly1.cif.gz_A	2b55-assembly1.cif.gz_A Human cyclin dependent kinase 2 (cdk2) complexed with indenopyraxole DIN-101312	1.562E-08	1.000	253	176	466	621	4	259	276	324	0.469	0.928
LOKIASV2_1322_ESMFold_hypothetical_protein	5dbx-assembly1.cif.gz_B	5dbx-assembly1.cif.gz_B Crystal structure of murine SPAK(T243D) in complex with AMPPNP	4.510E-09	1.000	253	169	477	621	4	281	282	337	0.498	0.986
LOKIASV2_1322_ESMFold_hypothetical_protein	7wtt-assembly1.cif.gz_a	7wtt-assembly1.cif.gz_a Cryo-EM structure of a human pre-40S ribosomal subunit - State RRP12-A1 (with CK1)	9.310E-09	1.000	253	169	485	621	3	285	297	338	0.510	0.953
LOKIASV2_1322_ESMFold_hypothetical_protein	3n9x-assembly1.cif.gz_A	3n9x-assembly1.cif.gz_A Crystal structure of Map Kinase from plasmodium berghei, PB000659.00.0	2.423E-09	1.000	253	169	469	621	12	317	374	364	0.485	0.818
LOKIASV2_1322_ESMFold_hypothetical_protein	7ejv-assembly1.cif.gz_A	7ejv-assembly1.cif.gz_A The co-crystal structure of DYRK2 with YK-2-69	3.139E-09	1.000	253	176	470	621	72	382	385	362	0.475	0.808
LOKIASV2_1322_ESMFold_hypothetical_protein	4yga-assembly1.cif.gz_A	4yga-assembly1.cif.gz_A CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	4.067E-09	1.000	253	169	484	621	1	282	448	342	0.509	0.629
LOKIASV2_1322_ESMFold_hypothetical_protein	3o50-assembly1.cif.gz_A	3o50-assembly1.cif.gz_A Crystal structure of benzamide 9 bound to AuroraA	3.577E-08	1.000	252	169	470	621	3	240	246	313	0.486	0.967
LOKIASV2_1322_ESMFold_hypothetical_protein	3ocb-assembly2.cif.gz_B	3ocb-assembly2.cif.gz_B Akt1 kinase domain with pyrrolopyrimidine inhibitor	7.569E-09	1.000	252	176	484	621	7	285	320	330	0.498	0.872
LOKIASV2_1322_ESMFold_hypothetical_protein	1ctp-assembly1.cif.gz_E-2	1ctp-assembly1.cif.gz_E-2 STRUCTURE OF THE MAMMALIAN CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE AND AN INHIBITOR PEPTIDE DISPLAYS AN OPEN CONFORMATION	7.971E-09	1.000	252	154	469	621	18	291	333	333	0.509	0.823
LOKIASV2_1322_ESMFold_hypothetical_protein	5n1o-assembly1.cif.gz_A	5n1o-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 2-chloro-4-(chloromethyl)-5-hydroxyphenyl)ethan-1-one	6.153E-09	1.000	252	167	476	621	26	298	340	333	0.499	0.803
LOKIASV2_1322_ESMFold_hypothetical_protein	7qwk-assembly8.cif.gz_H	7qwk-assembly8.cif.gz_H GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	1.484E-08	1.000	251	176	461	621	7	250	259	295	0.461	0.942
LOKIASV2_1322_ESMFold_hypothetical_protein	3dbf-assembly1.cif.gz_A	3dbf-assembly1.cif.gz_A Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with Compound 562	1.374E-07	1.000	251	163	467	621	1	243	261	319	0.491	0.931
LOKIASV2_1322_ESMFold_hypothetical_protein	2w4o-assembly1.cif.gz_A	2w4o-assembly1.cif.gz_A Crystal structure of Human CAMK4 in complex with 4-Amino(sulfamoyl- phenylamino)-triazole-carbothioic acid (2,6-difluoro-phenyl)-amide)	1.484E-08	1.000	251	163	483	621	1	278	278	351	0.517	1.000
LOKIASV2_1322_ESMFold_hypothetical_protein	4xbr-assembly1.cif.gz_A	4xbr-assembly1.cif.gz_A In cellulo Crystal Structure of PAK4 in complex with Inka	9.082E-08	1.000	251	181	467	621	53	300	316	297	0.462	0.785
LOKIASV2_1322_ESMFold_hypothetical_protein	4h3p-assembly2.cif.gz_D	4h3p-assembly2.cif.gz_D Crystal structure of human ERK2 complexed with a MAPK docking peptide	1.871E-09	1.000	251	176	481	621	15	300	338	344	0.493	0.846
LOKIASV2_1322_ESMFold_hypothetical_protein	1lew-assembly1.cif.gz_A	1lew-assembly1.cif.gz_A CRYSTAL STRUCTURE OF MAP KINASE P38 COMPLEXED TO THE DOCKING SITE ON ITS NUCLEAR SUBSTRATE MEF2A	4.391E-10	1.000	251	167	484	621	5	305	341	361	0.512	0.883
LOKIASV2_1322_ESMFold_hypothetical_protein	3n9x-assembly1.cif.gz_B	3n9x-assembly1.cif.gz_B Crystal structure of Map Kinase from plasmodium berghei, PB000659.00.0	1.302E-09	1.000	251	169	483	621	13	325	374	375	0.507	0.837
LOKIASV2_1322_ESMFold_hypothetical_protein	5wnh-assembly2.cif.gz_C	5wnh-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	8.395E-09	1.000	251	151	485	621	54	348	388	351	0.539	0.760
LOKIASV2_1322_ESMFold_hypothetical_protein	4wbo-assembly3.cif.gz_C	4wbo-assembly3.cif.gz_C Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	9.310E-09	1.000	251	176	484	621	157	441	481	330	0.498	0.593
LOKIASV2_1322_ESMFold_hypothetical_protein	2bal-assembly1.cif.gz_A	2bal-assembly1.cif.gz_A p38alpha MAP kinase bound to pyrazoloamine	8.606E-10	1.000	250	167	484	621	5	302	337	361	0.512	0.884
LOKIASV2_1322_ESMFold_hypothetical_protein	3n51-assembly1.cif.gz_A	3n51-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with bumped kinase inhibitor RM-1-95	9.310E-09	1.000	250	169	479	621	1	274	448	329	0.501	0.612
LOKIASV2_1322_ESMFold_hypothetical_protein	4rvt-assembly1.cif.gz_A	4rvt-assembly1.cif.gz_A MAP4K4 in complex with a pyridin-2(1H)-one derivative	3.767E-08	1.000	249	176	475	621	12	280	281	328	0.483	0.957
LOKIASV2_1322_ESMFold_hypothetical_protein	2w9z-assembly1.cif.gz_B	2w9z-assembly1.cif.gz_B Crystal Structure of CDK4 in complex with a D-type cyclin	2.622E-08	1.000	249	176	470	621	5	286	287	325	0.475	0.983
LOKIASV2_1322_ESMFold_hypothetical_protein	3e8n-assembly1.cif.gz_A	3e8n-assembly1.cif.gz_A X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) complexed with a potent inhibitor RDEA119 and MgATP	9.805E-09	1.000	249	169	474	621	3	289	291	349	0.493	0.986
LOKIASV2_1322_ESMFold_hypothetical_protein	5osj-assembly1.cif.gz_A	5osj-assembly1.cif.gz_A Cdk2(WT) with covalent adduct at C177	2.423E-09	1.000	249	176	470	621	3	281	292	338	0.475	0.955
LOKIASV2_1322_ESMFold_hypothetical_protein	3o71-assembly1.cif.gz_A	3o71-assembly1.cif.gz_A Crystal structure of ERK2/DCC peptide complex	2.981E-09	1.000	249	176	470	621	15	301	340	336	0.475	0.844
LOKIASV2_1322_ESMFold_hypothetical_protein	7p6n-assembly2.cif.gz_C-3	7p6n-assembly2.cif.gz_C-3 ROCK2 IN COMPLEX WITH COMPOUND 12	1.087E-08	1.000	249	151	485	621	51	343	378	355	0.539	0.775
LOKIASV2_1322_ESMFold_hypothetical_protein	7p6n-assembly2.cif.gz_B	7p6n-assembly2.cif.gz_B ROCK2 IN COMPLEX WITH COMPOUND 12	8.395E-09	1.000	249	151	485	621	49	345	385	361	0.539	0.771
LOKIASV2_1322_ESMFold_hypothetical_protein	4uak-assembly1.cif.gz_A-2	4uak-assembly1.cif.gz_A-2 MRCK beta in complex with ADP	2.245E-08	1.000	249	151	475	621	62	354	404	348	0.523	0.725
LOKIASV2_1322_ESMFold_hypothetical_protein	4wbo-assembly4.cif.gz_D	4wbo-assembly4.cif.gz_D Bovine G Protein Coupled Receptor Kinase 1 in Complex with Amlexanox	5.002E-09	1.000	249	176	482	621	153	435	491	329	0.494	0.576
LOKIASV2_1322_ESMFold_hypothetical_protein	1zxe-assembly1.cif.gz_B	1zxe-assembly1.cif.gz_B Crystal Structure of eIF2alpha Protein Kinase GCN2: D835N Inactivating Mutant in Apo Form	7.775E-08	1.000	248	169	462	621	2	243	252	308	0.473	0.960
LOKIASV2_1322_ESMFold_hypothetical_protein	1zxe-assembly3.cif.gz_E	1zxe-assembly3.cif.gz_E Crystal Structure of eIF2alpha Protein Kinase GCN2: D835N Inactivating Mutant in Apo Form	6.657E-08	1.000	248	169	462	621	2	245	264	304	0.473	0.924
LOKIASV2_1322_ESMFold_hypothetical_protein	4aot-assembly1.cif.gz_A	4aot-assembly1.cif.gz_A Crystal Structure of Human Serine Threonine Kinase-10 (LOK) Bound to GW830263A	7.011E-08	1.000	248	176	477	621	21	278	278	326	0.486	0.928
LOKIASV2_1322_ESMFold_hypothetical_protein	3dak-assembly2.cif.gz_A	3dak-assembly2.cif.gz_A Crystal Structure of Domain-Swapped OSR1 kinase domain	1.409E-08	1.000	248	176	466	621	12	277	279	316	0.469	0.953
LOKIASV2_1322_ESMFold_hypothetical_protein	4czu-assembly2.cif.gz_B	4czu-assembly2.cif.gz_B Crystal structure of the kinase domain of CIPK23 T190D mutant	1.922E-08	1.000	248	176	468	621	11	265	287	306	0.472	0.889
LOKIASV2_1322_ESMFold_hypothetical_protein	3vvh-assembly2.cif.gz_B	3vvh-assembly2.cif.gz_B X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in complex with an inhibitor and MgATP	1.562E-08	1.000	248	169	474	621	3	288	290	341	0.493	0.986
LOKIASV2_1322_ESMFold_hypothetical_protein	4e73-assembly1.cif.gz_A	4e73-assembly1.cif.gz_A Crystal structure of JNK1beta-JIP in complex with an azaquinolone inhbitor	5.548E-09	1.000	248	164	482	621	1	296	318	366	0.514	0.931
LOKIASV2_1322_ESMFold_hypothetical_protein	8aco-assembly1.cif.gz_AAA	8aco-assembly1.cif.gz_AAA Crystal structure of WT p38alpha	8.172E-10	1.000	248	163	484	621	1	300	334	367	0.519	0.898
LOKIASV2_1322_ESMFold_hypothetical_protein	6sou-assembly1.cif.gz_A	6sou-assembly1.cif.gz_A Fragment N13565a in complex with MAP kinase p38-alpha	3.759E-10	1.000	248	163	470	621	1	302	342	356	0.496	0.883
LOKIASV2_1322_ESMFold_hypothetical_protein	1xha-assembly1.cif.gz_A	1xha-assembly1.cif.gz_A Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mutants	1.059E-09	1.000	248	154	482	621	24	301	350	351	0.530	0.794
LOKIASV2_1322_ESMFold_hypothetical_protein	7jnt-assembly2.cif.gz_D	7jnt-assembly2.cif.gz_D CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A POTENT AND SELECTIVE DUAL ROCK INHIBITOR	1.733E-08	1.000	248	151	475	621	49	315	360	340	0.523	0.742
LOKIASV2_1322_ESMFold_hypothetical_protein	7p6n-assembly1.cif.gz_H-2	7p6n-assembly1.cif.gz_H-2 ROCK2 IN COMPLEX WITH COMPOUND 12	1.645E-08	1.000	248	151	475	621	49	319	366	345	0.523	0.740
LOKIASV2_1322_ESMFold_hypothetical_protein	4fi1-assembly1.cif.gz_A	4fi1-assembly1.cif.gz_A Crystal structure of scCK2 alpha in complex with ATP	2.552E-09	1.000	248	176	478	621	40	371	371	390	0.488	0.895
LOKIASV2_1322_ESMFold_hypothetical_protein	3c4x-assembly1.cif.gz_B	3c4x-assembly1.cif.gz_B Crystal Structure of G protein coupled receptor kinase 1 bound to ATP and magnesium chloride at 2.9A	1.033E-08	1.000	248	176	482	621	149	431	475	327	0.494	0.596
LOKIASV2_1322_ESMFold_hypothetical_protein	6o8b-assembly1.cif.gz_B	6o8b-assembly1.cif.gz_B Crystal structure of STING CTD in complex with TBK1	1.922E-08	1.000	248	165	471	621	1	310	657	349	0.494	0.472
LOKIASV2_1322_ESMFold_hypothetical_protein	2yza-assembly1.cif.gz_A	2yza-assembly1.cif.gz_A Crystal structure of kinase domain of Human 5'-AMP-activated protein kinase alpha-2 subunit mutant (T172D)	6.657E-08	1.000	247	169	462	621	2	242	258	305	0.473	0.934
LOKIASV2_1322_ESMFold_hypothetical_protein	8guw-assembly1.cif.gz_A	8guw-assembly1.cif.gz_A Structure of Aurora Kinase A in complex with activator peptide	2.423E-09	1.000	247	150	470	621	8	276	282	335	0.517	0.954
LOKIASV2_1322_ESMFold_hypothetical_protein	4h3p-assembly1.cif.gz_A	4h3p-assembly1.cif.gz_A Crystal structure of human ERK2 complexed with a MAPK docking peptide	2.688E-09	1.000	247	176	484	621	15	306	342	347	0.498	0.854
LOKIASV2_1322_ESMFold_hypothetical_protein	4czt-assembly2.cif.gz_D	4czt-assembly2.cif.gz_D Crystal structure of the kinase domain of CIPK23	1.145E-08	1.000	246	161	470	621	1	272	302	332	0.499	0.901
LOKIASV2_1322_ESMFold_hypothetical_protein	5cvf-assembly1.cif.gz_A	5cvf-assembly1.cif.gz_A Crystal Structure of CK2alpha with Compound 5 bound	2.908E-08	1.000	246	164	470	621	27	319	325	350	0.494	0.902
LOKIASV2_1322_ESMFold_hypothetical_protein	1xh9-assembly1.cif.gz_A	1xh9-assembly1.cif.gz_A Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase A and Mutants	5.548E-09	1.000	246	150	482	621	8	289	338	350	0.536	0.834
LOKIASV2_1322_ESMFold_hypothetical_protein	1apm-assembly1.cif.gz_E	1apm-assembly1.cif.gz_E 2.0 ANGSTROM REFINED CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE COMPLEXED WITH A PEPTIDE INHIBITOR AND DETERGENT	1.087E-08	1.000	246	154	476	621	15	299	341	344	0.520	0.836
LOKIASV2_1322_ESMFold_hypothetical_protein	7p6n-assembly1.cif.gz_A	7p6n-assembly1.cif.gz_A ROCK2 IN COMPLEX WITH COMPOUND 12	1.645E-08	1.000	246	151	485	621	50	348	384	355	0.539	0.779
LOKIASV2_1322_ESMFold_hypothetical_protein	3ncg-assembly1.cif.gz_A	3ncg-assembly1.cif.gz_A Activated Calcium-Dependent Protein Kinase 1 from Cryptosporidium parvum (CpCDPK1) in complex with bumped kinase inhibitor NM-PP1	1.338E-08	1.000	246	170	468	621	6	264	426	316	0.481	0.608
LOKIASV2_1322_ESMFold_hypothetical_protein	8cav-assembly1.cif.gz_A	8cav-assembly1.cif.gz_A Discovery of the lanthipeptide Curvocidin and structural insights into its trifunctional synthetase CuvL	1.484E-08	1.000	246	162	468	621	199	463	860	316	0.494	0.308
LOKIASV2_1322_ESMFold_hypothetical_protein	7b9l-assembly1.cif.gz_A	7b9l-assembly1.cif.gz_A MEK1 in complex with compound 23	1.484E-08	1.000	245	151	474	621	16	297	299	348	0.522	0.943
LOKIASV2_1322_ESMFold_hypothetical_protein	7b3m-assembly1.cif.gz_A	7b3m-assembly1.cif.gz_A MEK1 in complex with compound 6	7.569E-09	1.000	245	151	473	621	16	299	302	344	0.520	0.940
LOKIASV2_1322_ESMFold_hypothetical_protein	5cs6-assembly2.cif.gz_B	5cs6-assembly2.cif.gz_B Crystal Structure of CK2alpha with Compound 3 bound	2.490E-08	1.000	245	152	470	621	8	312	316	367	0.514	0.965
LOKIASV2_1322_ESMFold_hypothetical_protein	6una-assembly1.cif.gz_A	6una-assembly1.cif.gz_A Crystal structure of inactive p38gamma	1.371E-09	1.000	245	162	483	621	1	300	329	367	0.519	0.912
LOKIASV2_1322_ESMFold_hypothetical_protein	2gu8-assembly1.cif.gz_A	2gu8-assembly1.cif.gz_A Discovery of 2-Pyrimidyl-5-Amidothiophenes as Novel and Potent Inhibitors for AKT: Synthesis and SAR Studies	3.139E-09	1.000	245	154	484	621	11	307	337	359	0.533	0.881
LOKIASV2_1322_ESMFold_hypothetical_protein	4wb6-assembly1.cif.gz_A	4wb6-assembly1.cif.gz_A Crystal structure of a L205R mutant of human cAMP-dependent protein kinase A (catalytic alpha subunit)	4.067E-09	1.000	245	154	486	621	12	307	338	358	0.536	0.876
LOKIASV2_1322_ESMFold_hypothetical_protein	4yve-assembly1.cif.gz_B	4yve-assembly1.cif.gz_B ROCK 1 bound to methoxyphenyl thiazole inhibitor	2.131E-08	1.000	245	151	485	621	53	357	393	359	0.539	0.776
LOKIASV2_1322_ESMFold_hypothetical_protein	7qwk-assembly2.cif.gz_B	7qwk-assembly2.cif.gz_B GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 2	3.396E-08	1.000	244	176	463	621	8	247	249	305	0.464	0.964
LOKIASV2_1322_ESMFold_hypothetical_protein	8guw-assembly1.cif.gz_C	8guw-assembly1.cif.gz_C Structure of Aurora Kinase A in complex with activator peptide	2.245E-08	1.000	244	151	470	621	11	264	270	330	0.515	0.941
LOKIASV2_1322_ESMFold_hypothetical_protein	7pvu-assembly1.cif.gz_A	7pvu-assembly1.cif.gz_A Crystal structure of p38alpha C162S in complex with CAS2094511-69-8, P 1 21 1	9.545E-10	1.000	244	167	484	621	5	302	337	361	0.512	0.884
LOKIASV2_1322_ESMFold_hypothetical_protein	3zo4-assembly1.cif.gz_A	3zo4-assembly1.cif.gz_A The Synthesis and Evaluation of Diazaspirocyclic Protein Kinase Inhibitors	3.139E-09	1.000	244	154	484	621	11	307	337	360	0.533	0.881
LOKIASV2_1322_ESMFold_hypothetical_protein	5r96-assembly1.cif.gz_A	5r96-assembly1.cif.gz_A PanDDA analysis group deposition Form1 MAP kinase p38-alpha -- Fragment KCL095 in complex with MAP kinase p38-alpha	5.401E-10	1.000	244	167	484	621	5	313	347	363	0.512	0.890
LOKIASV2_1322_ESMFold_hypothetical_protein	3qam-assembly1.cif.gz_E	3qam-assembly1.cif.gz_E Crystal Structure of Glu208Ala mutant of catalytic subunit of cAMP-dependent protein kinase	1.521E-09	1.000	244	154	486	621	24	319	350	358	0.536	0.846
LOKIASV2_1322_ESMFold_hypothetical_protein	5wne-assembly2.cif.gz_C	5wne-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	9.805E-09	1.000	244	151	485	621	54	349	384	357	0.539	0.771
LOKIASV2_1322_ESMFold_hypothetical_protein	7p6n-assembly4.cif.gz_G-5	7p6n-assembly4.cif.gz_G-5 ROCK2 IN COMPLEX WITH COMPOUND 12	2.024E-08	1.000	244	151	485	621	49	349	385	358	0.539	0.782
LOKIASV2_1322_ESMFold_hypothetical_protein	1zyc-assembly1.cif.gz_A	1zyc-assembly1.cif.gz_A Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type in Apo Form.	7.383E-08	1.000	243	169	462	621	2	247	261	303	0.473	0.943
LOKIASV2_1322_ESMFold_hypothetical_protein	3dak-assembly3.cif.gz_B	3dak-assembly3.cif.gz_B Crystal Structure of Domain-Swapped OSR1 kinase domain	3.062E-08	1.000	243	176	466	621	12	276	278	313	0.469	0.953
LOKIASV2_1322_ESMFold_hypothetical_protein	3uvq-assembly1.cif.gz_A	3uvq-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with a Dibenzosuberone Derivative	5.548E-09	1.000	243	163	470	621	1	292	333	355	0.496	0.877
LOKIASV2_1322_ESMFold_hypothetical_protein	6tca-assembly4.cif.gz_G	6tca-assembly4.cif.gz_G Phosphorylated p38 and MAPKAPK2 complex with inhibitor	5.548E-09	1.000	243	162	479	621	1	271	337	333	0.512	0.804
LOKIASV2_1322_ESMFold_hypothetical_protein	7siu-assembly1.cif.gz_A	7siu-assembly1.cif.gz_A Crystal structure of HPK1 (MAP4K1) complex with inhibitor A-745	1.033E-08	1.000	242	176	467	621	18	276	295	312	0.470	0.878
LOKIASV2_1322_ESMFold_hypothetical_protein	7b94-assembly1.cif.gz_A	7b94-assembly1.cif.gz_A MEK1 in complex with compound 6	9.805E-09	1.000	242	151	474	621	16	299	301	351	0.522	0.944
LOKIASV2_1322_ESMFold_hypothetical_protein	6ncg-assembly1.cif.gz_A	6ncg-assembly1.cif.gz_A Crystal Structure of Human Vaccinia-related kinase 2 (VRK-2) bound to pyridin-benzenesulfonamide inhibitor	9.805E-09	1.000	242	163	467	621	2	296	308	349	0.491	0.958
LOKIASV2_1322_ESMFold_hypothetical_protein	5ukf-assembly3.cif.gz_C	5ukf-assembly3.cif.gz_C Crystal Structure of the Human Vaccinia-related Kinase 1 Bound to an Oxindole Inhibitor	7.569E-09	1.000	242	163	466	621	3	300	317	349	0.490	0.940
LOKIASV2_1322_ESMFold_hypothetical_protein	3op5-assembly1.cif.gz_A	3op5-assembly1.cif.gz_A Human vaccinia-related kinase 1	9.310E-09	1.000	242	163	466	621	3	303	320	349	0.490	0.941
LOKIASV2_1322_ESMFold_hypothetical_protein	5otl-assembly1.cif.gz_A	5otl-assembly1.cif.gz_A The crystal structure of CK2alpha in complex with compound 29	2.490E-08	1.000	242	152	470	621	8	316	320	368	0.514	0.966
LOKIASV2_1322_ESMFold_hypothetical_protein	4r3c-assembly1.cif.gz_A	4r3c-assembly1.cif.gz_A Crystal structure of p38 alpha MAP kinase in complex with a novel isoform selective drug candidate	1.444E-09	1.000	242	163	484	621	2	302	336	367	0.519	0.896
LOKIASV2_1322_ESMFold_hypothetical_protein	1q24-assembly1.cif.gz_A	1q24-assembly1.cif.gz_A PKA double mutant model of PKB in complex with MgATP	8.841E-09	1.000	242	154	482	621	11	288	337	350	0.530	0.825
LOKIASV2_1322_ESMFold_hypothetical_protein	7jov-assembly2.cif.gz_D	7jov-assembly2.cif.gz_D CRYSTAL STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE 2 (ROCK2) IN COMPLEX WITH A PHENYLPYRAZOLE AMIDE INHIBITOR	1.562E-08	1.000	242	151	475	621	49	316	361	345	0.523	0.742
LOKIASV2_1322_ESMFold_hypothetical_protein	3a2c-assembly1.cif.gz_K	3a2c-assembly1.cif.gz_K Crystal structure of a pyrazolopyrimidine inhibitor complex bound to MAPKAP Kinase-2 (MK2)	1.562E-08	1.000	241	188	484	621	29	263	273	312	0.478	0.861
LOKIASV2_1322_ESMFold_hypothetical_protein	3vn9-assembly1.cif.gz_A	3vn9-assembly1.cif.gz_A Rifined Crystal structure of non-phosphorylated MAP2K6 in a putative auto-inhibition state	9.310E-09	1.000	241	169	475	621	1	276	291	335	0.494	0.948
LOKIASV2_1322_ESMFold_hypothetical_protein	5czo-assembly2.cif.gz_B	5czo-assembly2.cif.gz_B Structure of S. cerevisiae Hrr25:Mam1 complex, form 2	2.024E-08	1.000	241	168	479	621	3	279	374	326	0.502	0.741
LOKIASV2_1322_ESMFold_hypothetical_protein	3i6u-assembly1.cif.gz_B	3i6u-assembly1.cif.gz_B Structure and Activation Mechanism of the CHK2 DNA-Damage Checkpoint Kinase	2.024E-08	1.000	241	176	469	621	132	361	376	305	0.473	0.612
LOKIASV2_1322_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_C	4w7p-assembly3.cif.gz_C Crystal Structure of ROCK 1 bound to YB-15-QD37	3.767E-08	1.000	241	151	485	621	52	348	383	352	0.539	0.775
LOKIASV2_1322_ESMFold_hypothetical_protein	5uzj-assembly1.cif.gz_A	5uzj-assembly1.cif.gz_A Crystal Structure of ROCK1 bound to an aminopyridine inhibitor	3.225E-08	1.000	241	151	485	621	52	348	387	353	0.539	0.767
LOKIASV2_1322_ESMFold_hypothetical_protein	6cmm-assembly4.cif.gz_D	6cmm-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropynyl-dihydropteridine inhibitor	2.908E-08	1.000	240	163	466	621	1	298	315	341	0.490	0.946
LOKIASV2_1322_ESMFold_hypothetical_protein	5n3d-assembly1.cif.gz_A	5n3d-assembly1.cif.gz_A cAMP-dependent Protein Kinase A from Cricetulus griseus in complex with fragment like molecule 4-(trifluoromethyl)benzenecarboximidamide	1.033E-08	1.000	240	169	476	621	38	308	350	333	0.496	0.774
LOKIASV2_1322_ESMFold_hypothetical_protein	2h9v-assembly1.cif.gz_A	2h9v-assembly1.cif.gz_A Structural basis for induced-fit binding of Rho-kinase to the inhibitor Y27632	2.622E-08	1.000	240	151	475	621	49	342	383	348	0.523	0.768
LOKIASV2_1322_ESMFold_hypothetical_protein	4yga-assembly2.cif.gz_C	4yga-assembly2.cif.gz_C CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	5.002E-09	1.000	240	169	484	621	1	267	449	341	0.509	0.595
LOKIASV2_1322_ESMFold_hypothetical_protein	1zxe-assembly2.cif.gz_C	1zxe-assembly2.cif.gz_C Crystal Structure of eIF2alpha Protein Kinase GCN2: D835N Inactivating Mutant in Apo Form	7.775E-08	1.000	239	169	482	621	2	275	275	330	0.506	0.996
LOKIASV2_1322_ESMFold_hypothetical_protein	3a2c-assembly1.cif.gz_D	3a2c-assembly1.cif.gz_D Crystal structure of a pyrazolopyrimidine inhibitor complex bound to MAPKAP Kinase-2 (MK2)	3.062E-08	1.000	239	186	477	621	26	263	277	312	0.470	0.859
LOKIASV2_1322_ESMFold_hypothetical_protein	8fjz-assembly3.cif.gz_E-2	8fjz-assembly3.cif.gz_E-2 Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(3R,5S)-3-Amino-5-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	9.805E-09	1.000	239	167	479	621	2	270	283	336	0.504	0.951
LOKIASV2_1322_ESMFold_hypothetical_protein	5dbx-assembly1.cif.gz_A	5dbx-assembly1.cif.gz_A Crystal structure of murine SPAK(T243D) in complex with AMPPNP	1.206E-08	1.000	239	169	470	621	4	278	284	328	0.486	0.968
LOKIASV2_1322_ESMFold_hypothetical_protein	7l25-assembly2.cif.gz_B	7l25-assembly2.cif.gz_B HPK1 IN COMPLEX WITH COMPOUND 18	1.825E-08	1.000	239	165	467	621	4	270	288	329	0.488	0.927
LOKIASV2_1322_ESMFold_hypothetical_protein	5d9h-assembly1.cif.gz_B	5d9h-assembly1.cif.gz_B Crystal structure of SPAK (STK39) dimer in the basal activity state	9.805E-09	1.000	239	176	475	621	11	290	293	333	0.483	0.956
LOKIASV2_1322_ESMFold_hypothetical_protein	1zz2-assembly1.cif.gz_A	1zz2-assembly1.cif.gz_A Two Classes of p38alpha MAP Kinase Inhibitors Having a Common Diphenylether Core but Exhibiting Divergent Binding Modes	2.552E-09	1.000	239	163	484	621	1	303	337	366	0.519	0.899
LOKIASV2_1322_ESMFold_hypothetical_protein	7sxf-assembly1.cif.gz_A	7sxf-assembly1.cif.gz_A BIO-2895 (BRD0705) bound GSK3alpha-axin complex	2.024E-08	1.000	239	175	466	621	16	293	340	329	0.470	0.818
LOKIASV2_1322_ESMFold_hypothetical_protein	2gnf-assembly1.cif.gz_A	2gnf-assembly1.cif.gz_A Protein kinase A fivefold mutant model of Rho-kinase with Y-27632	1.371E-09	1.000	239	154	482	621	15	292	341	353	0.530	0.815
LOKIASV2_1322_ESMFold_hypothetical_protein	5bx7-assembly1.cif.gz_A	5bx7-assembly1.cif.gz_A PKA in complex with a benzothiophene fragment compound.	6.480E-09	1.000	239	154	475	621	20	303	346	350	0.519	0.821
LOKIASV2_1322_ESMFold_hypothetical_protein	5wne-assembly1.cif.gz_A	5wne-assembly1.cif.gz_A X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	3.062E-08	1.000	239	151	485	621	44	348	384	361	0.539	0.794
LOKIASV2_1322_ESMFold_hypothetical_protein	1zyd-assembly1.cif.gz_B	1zyd-assembly1.cif.gz_B Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type Complexed with ATP.	1.974E-07	1.000	238	169	462	621	2	245	253	303	0.473	0.964
LOKIASV2_1322_ESMFold_hypothetical_protein	3a2c-assembly1.cif.gz_B	3a2c-assembly1.cif.gz_B Crystal structure of a pyrazolopyrimidine inhibitor complex bound to MAPKAP Kinase-2 (MK2)	8.189E-08	1.000	238	188	463	621	30	252	277	286	0.444	0.805
LOKIASV2_1322_ESMFold_hypothetical_protein	4an9-assembly1.cif.gz_A	4an9-assembly1.cif.gz_A Crystal structures of human MEK1 with carboxamide-based allosteric inhibitor XL518 (GDC-0973), or related analogs.	2.245E-08	1.000	238	169	479	621	6	281	281	337	0.501	0.982
LOKIASV2_1322_ESMFold_hypothetical_protein	4hni-assembly2.cif.gz_B	4hni-assembly2.cif.gz_B crystal structure of ck1e in complex with PF4800567	2.908E-08	1.000	238	167	482	621	1	276	284	334	0.509	0.972
LOKIASV2_1322_ESMFold_hypothetical_protein	6ac9-assembly3.cif.gz_C	6ac9-assembly3.cif.gz_C Crystal structure of human Vaccinia-related kinase 1 (VRK1) in complex with AMP-PNP	3.967E-08	1.000	238	164	466	621	1	290	307	337	0.488	0.945
LOKIASV2_1322_ESMFold_hypothetical_protein	3eqd-assembly1.cif.gz_A	3eqd-assembly1.cif.gz_A X-ray structure of the human mitogen-activated protein kinase kinase 1 (MEK1) in a binary complex with ATP-GS and MG2P	5.002E-09	1.000	238	151	474	621	13	313	315	366	0.522	0.956
LOKIASV2_1322_ESMFold_hypothetical_protein	1syk-assembly2.cif.gz_B	1syk-assembly2.cif.gz_B Crystal structure of E230Q mutant of cAMP-dependent protein kinase reveals unexpected apoenzyme conformation	7.187E-09	1.000	238	151	473	621	9	297	325	348	0.520	0.889
LOKIASV2_1322_ESMFold_hypothetical_protein	6yqj-assembly1.cif.gz_A	6yqj-assembly1.cif.gz_A Crystal structure of cAMP-dependent Protein Kinase (PKA) in complex with open-chain Fasudil-derivative 2-[isoquinolin-5-ylsulfonyl(propyl)amino]ethylazanium (soaked)	1.087E-08	1.000	238	169	476	621	38	308	350	334	0.496	0.774
LOKIASV2_1322_ESMFold_hypothetical_protein	4iw0-assembly1.cif.gz_A-2	4iw0-assembly1.cif.gz_A-2 Crystal structure and mechanism of activation of TBK1	1.270E-08	1.000	238	167	471	621	1	308	648	352	0.491	0.475
LOKIASV2_1322_ESMFold_hypothetical_protein	2wtk-assembly1.cif.gz_F	2wtk-assembly1.cif.gz_F Structure of the heterotrimeric LKB1-STRADalpha-MO25alpha complex	6.657E-08	1.000	237	176	462	621	5	243	268	293	0.462	0.892
LOKIASV2_1322_ESMFold_hypothetical_protein	6gtt-assembly1.cif.gz_A	6gtt-assembly1.cif.gz_A Human STK10 bound to BIRB-796	2.622E-08	1.000	237	164	478	621	12	281	282	342	0.507	0.957
LOKIASV2_1322_ESMFold_hypothetical_protein	4czt-assembly2.cif.gz_B	4czt-assembly2.cif.gz_B Crystal structure of the kinase domain of CIPK23	1.033E-08	1.000	237	176	485	621	10	277	286	330	0.499	0.937
LOKIASV2_1322_ESMFold_hypothetical_protein	5j5t-assembly1.cif.gz_A-2	5j5t-assembly1.cif.gz_A-2 GLK co-crystal structure with aminopyrrolopyrimidine inhibitor	1.871E-09	1.000	237	176	485	621	5	289	298	337	0.499	0.956
LOKIASV2_1322_ESMFold_hypothetical_protein	6btw-assembly4.cif.gz_D	6btw-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a phenyl-pteridinone inhibitor	3.396E-08	1.000	237	163	466	621	1	290	307	341	0.490	0.945
LOKIASV2_1322_ESMFold_hypothetical_protein	1syk-assembly1.cif.gz_A	1syk-assembly1.cif.gz_A Crystal structure of E230Q mutant of cAMP-dependent protein kinase reveals unexpected apoenzyme conformation	2.688E-09	1.000	237	154	486	621	24	322	350	358	0.536	0.854
LOKIASV2_1322_ESMFold_hypothetical_protein	5vib-assembly1.cif.gz_A	5vib-assembly1.cif.gz_A Crystal structure of Protein Kinase A in complex with the PKI peptide and Aminobenzothiazole based inhibitors	1.922E-08	1.000	236	154	475	621	7	290	309	350	0.519	0.919
LOKIASV2_1322_ESMFold_hypothetical_protein	3ag9-assembly3.cif.gz_B-2	3ag9-assembly3.cif.gz_B-2 Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1012	8.841E-09	1.000	236	154	482	621	10	287	319	349	0.530	0.871
LOKIASV2_1322_ESMFold_hypothetical_protein	6csw-assembly3.cif.gz_C	6csw-assembly3.cif.gz_C Crystal Structure of the Human vaccinia-related kinase bound to a N-methyl-N-propyl-dihydropteridine inhibitor	1.645E-08	1.000	236	163	466	621	4	302	319	346	0.490	0.937
LOKIASV2_1322_ESMFold_hypothetical_protein	5ukf-assembly1.cif.gz_A	5ukf-assembly1.cif.gz_A Crystal Structure of the Human Vaccinia-related Kinase 1 Bound to an Oxindole Inhibitor	1.206E-08	1.000	236	163	466	621	4	305	322	348	0.490	0.938
LOKIASV2_1322_ESMFold_hypothetical_protein	6k0j-assembly1.cif.gz_A	6k0j-assembly1.cif.gz_A The co-crystal structure of DYRK2 with a small molecule inhibitor	4.400E-08	1.000	236	163	470	621	1	323	327	373	0.496	0.988
LOKIASV2_1322_ESMFold_hypothetical_protein	2gnj-assembly1.cif.gz_A	2gnj-assembly1.cif.gz_A PKA three fold mutant model of Rho-kinase with Y-27632	3.862E-09	1.000	236	154	482	621	11	288	337	349	0.530	0.825
LOKIASV2_1322_ESMFold_hypothetical_protein	5wng-assembly2.cif.gz_C	5wng-assembly2.cif.gz_C X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	5.139E-08	1.000	236	151	485	621	54	349	387	351	0.539	0.765
LOKIASV2_1322_ESMFold_hypothetical_protein	7s26-assembly1.cif.gz_A	7s26-assembly1.cif.gz_A ROCK1 IN COMPLEX WITH LIGAND G5018	3.225E-08	1.000	236	151	485	621	53	347	388	356	0.539	0.760
LOKIASV2_1322_ESMFold_hypothetical_protein	8fh4-assembly4.cif.gz_D	8fh4-assembly4.cif.gz_D Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-[6-chloro-4-(9-methyl-1-oxa-4,9-diazaspiro[5.5]undec-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile	2.131E-08	1.000	235	176	467	621	10	259	276	317	0.470	0.906
LOKIASV2_1322_ESMFold_hypothetical_protein	4czu-assembly2.cif.gz_D	4czu-assembly2.cif.gz_D Crystal structure of the kinase domain of CIPK23 T190D mutant	3.767E-08	1.000	235	161	465	621	1	265	302	316	0.491	0.877
LOKIASV2_1322_ESMFold_hypothetical_protein	2w1z-assembly1.cif.gz_A	2w1z-assembly1.cif.gz_A ROP2 from Toxoplasma gondii: A virulence factor with a protein- kinase fold and no enzymatic activity.	1.206E-08	1.000	235	152	482	621	30	354	354	372	0.533	0.918
LOKIASV2_1322_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_B	7kac-assembly1.cif.gz_B Crystal structure of HPK1 (MAP4K1) kinase in complex with 5-{[4-{[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}-5-(1,3,4-OXADIAZOL-2-YL)PYRIMIDIN-2-YL]AMINO}-3,3-DIMETHYL-2-BENZOFURAN-1(3H)-ONE	1.409E-08	1.000	234	167	467	621	1	269	288	330	0.485	0.934
LOKIASV2_1322_ESMFold_hypothetical_protein	7b9l-assembly2.cif.gz_B	7b9l-assembly2.cif.gz_B MEK1 in complex with compound 23	2.024E-08	1.000	234	151	473	621	8	294	296	349	0.520	0.970
LOKIASV2_1322_ESMFold_hypothetical_protein	3nx8-assembly1.cif.gz_A	3nx8-assembly1.cif.gz_A human cAMP dependent protein kinase in complex with phenol	6.153E-09	1.000	234	154	476	621	10	293	335	348	0.520	0.848
LOKIASV2_1322_ESMFold_hypothetical_protein	2qur-assembly1.cif.gz_A	2qur-assembly1.cif.gz_A Crystal Structure of F327A/K285P Mutant of cAMP-dependent Protein Kinase	7.971E-09	1.000	234	151	482	621	11	291	340	352	0.535	0.826
LOKIASV2_1322_ESMFold_hypothetical_protein	5ezv-assembly2.cif.gz_C	5ezv-assembly2.cif.gz_C X-ray crystal structure of AMP-activated protein kinase alpha-2/alpha-1 RIM chimaera (alpha-2(1-347)/alpha-1(349-401)/alpha-2(397-end) beta-1 gamma-1) co-crystallized with C2 (5-(5-hydroxyl-isoxazol-3-yl)-furan-2-phosphonic acid)	2.902E-10	1.000	234	167	621	621	1	414	441	526	0.733	0.939
LOKIASV2_1322_ESMFold_hypothetical_protein	5jn2-assembly1.cif.gz_A	5jn2-assembly1.cif.gz_A Crystal structure of TgCDPK1 bound to NVPACU106	9.310E-09	1.000	234	169	476	621	3	288	450	340	0.496	0.636
LOKIASV2_1322_ESMFold_hypothetical_protein	3vw8-assembly1.cif.gz_A	3vw8-assembly1.cif.gz_A Crystal structure of human c-Met kinase domain with its inhibitor	8.624E-08	1.000	233	176	470	621	38	292	303	305	0.475	0.842
LOKIASV2_1322_ESMFold_hypothetical_protein	3ncz-assembly2.cif.gz_C	3ncz-assembly2.cif.gz_C X-Ray Co-structure of Rho-Associated Protein Kinase (ROCK1) with a potent 2H-isoquinolin-1-one inhibitor	5.699E-08	1.000	233	151	485	621	52	349	389	355	0.539	0.766
LOKIASV2_1322_ESMFold_hypothetical_protein	5w91-assembly1.cif.gz_A	5w91-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor LZH118	1.602E-09	1.000	233	169	476	621	3	288	451	344	0.496	0.634
LOKIASV2_1322_ESMFold_hypothetical_protein	6dd4-assembly3.cif.gz_C	6dd4-assembly3.cif.gz_C Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropyl-dihydropteridine inhibitor	3.577E-08	1.000	232	163	466	621	3	300	317	345	0.490	0.940
LOKIASV2_1322_ESMFold_hypothetical_protein	6cmm-assembly1.cif.gz_A	6cmm-assembly1.cif.gz_A Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropynyl-dihydropteridine inhibitor	2.024E-08	1.000	232	163	466	621	4	301	318	349	0.490	0.937
LOKIASV2_1322_ESMFold_hypothetical_protein	3op5-assembly2.cif.gz_B	3op5-assembly2.cif.gz_B Human vaccinia-related kinase 1	1.484E-08	1.000	232	163	466	621	3	302	319	351	0.490	0.940
LOKIASV2_1322_ESMFold_hypothetical_protein	2gtn-assembly1.cif.gz_A	2gtn-assembly1.cif.gz_A Mutated MAP kinase P38 (Mus Musculus) in complex with Inhbitor PG-951717	2.075E-09	1.000	232	167	484	621	5	303	337	362	0.512	0.887
LOKIASV2_1322_ESMFold_hypothetical_protein	7s26-assembly1.cif.gz_B	7s26-assembly1.cif.gz_B ROCK1 IN COMPLEX WITH LIGAND G5018	2.622E-08	1.000	232	151	485	621	52	337	372	360	0.539	0.769
LOKIASV2_1322_ESMFold_hypothetical_protein	2jam-assembly1.cif.gz_A	2jam-assembly1.cif.gz_A Crystal structure of human calmodulin-dependent protein kinase I G	2.622E-08	1.000	231	176	470	621	6	253	279	317	0.475	0.889
LOKIASV2_1322_ESMFold_hypothetical_protein	5g6v-assembly1.cif.gz_A	5g6v-assembly1.cif.gz_A Crystal structure of the PCTAIRE1 kinase in complex with inhibitor	1.409E-08	1.000	231	174	485	621	2	293	308	350	0.502	0.948
LOKIASV2_1322_ESMFold_hypothetical_protein	2jii-assembly2.cif.gz_B	2jii-assembly2.cif.gz_B Structure of vaccinia related kinase 3	5.699E-08	1.000	231	152	474	621	5	315	326	352	0.520	0.954
LOKIASV2_1322_ESMFold_hypothetical_protein	3q5z-assembly1.cif.gz_A	3q5z-assembly1.cif.gz_A Crystal structure of virulent allele ROP5B pseudokinase domain	7.011E-08	1.000	231	151	475	621	31	335	336	349	0.523	0.908
LOKIASV2_1322_ESMFold_hypothetical_protein	2w1z-assembly2.cif.gz_B	2w1z-assembly2.cif.gz_B ROP2 from Toxoplasma gondii: A virulence factor with a protein- kinase fold and no enzymatic activity.	2.024E-08	1.000	231	164	484	621	42	358	358	358	0.517	0.885
LOKIASV2_1322_ESMFold_hypothetical_protein	4ihp-assembly1.cif.gz_A	4ihp-assembly1.cif.gz_A Crystal structure of TgCDPK1 with inhibitor bound	1.206E-08	1.000	231	169	482	621	2	274	454	337	0.506	0.601
LOKIASV2_1322_ESMFold_hypothetical_protein	4e5a-assembly1.cif.gz_X	4e5a-assembly1.cif.gz_X The W197A mutant of p38a MAP kinase	1.970E-09	1.000	230	163	484	621	2	297	332	368	0.519	0.892
LOKIASV2_1322_ESMFold_hypothetical_protein	3l9n-assembly1.cif.gz_A	3l9n-assembly1.cif.gz_A crystal structure of PKAB3 (pka triple mutant V123A, L173M, Q181K) with compound 27	1.562E-08	1.000	230	154	485	621	11	308	334	364	0.535	0.892
LOKIASV2_1322_ESMFold_hypothetical_protein	4z84-assembly1.cif.gz_A	4z84-assembly1.cif.gz_A PKAB3 in complex with pyrrolidine inhibitor 34a	9.310E-09	1.000	230	154	482	621	11	288	337	351	0.530	0.825
LOKIASV2_1322_ESMFold_hypothetical_protein	1r39-assembly1.cif.gz_A	1r39-assembly1.cif.gz_A THE STRUCTURE OF P38ALPHA	1.236E-09	1.000	230	163	484	621	1	312	345	366	0.519	0.904
LOKIASV2_1322_ESMFold_hypothetical_protein	5x3f-assembly1.cif.gz_B	5x3f-assembly1.cif.gz_B Crystal structure of the YgjG-Protein A-Zpa963-PKA catalytic domain	1.270E-08	1.000	230	154	462	621	57	324	349	328	0.498	0.768
LOKIASV2_1322_ESMFold_hypothetical_protein	4aw2-assembly1.cif.gz_A-2	4aw2-assembly1.cif.gz_A-2 Crystal structure of CDC42 binding protein kinase alpha (MRCK alpha)	3.062E-08	1.000	230	151	475	621	60	352	398	355	0.523	0.736
LOKIASV2_1322_ESMFold_hypothetical_protein	8fe2-assembly2.cif.gz_B	8fe2-assembly2.cif.gz_B Structure of J-PKAc chimera complexed with Aplithianine A	2.761E-08	1.000	230	154	482	621	77	354	400	345	0.530	0.695
LOKIASV2_1322_ESMFold_hypothetical_protein	3qal-assembly1.cif.gz_E	3qal-assembly1.cif.gz_E Crystal Structure of Arg280Ala mutant of Catalytic subunit of cAMP-dependent Protein Kinase	8.841E-09	1.000	229	150	473	621	4	296	341	359	0.522	0.859
LOKIASV2_1322_ESMFold_hypothetical_protein	6b2e-assembly1.cif.gz_A	6b2e-assembly1.cif.gz_A Structure of full length human AMPK (a2b2g1) in complex with a small molecule activator SC4.	3.759E-10	1.000	229	167	621	621	1	423	443	535	0.733	0.955
LOKIASV2_1322_ESMFold_hypothetical_protein	3c50-assembly1.cif.gz_B	3c50-assembly1.cif.gz_B Crystal Structure of G protein coupled receptor kinase 1 bound to ADP and magnesium chloride at 2.6A	3.577E-08	1.000	229	176	468	621	158	433	496	319	0.472	0.556
LOKIASV2_1322_ESMFold_hypothetical_protein	1mry-assembly1.cif.gz_A	1mry-assembly1.cif.gz_A crystal structure of an inactive akt2 kinase domain	8.189E-08	1.000	228	169	485	621	2	261	270	336	0.510	0.963
LOKIASV2_1322_ESMFold_hypothetical_protein	4fg9-assembly2.cif.gz_B	4fg9-assembly2.cif.gz_B Crystal structure of human calcium/calmodulin-dependent protein kinase I 1-320 in complex with ATP	1.117E-07	1.000	228	176	476	621	7	275	279	337	0.485	0.964
LOKIASV2_1322_ESMFold_hypothetical_protein	4c38-assembly1.cif.gz_A	4c38-assembly1.cif.gz_A PKA-S6K1 Chimera with compound 21e (CCT239066) bound	1.484E-08	1.000	228	154	484	621	11	307	337	365	0.533	0.881
LOKIASV2_1322_ESMFold_hypothetical_protein	6o8b-assembly1.cif.gz_A	6o8b-assembly1.cif.gz_A Crystal structure of STING CTD in complex with TBK1	9.310E-09	1.000	228	166	503	621	5	369	656	406	0.544	0.556
LOKIASV2_1322_ESMFold_hypothetical_protein	3dae-assembly1.cif.gz_A	3dae-assembly1.cif.gz_A Crystal structure of phosphorylated SNF1 kinase domain	2.306E-07	1.000	227	176	468	621	8	241	248	314	0.472	0.944
LOKIASV2_1322_ESMFold_hypothetical_protein	4ae6-assembly1.cif.gz_A	4ae6-assembly1.cif.gz_A Structure and Function of the Human Sperm-Specific Isoform of Protein Kinase A (PKA) Catalytic Subunit Calpha 2	1.145E-08	1.000	227	150	482	621	1	290	321	363	0.536	0.903
LOKIASV2_1322_ESMFold_hypothetical_protein	4aa0-assembly1.cif.gz_A	4aa0-assembly1.cif.gz_A P38ALPHA MAP KINASE BOUND TO CMPD 2	4.067E-09	1.000	227	167	462	621	5	279	328	339	0.477	0.838
LOKIASV2_1322_ESMFold_hypothetical_protein	1ywr-assembly1.cif.gz_A	1ywr-assembly1.cif.gz_A Crystal Structure Analysis of inactive P38 kinase domain in complex with a Monocyclic Pyrazolone Inhibitor	8.841E-09	1.000	227	163	484	621	1	304	338	366	0.519	0.899
LOKIASV2_1322_ESMFold_hypothetical_protein	5wnh-assembly1.cif.gz_A	5wnh-assembly1.cif.gz_A X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	4.178E-08	1.000	227	151	485	621	52	355	394	362	0.539	0.772
LOKIASV2_1322_ESMFold_hypothetical_protein	5ztn-assembly1.cif.gz_B	5ztn-assembly1.cif.gz_B The crystal structure of human DYRK2 in complex with Curcumin	3.577E-08	1.000	227	176	467	621	90	392	397	354	0.470	0.763
LOKIASV2_1322_ESMFold_hypothetical_protein	4yga-assembly3.cif.gz_E	4yga-assembly3.cif.gz_E CDPK1, from Toxoplasma gondii, bound to inhibitory VHH-1B7	2.075E-09	1.000	227	169	518	621	1	327	442	400	0.564	0.740
LOKIASV2_1322_ESMFold_hypothetical_protein	5o1v-assembly1.cif.gz_B	5o1v-assembly1.cif.gz_B Crystal structure of WNK3 kinase domain in a monophosphorylated apo state (A-loop swapped)	1.176E-07	1.000	226	176	485	621	13	270	271	322	0.499	0.952
LOKIASV2_1322_ESMFold_hypothetical_protein	8enj-assembly1.cif.gz_A	8enj-assembly1.cif.gz_A Design, synthesis, biological evaluation, and X-ray crystallography of diarylpyrazole derivatives possessing terminal arylsulfonamide moieties as anti-proliferative agents targeting c-Jun N-terminal kinase (JNK)	6.480E-09	1.000	226	167	478	621	5	332	333	379	0.502	0.985
LOKIASV2_1322_ESMFold_hypothetical_protein	8acm-assembly1.cif.gz_AAA	8acm-assembly1.cif.gz_AAA Crystal structure of WT p38alpha	9.805E-09	1.000	226	163	484	621	1	302	337	367	0.519	0.896
LOKIASV2_1322_ESMFold_hypothetical_protein	4o2z-assembly1.cif.gz_A-2	4o2z-assembly1.cif.gz_A-2 Crystal Structure of MPK3 from Leishmania donovani, LdBPK_100540 in the presence of NVP-BBT594	2.688E-09	1.000	226	162	470	621	6	324	363	365	0.498	0.879
LOKIASV2_1322_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_D	4w7p-assembly3.cif.gz_D Crystal Structure of ROCK 1 bound to YB-15-QD37	8.624E-08	1.000	226	151	485	621	52	349	387	357	0.539	0.770
LOKIASV2_1322_ESMFold_hypothetical_protein	2v55-assembly1.cif.gz_A	2v55-assembly1.cif.gz_A Mechanism of multi-site phosphorylation from a ROCK-I:RhoE complex structure	9.082E-08	1.000	226	151	485	621	52	356	393	361	0.539	0.776
LOKIASV2_1322_ESMFold_hypothetical_protein	7l24-assembly3.cif.gz_C	7l24-assembly3.cif.gz_C HPK1 IN COMPLEX WITH COMPOUND 11	6.657E-08	1.000	225	176	467	621	10	265	283	313	0.470	0.905
LOKIASV2_1322_ESMFold_hypothetical_protein	6ac9-assembly4.cif.gz_D	6ac9-assembly4.cif.gz_D Crystal structure of human Vaccinia-related kinase 1 (VRK1) in complex with AMP-PNP	3.767E-08	1.000	225	163	466	621	1	289	306	342	0.490	0.944
LOKIASV2_1322_ESMFold_hypothetical_protein	6bru-assembly4.cif.gz_D	6bru-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase bound to a (S)-2-phenylaminopteridinone inhibitor	1.176E-07	1.000	225	163	466	621	2	294	311	343	0.490	0.942
LOKIASV2_1322_ESMFold_hypothetical_protein	6cmm-assembly3.cif.gz_C	6cmm-assembly3.cif.gz_C Crystal Structure of the Human vaccinia-related kinase bound to a N,N-dipropynyl-dihydropteridine inhibitor	3.767E-08	1.000	225	163	466	621	3	299	316	351	0.490	0.940
LOKIASV2_1322_ESMFold_hypothetical_protein	2uzt-assembly1.cif.gz_A	2uzt-assembly1.cif.gz_A PKA structures of AKT, indazole-pyridine inhibitors	2.245E-08	1.000	225	154	485	621	10	307	336	363	0.535	0.887
LOKIASV2_1322_ESMFold_hypothetical_protein	7e11-assembly1.cif.gz_A	7e11-assembly1.cif.gz_A Crystal structure of PKAc-PLN R9C complex	5.268E-09	1.000	225	150	482	621	1	288	337	360	0.536	0.855
LOKIASV2_1322_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_A	4lgd-assembly5.cif.gz_A Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	1.033E-08	1.000	225	176	482	621	12	297	350	344	0.494	0.817
LOKIASV2_1322_ESMFold_hypothetical_protein	6e9w-assembly1.cif.gz_B-2	6e9w-assembly1.cif.gz_B-2 Crystal structure of Rock1 with a pyridinylbenzamide based inhibitor	1.780E-07	1.000	225	151	485	621	51	346	380	352	0.539	0.779
LOKIASV2_1322_ESMFold_hypothetical_protein	3i6u-assembly1.cif.gz_A	3i6u-assembly1.cif.gz_A Structure and Activation Mechanism of the CHK2 DNA-Damage Checkpoint Kinase	1.562E-08	1.000	225	176	475	621	132	389	390	323	0.483	0.662
LOKIASV2_1322_ESMFold_hypothetical_protein	5t6a-assembly1.cif.gz_A	5t6a-assembly1.cif.gz_A Crystal Structure of TgCDPK1 from toxoplasma gondii complexed with 5GA	1.270E-08	1.000	225	169	476	621	1	284	431	341	0.496	0.659
LOKIASV2_1322_ESMFold_hypothetical_protein	4usf-assembly1.cif.gz_A	4usf-assembly1.cif.gz_A Human SLK with SB-440719	7.775E-08	1.000	224	163	475	621	2	276	277	342	0.504	0.993
LOKIASV2_1322_ESMFold_hypothetical_protein	6cqf-assembly1.cif.gz_A-2	6cqf-assembly1.cif.gz_A-2 Crystal structure of HPK1 in complex an inhibitor G1858	5.139E-08	1.000	224	176	463	621	12	258	282	300	0.464	0.876
LOKIASV2_1322_ESMFold_hypothetical_protein	6gu7-assembly1.cif.gz_A	6gu7-assembly1.cif.gz_A CDK1/Cks2 in complex with AZD5438	1.305E-07	1.000	224	176	470	621	4	277	284	334	0.475	0.965
LOKIASV2_1322_ESMFold_hypothetical_protein	1kv2-assembly1.cif.gz_A	1kv2-assembly1.cif.gz_A Human p38 MAP Kinase in Complex with BIRB 796	8.395E-09	1.000	224	164	484	621	1	291	325	367	0.517	0.895
LOKIASV2_1322_ESMFold_hypothetical_protein	3gcp-assembly1.cif.gz_A	3gcp-assembly1.cif.gz_A Human P38 MAP Kinase in Complex with SB203580	5.002E-09	1.000	224	163	470	621	1	297	337	354	0.496	0.881
LOKIASV2_1322_ESMFold_hypothetical_protein	4lv8-assembly2.cif.gz_A	4lv8-assembly2.cif.gz_A Murine IRGa6 bound to Toxoplasma ROP5C, a pseudokinase GDI	1.447E-07	1.000	224	167	477	621	49	359	360	348	0.501	0.864
LOKIASV2_1322_ESMFold_hypothetical_protein	2v55-assembly2.cif.gz_C	2v55-assembly2.cif.gz_C Mechanism of multi-site phosphorylation from a ROCK-I:RhoE complex structure	8.624E-08	1.000	224	151	485	621	52	356	396	362	0.539	0.770
LOKIASV2_1322_ESMFold_hypothetical_protein	4ih8-assembly1.cif.gz_A	4ih8-assembly1.cif.gz_A Crystal structure of TgCDPK1 with inhibitor bound	5.002E-09	1.000	224	169	476	621	1	283	433	344	0.496	0.654
LOKIASV2_1322_ESMFold_hypothetical_protein	5d9h-assembly1.cif.gz_A	5d9h-assembly1.cif.gz_A Crystal structure of SPAK (STK39) dimer in the basal activity state	2.364E-08	1.000	223	176	470	621	11	286	290	323	0.475	0.952
LOKIASV2_1322_ESMFold_hypothetical_protein	4izy-assembly1.cif.gz_A	4izy-assembly1.cif.gz_A Crystal structure of JNK1 in complex with JIP1 peptide and 4-{4-[4-(4-Methanesulfonyl-piperidin-1-yl)-indol-1-yl]-pyrimidin-2-ylamino}-cyclohexan	9.310E-09	1.000	223	164	474	621	1	295	322	367	0.501	0.916
LOKIASV2_1322_ESMFold_hypothetical_protein	5ntj-assembly1.cif.gz_A	5ntj-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compound RKp032	6.153E-09	1.000	223	154	486	621	27	322	350	359	0.536	0.846
LOKIASV2_1322_ESMFold_hypothetical_protein	4w7p-assembly3.cif.gz_B	4w7p-assembly3.cif.gz_B Crystal Structure of ROCK 1 bound to YB-15-QD37	6.657E-08	1.000	223	151	485	621	52	349	387	359	0.539	0.770
LOKIASV2_1322_ESMFold_hypothetical_protein	3qfv-assembly1.cif.gz_B	3qfv-assembly1.cif.gz_B MRCK beta in complex with TPCA-1	1.117E-07	1.000	223	152	475	621	60	351	396	344	0.522	0.737
LOKIASV2_1322_ESMFold_hypothetical_protein	4ual-assembly1.cif.gz_A-2	4ual-assembly1.cif.gz_A-2 MRCK beta in complex with BDP00005290	6.321E-08	1.000	223	151	475	621	62	349	403	350	0.523	0.715
LOKIASV2_1322_ESMFold_hypothetical_protein	4btf-assembly1.cif.gz_A	4btf-assembly1.cif.gz_A Structure of MLKL	2.688E-09	1.000	223	149	466	621	130	411	413	340	0.512	0.683
LOKIASV2_1322_ESMFold_hypothetical_protein	3v5w-assembly1.cif.gz_A	3v5w-assembly1.cif.gz_A Human G Protein-Coupled Receptor Kinase 2 in Complex with Soluble Gbetagamma Subunits and Paroxetine	1.406E-10	1.000	223	166	615	621	154	588	623	531	0.725	0.698
LOKIASV2_1322_ESMFold_hypothetical_protein	3o51-assembly1.cif.gz_A	3o51-assembly1.cif.gz_A Crystal structure of anthranilamide 10 bound to AuroraA	1.524E-07	1.000	222	169	468	621	3	243	246	313	0.483	0.980
LOKIASV2_1322_ESMFold_hypothetical_protein	2c5y-assembly1.cif.gz_A	2c5y-assembly1.cif.gz_A DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN	8.189E-08	1.000	222	176	469	621	4	279	290	336	0.473	0.952
LOKIASV2_1322_ESMFold_hypothetical_protein	2gtm-assembly1.cif.gz_A	2gtm-assembly1.cif.gz_A Mutated Mouse P38 MAP Kinase Domain in complex with Inhibitor PG-892579	4.283E-09	1.000	222	163	484	621	1	307	341	365	0.519	0.900
LOKIASV2_1322_ESMFold_hypothetical_protein	6sov-assembly1.cif.gz_A	6sov-assembly1.cif.gz_A Fragments KCL_615 and KCL_802 in complex with MAP kinase p38-alpha	1.645E-08	1.000	222	167	484	621	4	304	345	366	0.512	0.872
LOKIASV2_1322_ESMFold_hypothetical_protein	6eh3-assembly1.cif.gz_A	6eh3-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp120 and RKp190	5.843E-09	1.000	222	154	486	621	27	322	353	362	0.536	0.839
LOKIASV2_1322_ESMFold_hypothetical_protein	4zji-assembly2.cif.gz_B	4zji-assembly2.cif.gz_B PAK1 in complex with 2-chloro-5-ethyl-8-fluoro-11-(4-methylpiperazin-1-yl)-dibenzodiazepine	1.524E-07	1.000	221	180	479	621	21	276	276	321	0.483	0.928
LOKIASV2_1322_ESMFold_hypothetical_protein	6gu7-assembly4.cif.gz_G	6gu7-assembly4.cif.gz_G CDK1/Cks2 in complex with AZD5438	1.007E-07	1.000	221	176	470	621	4	278	283	329	0.475	0.972
LOKIASV2_1322_ESMFold_hypothetical_protein	3a2c-assembly1.cif.gz_F	3a2c-assembly1.cif.gz_F Crystal structure of a pyrazolopyrimidine inhibitor complex bound to MAPKAP Kinase-2 (MK2)	1.447E-07	1.000	221	188	462	621	30	261	287	297	0.443	0.808
LOKIASV2_1322_ESMFold_hypothetical_protein	6cnx-assembly4.cif.gz_D	6cnx-assembly4.cif.gz_D Crystal Structure of the Human vaccinia-related kinase 1 (VRK1) bound to an N-propynyl-N-isopentyl-dihydropteridin inhibitor	1.305E-07	1.000	221	164	466	621	1	295	312	342	0.488	0.946
LOKIASV2_1322_ESMFold_hypothetical_protein	3zsi-assembly1.cif.gz_A	3zsi-assembly1.cif.gz_A X-ray structure of p38alpha bound to VX-745	1.825E-08	1.000	221	167	484	621	4	292	326	359	0.512	0.887
LOKIASV2_1322_ESMFold_hypothetical_protein	7s26-assembly2.cif.gz_C	7s26-assembly2.cif.gz_C ROCK1 IN COMPLEX WITH LIGAND G5018	7.383E-08	1.000	221	151	485	621	50	335	363	359	0.539	0.788
LOKIASV2_1322_ESMFold_hypothetical_protein	7l24-assembly1.cif.gz_A	7l24-assembly1.cif.gz_A HPK1 IN COMPLEX WITH COMPOUND 11	1.239E-07	1.000	220	176	467	621	11	265	283	313	0.470	0.901
LOKIASV2_1322_ESMFold_hypothetical_protein	8fh4-assembly2.cif.gz_B	8fh4-assembly2.cif.gz_B Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-[6-chloro-4-(9-methyl-1-oxa-4,9-diazaspiro[5.5]undec-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile	2.024E-08	1.000	220	176	479	621	12	274	297	326	0.490	0.886
LOKIASV2_1322_ESMFold_hypothetical_protein	5he2-assembly1.cif.gz_A	5he2-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and CCG224406	2.020E-10	1.000	220	153	615	621	148	593	628	545	0.746	0.710
LOKIASV2_1322_ESMFold_hypothetical_protein	6vpj-assembly1.cif.gz_A-2	6vpj-assembly1.cif.gz_A-2 TPX2 residues 7-20 fused to Aurora A residues 116-389 C247V + C319V double mutant dephosphorylated, and in complex with AMP-PNP	4.178E-08	1.000	219	160	470	621	3	272	279	330	0.501	0.968
LOKIASV2_1322_ESMFold_hypothetical_protein	3o7l-assembly1.cif.gz_D	3o7l-assembly1.cif.gz_D Crystal Structure of phospholamban (1-19):PKA C-subunit:AMP-PNP:Mg2+ complex	1.374E-07	1.000	218	150	482	621	1	289	335	362	0.536	0.863
LOKIASV2_1322_ESMFold_hypothetical_protein	8fko-assembly3.cif.gz_D	8fko-assembly3.cif.gz_D Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(2S,5R)-5-Amino-2-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	1.176E-07	1.000	217	176	467	621	13	262	279	310	0.470	0.896
LOKIASV2_1322_ESMFold_hypothetical_protein	3ku2-assembly1.cif.gz_A	3ku2-assembly1.cif.gz_A Crystal Structure of inactivated form of CDPK1 from toxoplasma gondii, TGME49.101440	2.245E-08	1.000	217	169	484	621	2	272	457	340	0.509	0.593
LOKIASV2_1322_ESMFold_hypothetical_protein	5g6v-assembly2.cif.gz_B	5g6v-assembly2.cif.gz_B Crystal structure of the PCTAIRE1 kinase in complex with inhibitor	4.633E-08	1.000	216	176	467	621	4	269	302	334	0.470	0.881
LOKIASV2_1322_ESMFold_hypothetical_protein	4dfy-assembly2.cif.gz_E	4dfy-assembly2.cif.gz_E Crystal structure of R194A mutant of cAMP-dependent protein kinase with unphosphorylated activation loop	3.967E-08	1.000	216	151	476	621	8	285	313	349	0.525	0.888
LOKIASV2_1322_ESMFold_hypothetical_protein	6egw-assembly1.cif.gz_A	6egw-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp017 and RKp117	1.825E-08	1.000	216	150	486	621	1	306	336	374	0.543	0.911
LOKIASV2_1322_ESMFold_hypothetical_protein	3q60-assembly1.cif.gz_A	3q60-assembly1.cif.gz_A Crystal structure of virulent allele ROP5B pseudokinase domain bound to ATP	1.176E-07	1.000	216	152	477	621	32	349	350	362	0.525	0.909
LOKIASV2_1322_ESMFold_hypothetical_protein	6s9w-assembly1.cif.gz_A	6s9w-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 16a	5.412E-08	1.000	216	151	485	621	103	395	411	354	0.539	0.713
LOKIASV2_1322_ESMFold_hypothetical_protein	8fjz-assembly2.cif.gz_B	8fjz-assembly2.cif.gz_B Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(3R,5S)-3-Amino-5-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	5.412E-08	1.000	215	176	467	621	13	267	284	312	0.470	0.898
LOKIASV2_1322_ESMFold_hypothetical_protein	2v62-assembly2.cif.gz_B	2v62-assembly2.cif.gz_B Structure of vaccinia-related kinase 2	8.624E-08	1.000	215	163	467	621	1	294	310	347	0.491	0.948
LOKIASV2_1322_ESMFold_hypothetical_protein	3fe3-assembly1.cif.gz_B	3fe3-assembly1.cif.gz_B Crystal structure of the kinase MARK3/Par-1: T211A-S215A double mutant	8.624E-08	1.000	215	176	455	621	7	246	317	294	0.451	0.757
LOKIASV2_1322_ESMFold_hypothetical_protein	3ncz-assembly1.cif.gz_B	3ncz-assembly1.cif.gz_B X-Ray Co-structure of Rho-Associated Protein Kinase (ROCK1) with a potent 2H-isoquinolin-1-one inhibitor	5.699E-08	1.000	215	151	485	621	57	342	379	349	0.539	0.755
LOKIASV2_1322_ESMFold_hypothetical_protein	5ote-assembly1.cif.gz_A-2	5ote-assembly1.cif.gz_A-2 MRCK beta in complex with BDP-00008900	8.624E-08	1.000	215	151	475	621	62	352	407	350	0.523	0.715
LOKIASV2_1322_ESMFold_hypothetical_protein	3v51-assembly1.cif.gz_A	3v51-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with inhibitor RM-1-176	1.825E-08	1.000	214	167	476	621	1	289	459	347	0.499	0.630
LOKIASV2_1322_ESMFold_hypothetical_protein	5izj-assembly2.cif.gz_B	5izj-assembly2.cif.gz_B Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1411	3.396E-08	1.000	213	154	462	621	11	278	327	330	0.498	0.820
LOKIASV2_1322_ESMFold_hypothetical_protein	5izj-assembly1.cif.gz_A	5izj-assembly1.cif.gz_A Complex of PKA with the bisubstrate protein kinase inhibitor ARC-1411	1.645E-08	1.000	213	156	482	621	14	288	330	349	0.527	0.833
LOKIASV2_1322_ESMFold_hypothetical_protein	1rej-assembly1.cif.gz_A	1rej-assembly1.cif.gz_A Crystal structure of cAMP-dependent protein kinase complexed with balanol analog 1	5.139E-08	1.000	213	154	485	621	9	302	335	356	0.535	0.878
LOKIASV2_1322_ESMFold_hypothetical_protein	7ejv-assembly1.cif.gz_B	7ejv-assembly1.cif.gz_B The co-crystal structure of DYRK2 with YK-2-69	7.569E-09	1.000	213	176	470	621	70	382	391	364	0.475	0.801
LOKIASV2_1322_ESMFold_hypothetical_protein	2hak-assembly1.cif.gz_A	2hak-assembly1.cif.gz_A Catalytic and ubiqutin-associated domains of MARK1/PAR-1	1.974E-07	1.000	212	176	475	621	6	256	309	311	0.483	0.812
LOKIASV2_1322_ESMFold_hypothetical_protein	8q1z-assembly1.cif.gz_A	8q1z-assembly1.cif.gz_A Crystal Structure of Human Vaccinia-related kinase 2 (VRK-2) bound to JA-296	1.374E-07	1.000	212	163	467	621	1	295	311	348	0.491	0.949
LOKIASV2_1322_ESMFold_hypothetical_protein	1ydt-assembly1.cif.gz_E	1ydt-assembly1.cif.gz_E STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT IN COMPLEX WITH H89 PROTEIN KINASE INHIBITOR N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE	5.412E-08	1.000	212	154	470	621	10	292	336	347	0.510	0.842
LOKIASV2_1322_ESMFold_hypothetical_protein	6erv-assembly1.cif.gz_A	6erv-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp013	2.761E-08	1.000	212	151	473	621	17	312	343	364	0.520	0.863
LOKIASV2_1322_ESMFold_hypothetical_protein	4lgd-assembly5.cif.gz_B	4lgd-assembly5.cif.gz_B Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	1.562E-08	1.000	212	176	485	621	18	306	350	346	0.499	0.826
LOKIASV2_1322_ESMFold_hypothetical_protein	5jms-assembly1.cif.gz_A	5jms-assembly1.cif.gz_A Crystal structure of TgCDPK1 bound to CGP060476	1.270E-08	1.000	212	169	476	621	2	287	447	344	0.496	0.640
LOKIASV2_1322_ESMFold_hypothetical_protein	5eak-assembly2.cif.gz_B	5eak-assembly2.cif.gz_B Optimization of Microtubule Affinity Regulating Kinase (MARK) Inhibitors with Improved Physical Properties	2.987E-07	1.000	211	176	467	621	3	244	300	310	0.470	0.807
LOKIASV2_1322_ESMFold_hypothetical_protein	5w80-assembly1.cif.gz_A	5w80-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor GXJ-237	2.622E-08	1.000	211	169	476	621	2	289	453	346	0.496	0.636
LOKIASV2_1322_ESMFold_hypothetical_protein	7k7l-assembly1.cif.gz_A	7k7l-assembly1.cif.gz_A Structure of a hit for G Protein Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	7.554E-11	1.000	211	150	619	621	130	581	616	581	0.757	0.734
LOKIASV2_1322_ESMFold_hypothetical_protein	2baq-assembly1.cif.gz_A	2baq-assembly1.cif.gz_A p38alpha bound to Ro3201195	2.245E-08	1.000	210	163	484	621	1	296	329	367	0.519	0.900
LOKIASV2_1322_ESMFold_hypothetical_protein	5wnh-assembly1.cif.gz_B	5wnh-assembly1.cif.gz_B X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	6.657E-08	1.000	210	151	485	621	53	330	365	352	0.539	0.762
LOKIASV2_1322_ESMFold_hypothetical_protein	1kwp-assembly1.cif.gz_A	1kwp-assembly1.cif.gz_A Crystal Structure of MAPKAP2	1.447E-07	1.000	209	188	479	621	31	265	319	303	0.470	0.737
LOKIASV2_1322_ESMFold_hypothetical_protein	6vxu-assembly1.cif.gz_A	6vxu-assembly1.cif.gz_A Structure of Human Vaccinia-related Kinase 1 (VRK1) bound to ACH471	8.624E-08	1.000	209	163	466	621	4	303	320	355	0.490	0.938
LOKIASV2_1322_ESMFold_hypothetical_protein	5wg4-assembly1.cif.gz_A	5wg4-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG257284	6.308E-10	1.000	209	166	615	621	153	586	621	528	0.725	0.699
LOKIASV2_1322_ESMFold_hypothetical_protein	6cqh-assembly1.cif.gz_A	6cqh-assembly1.cif.gz_A Crystal Structure of the Human vaccinia-related kinase bound to a N-propynyl-N-ethyl-dihydropteridine inhibitor	2.557E-07	1.000	208	163	466	621	4	299	316	347	0.490	0.937
LOKIASV2_1322_ESMFold_hypothetical_protein	2v62-assembly1.cif.gz_A	2v62-assembly1.cif.gz_A Structure of vaccinia-related kinase 2	1.176E-07	1.000	207	163	467	621	1	293	309	350	0.491	0.948
LOKIASV2_1322_ESMFold_hypothetical_protein	2w9f-assembly1.cif.gz_B	2w9f-assembly1.cif.gz_B Crystal Structure of CDK4 in complex with a D-type cyclin	2.693E-07	1.000	206	176	470	621	2	260	261	309	0.475	0.992
LOKIASV2_1322_ESMFold_hypothetical_protein	5awm-assembly1.cif.gz_A	5awm-assembly1.cif.gz_A The Crystal Structure of JNK from Drosophila melanogaster Reveals an Evolutionarily Conserved Topology with that of Mammalian JNK Proteins.	4.400E-08	1.000	206	167	477	621	3	316	345	367	0.501	0.910
LOKIASV2_1322_ESMFold_hypothetical_protein	4eut-assembly1.cif.gz_A	4eut-assembly1.cif.gz_A Structure of BX-795 Complexed with Unphosphorylated Human TBK1 Kinase-ULD Domain	4.750E-09	1.000	206	167	592	621	1	383	384	482	0.686	0.997
LOKIASV2_1322_ESMFold_hypothetical_protein	1mrv-assembly1.cif.gz_A	1mrv-assembly1.cif.gz_A crystal structure of an inactive Akt2 kinase domain	2.136E-06	1.000	205	169	483	621	1	248	261	333	0.507	0.950
LOKIASV2_1322_ESMFold_hypothetical_protein	6vph-assembly1.cif.gz_A-2	6vph-assembly1.cif.gz_A-2 TPX2 residues 7-20 fused to Aurora A residues 116-389 modified with cacodylate and in complex with AMP-PNP	3.313E-07	1.000	205	169	470	621	23	275	282	314	0.486	0.897
LOKIASV2_1322_ESMFold_hypothetical_protein	8fjz-assembly1.cif.gz_A	8fjz-assembly1.cif.gz_A Crystal structure of HPK1 kinase domain T165E,S171E phosphomimetic mutant in complex with 3-{4-[(3R,5S)-3-Amino-5-methylpiperidin-1-yl]-6-chloro-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile	7.011E-08	1.000	205	161	467	621	4	271	288	335	0.494	0.931
LOKIASV2_1322_ESMFold_hypothetical_protein	4lgd-assembly6.cif.gz_D	4lgd-assembly6.cif.gz_D Structural Basis for Autoactivation of Human Mst2 Kinase and Its Regulation by RASSF5	2.024E-08	1.000	205	176	483	621	17	303	338	352	0.496	0.849
LOKIASV2_1322_ESMFold_hypothetical_protein	6s9x-assembly1.cif.gz_A	6s9x-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 15c	1.007E-07	1.000	205	151	485	621	91	367	382	351	0.539	0.725
LOKIASV2_1322_ESMFold_hypothetical_protein	6hhj-assembly1.cif.gz_A	6hhj-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 24b	6.321E-08	1.000	205	151	485	621	100	394	410	361	0.539	0.720
LOKIASV2_1322_ESMFold_hypothetical_protein	4ifg-assembly1.cif.gz_A	4ifg-assembly1.cif.gz_A Crystal structure of TgCDPK1 with inhibitor bound	2.908E-08	1.000	205	169	476	621	2	288	452	346	0.496	0.635
LOKIASV2_1322_ESMFold_hypothetical_protein	4x21-assembly1.cif.gz_A	4x21-assembly1.cif.gz_A The MAP kinase JNK3 as target for halogen bonding	3.577E-08	1.000	204	164	473	621	1	302	336	369	0.499	0.899
LOKIASV2_1322_ESMFold_hypothetical_protein	7s25-assembly1.cif.gz_B	7s25-assembly1.cif.gz_B ROCK1 IN COMPLEX WITH LIGAND G4998	3.870E-07	1.000	204	151	485	621	50	341	379	355	0.539	0.770
LOKIASV2_1322_ESMFold_hypothetical_protein	5w8r-assembly1.cif.gz_A	5w8r-assembly1.cif.gz_A Toxoplasma Gondii CDPK1 in complex with inhibitor 3CIB-PPI	1.270E-08	1.000	204	169	476	621	2	291	456	350	0.496	0.636
LOKIASV2_1322_ESMFold_hypothetical_protein	4oti-assembly1.cif.gz_A	4oti-assembly1.cif.gz_A Crystal Structure of PRK1 Catalytic Domain in Complex with Tofacitinib	6.166E-07	1.000	203	167	482	621	3	255	304	333	0.509	0.832
LOKIASV2_1322_ESMFold_hypothetical_protein	4lv5-assembly2.cif.gz_A	4lv5-assembly2.cif.gz_A Murine IRGa6 bound to Toxoplasma ROP5B, a pseudokinase GDI	1.605E-07	1.000	203	151	476	621	30	348	350	363	0.525	0.911
LOKIASV2_1322_ESMFold_hypothetical_protein	6hhg-assembly1.cif.gz_A	6hhg-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 27	2.557E-07	1.000	203	169	485	621	108	370	386	339	0.510	0.681
LOKIASV2_1322_ESMFold_hypothetical_protein	6byr-assembly1.cif.gz_A	6byr-assembly1.cif.gz_A Structures of the PKA RI alpha holoenzyme with the FLHCC driver J-PKAc alpha or native PKAc alpha	7.775E-08	1.000	203	151	485	621	64	356	405	365	0.539	0.723
LOKIASV2_1322_ESMFold_hypothetical_protein	7kac-assembly1.cif.gz_A	7kac-assembly1.cif.gz_A Crystal structure of HPK1 (MAP4K1) kinase in complex with 5-{[4-{[(1S)-2-HYDROXY-1-PHENYLETHYL]AMINO}-5-(1,3,4-OXADIAZOL-2-YL)PYRIMIDIN-2-YL]AMINO}-3,3-DIMETHYL-2-BENZOFURAN-1(3H)-ONE	7.383E-08	1.000	202	176	485	621	11	279	283	335	0.499	0.951
LOKIASV2_1322_ESMFold_hypothetical_protein	2w99-assembly1.cif.gz_B	2w99-assembly1.cif.gz_B Crystal Structure of CDK4 in complex with a D-type cyclin	6.494E-07	1.000	202	176	470	621	5	290	291	337	0.475	0.983
LOKIASV2_1322_ESMFold_hypothetical_protein	2o0u-assembly1.cif.gz_A	2o0u-assembly1.cif.gz_A Crystal structure of human JNK3 complexed with N-{3-cyano-6-[3-(1-piperidinyl)propanoyl]-4,5,6,7-tetrahydrothieno[2,3-c]pyridin-2-yl}-1-naphthalenecarboxamide	2.245E-08	1.000	202	164	470	621	1	328	331	378	0.494	0.991
LOKIASV2_1322_ESMFold_hypothetical_protein	6c9d-assembly2.cif.gz_B	6c9d-assembly2.cif.gz_B Crystal structure of KA1-autoinhibited MARK1 kinase	1.338E-08	1.000	202	164	619	621	1	402	422	515	0.734	0.953
LOKIASV2_1322_ESMFold_hypothetical_protein	6vxu-assembly3.cif.gz_C	6vxu-assembly3.cif.gz_C Structure of Human Vaccinia-related Kinase 1 (VRK1) bound to ACH471	3.674E-07	1.000	201	163	466	621	3	294	311	349	0.490	0.939
LOKIASV2_1322_ESMFold_hypothetical_protein	6bxi-assembly2.cif.gz_B	6bxi-assembly2.cif.gz_B X-ray crystal structure of NDR1 kinase domain	2.987E-07	1.000	201	169	485	621	2	321	332	366	0.510	0.964
LOKIASV2_1322_ESMFold_hypothetical_protein	5o5m-assembly1.cif.gz_A	5o5m-assembly1.cif.gz_A Crystal Structure of the Protein-Kinase A catalytic subunit from Criteculus Griseus in complex with compounds RKp120 and RKp117	7.775E-08	1.000	201	154	476	621	16	300	340	351	0.520	0.838
LOKIASV2_1322_ESMFold_hypothetical_protein	7s25-assembly2.cif.gz_C	7s25-assembly2.cif.gz_C ROCK1 IN COMPLEX WITH LIGAND G4998	3.489E-07	1.000	201	151	485	621	45	330	361	359	0.539	0.792
LOKIASV2_1322_ESMFold_hypothetical_protein	5wng-assembly1.cif.gz_B	5wng-assembly1.cif.gz_B X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	5.013E-07	1.000	201	151	485	621	53	334	365	348	0.539	0.773
LOKIASV2_1322_ESMFold_hypothetical_protein	3i79-assembly1.cif.gz_A	3i79-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1)	5.412E-08	1.000	201	169	476	621	1	292	455	350	0.496	0.642
LOKIASV2_1322_ESMFold_hypothetical_protein	5o2b-assembly2.cif.gz_B	5o2b-assembly2.cif.gz_B Crystal structure of WNK3 kinase domain in a diphosphorylated state and in a complex with the inhibitor PP-121	5.560E-07	1.000	200	176	462	621	12	250	257	299	0.462	0.930
LOKIASV2_1322_ESMFold_hypothetical_protein	8cdw-assembly1.cif.gz_A	8cdw-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN HPK1 (MAP4K1) COMPLEX WITH 7-(1-methyl-1H-pyrazol-4-yl)-N-[4-(1-methylpiperidin-4-yl)phenyl]quinazolin-2-amine	2.987E-07	1.000	198	176	467	621	11	266	285	317	0.470	0.898
LOKIASV2_1322_ESMFold_hypothetical_protein	3o96-assembly1.cif.gz_A	3o96-assembly1.cif.gz_A Crystal Structure of Human AKT1 with an Allosteric Inhibitor	4.760E-07	1.000	196	151	485	621	98	366	367	348	0.539	0.733
LOKIASV2_1322_ESMFold_hypothetical_protein	5wne-assembly1.cif.gz_B	5wne-assembly1.cif.gz_B X-RAY CO-STRUCTURE OF RHO-ASSOCIATED PROTEIN KINASE (ROCK1) WITH A HIGHLY SELECTIVE INHIBITOR	1.176E-07	1.000	195	151	484	621	53	303	352	336	0.538	0.713
LOKIASV2_1322_ESMFold_hypothetical_protein	8elc-assembly1.cif.gz_A	8elc-assembly1.cif.gz_A Human JNK2 bound to covalent inhibitor YL2056	9.564E-08	1.000	195	164	477	621	1	324	355	377	0.506	0.913
LOKIASV2_1322_ESMFold_hypothetical_protein	6cnx-assembly3.cif.gz_C	6cnx-assembly3.cif.gz_C Crystal Structure of the Human vaccinia-related kinase 1 (VRK1) bound to an N-propynyl-N-isopentyl-dihydropteridin inhibitor	6.494E-07	1.000	194	163	466	621	3	294	311	349	0.490	0.939
LOKIASV2_1322_ESMFold_hypothetical_protein	5kcv-assembly1.cif.gz_A	5kcv-assembly1.cif.gz_A Crystal structure of allosteric inhibitor, ARQ 092, in complex with autoinhibited form of AKT1	3.313E-07	1.000	194	151	485	621	81	343	353	350	0.539	0.745
LOKIASV2_1322_ESMFold_hypothetical_protein	7nh4-assembly1.cif.gz_A	7nh4-assembly1.cif.gz_A Co-Crystal Structure of Akt1 in Complex with Covalent-Allosteric Akt Inhibitor 3	2.190E-07	1.000	194	151	485	621	91	367	383	359	0.539	0.723
LOKIASV2_1322_ESMFold_hypothetical_protein	3i7b-assembly1.cif.gz_A	3i7b-assembly1.cif.gz_A Calcium-Dependent Protein Kinase 1 from Toxoplasma gondii (TgCDPK1) in complex with bumped kinase inhibitor NM-PP1	6.480E-09	1.000	194	176	530	621	6	360	459	433	0.572	0.773
LOKIASV2_1322_ESMFold_hypothetical_protein	5ukm-assembly1.cif.gz_A	5ukm-assembly1.cif.gz_A bovine GRK2 in complex with human Gbetagamma subunits and CCG258208 (14as)	7.760E-10	1.000	193	166	615	621	153	585	621	527	0.725	0.697
LOKIASV2_1322_ESMFold_hypothetical_protein	1kwp-assembly2.cif.gz_B	1kwp-assembly2.cif.gz_B Crystal Structure of MAPKAP2	8.412E-07	1.000	192	162	468	621	8	262	313	325	0.494	0.815
LOKIASV2_1322_ESMFold_hypothetical_protein	4ejn-assembly1.cif.gz_A	4ejn-assembly1.cif.gz_A Crystal structure of autoinhibited form of AKT1 in complex with N-(4-(5-(3-acetamidophenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo[4,5-b]pyridin-3-yl)benzyl)-3-fluorobenzamide	4.178E-08	1.000	192	151	485	621	87	366	376	359	0.539	0.745
LOKIASV2_1322_ESMFold_hypothetical_protein	6cqh-assembly3.cif.gz_C	6cqh-assembly3.cif.gz_C Crystal Structure of the Human vaccinia-related kinase bound to a N-propynyl-N-ethyl-dihydropteridine inhibitor	9.329E-07	1.000	191	163	466	621	3	291	308	353	0.490	0.938
LOKIASV2_1322_ESMFold_hypothetical_protein	3aln-assembly1.cif.gz_A	3aln-assembly1.cif.gz_A Crystal Structure of human non-phosphorylated MKK4 kinase domain complexed with AMP-PNP	3.775E-06	1.000	190	163	474	621	10	267	270	329	0.502	0.956
LOKIASV2_1322_ESMFold_hypothetical_protein	8x5l-assembly1.cif.gz_A	8x5l-assembly1.cif.gz_A The Crystal Structure of PRKACA from Biortus.	4.520E-07	1.000	190	154	466	621	9	290	331	345	0.504	0.852
LOKIASV2_1322_ESMFold_hypothetical_protein	8x5l-assembly2.cif.gz_B	8x5l-assembly2.cif.gz_B The Crystal Structure of PRKACA from Biortus.	2.836E-07	1.000	189	156	482	621	12	281	306	350	0.527	0.882
LOKIASV2_1322_ESMFold_hypothetical_protein	5idp-assembly1.cif.gz_A	5idp-assembly1.cif.gz_A CDK8-CYCC IN COMPLEX WITH (3-Amino-1H-indazol-5-yl)-[(S)-2-(4-fluoro-phenyl)-piperidin-1-yl]-methanone	6.494E-07	1.000	189	151	485	621	5	335	342	395	0.539	0.968
LOKIASV2_1322_ESMFold_hypothetical_protein	6hhf-assembly1.cif.gz_A	6hhf-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor Borussertib	1.090E-06	1.000	188	176	485	621	109	355	366	326	0.499	0.675
LOKIASV2_1322_ESMFold_hypothetical_protein	7s25-assembly1.cif.gz_A	7s25-assembly1.cif.gz_A ROCK1 IN COMPLEX WITH LIGAND G4998	1.273E-06	1.000	187	151	485	621	51	332	373	352	0.539	0.756
LOKIASV2_1322_ESMFold_hypothetical_protein	6hhh-assembly1.cif.gz_A	6hhh-assembly1.cif.gz_A Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 31	3.313E-07	1.000	187	154	485	621	104	370	379	349	0.535	0.704
LOKIASV2_1322_ESMFold_hypothetical_protein	7s26-assembly2.cif.gz_D	7s26-assembly2.cif.gz_D ROCK1 IN COMPLEX WITH LIGAND G5018	5.423E-06	1.000	183	151	354	621	52	215	256	208	0.329	0.641
LOKIASV2_1322_ESMFold_hypothetical_protein	3hdm-assembly1.cif.gz_A	3hdm-assembly1.cif.gz_A Crystal structure of serum and glucocorticoid-regulated kinase 1 in complex with compound 1	3.584E-06	1.000	170	162	485	621	6	282	285	349	0.522	0.972
LOKIASV2_1322_ESMFold_hypothetical_protein	3h4j-assembly3.cif.gz_A	3h4j-assembly3.cif.gz_A crystal structure of pombe AMPK KDAID fragment	5.560E-07	1.000	170	176	462	621	7	241	316	288	0.462	0.744
LOKIASV2_1322_ESMFold_hypothetical_protein	2onl-assembly1.cif.gz_C	2onl-assembly1.cif.gz_C Crystal Structure of the p38a-MAPKAP kinase 2 Heterodimer	2.627E-06	1.000	170	190	476	621	22	276	317	313	0.462	0.804
LOKIASV2_1322_ESMFold_hypothetical_protein	6o8c-assembly1.cif.gz_B	6o8c-assembly1.cif.gz_B Crystal structure of STING CTT in complex with TBK1	8.412E-07	1.000	169	164	494	621	1	345	643	397	0.533	0.537
LOKIASV2_1322_ESMFold_hypothetical_protein	5ce3-assembly2.cif.gz_D	5ce3-assembly2.cif.gz_D The Yersinia YopO - actin complex with MgADP	7.398E-06	1.000	167	176	474	621	24	313	598	339	0.481	0.485
LOKIASV2_1322_ESMFold_hypothetical_protein	2onl-assembly2.cif.gz_D	2onl-assembly2.cif.gz_D Crystal Structure of the p38a-MAPKAP kinase 2 Heterodimer	6.334E-06	1.000	160	192	485	621	20	254	313	306	0.473	0.751
LOKIASV2_1322_ESMFold_hypothetical_protein	6wjf-assembly1.cif.gz_A	6wjf-assembly1.cif.gz_A PKA RIIbeta holoenzyme with DnaJB1-PKAc fusion in fibrolamellar hepatoceullar carcinoma	7.025E-06	1.000	152	164	460	621	87	343	405	318	0.478	0.635
LOKIASV2_1322_ESMFold_hypothetical_protein	4ci6-assembly1.cif.gz_B	4ci6-assembly1.cif.gz_B Mechanisms of crippling actin-dependent phagocytosis by YopO	1.450E-05	1.000	143	228	470	621	47	289	576	283	0.391	0.422
LOKIASV2_1322_ESMFold_hypothetical_protein	4czy-assembly1.cif.gz_B	4czy-assembly1.cif.gz_B Complex of Neurospora crassa PAN2 (WD40-CS1) with PAN3 (pseudokinase and C-term)	1.009E-05	1.000	139	150	483	621	3	291	403	360	0.538	0.717
LOKIASV2_1322_ESMFold_hypothetical_protein	7szc-assembly1.cif.gz_A	7szc-assembly1.cif.gz_A Crystal Structure Analysis of human PRPK complex with a compound	5.723E-04	1.000	137	180	358	621	20	174	229	184	0.288	0.677
LOKIASV2_1322_ESMFold_hypothetical_protein	4bwx-assembly1.cif.gz_B	4bwx-assembly1.cif.gz_B Structure of Neurospora crassa PAN3 pseudokinase mutant	2.699E-05	1.000	137	150	483	621	3	291	397	357	0.538	0.728
LOKIASV2_1322_ESMFold_hypothetical_protein	7s25-assembly2.cif.gz_D	7s25-assembly2.cif.gz_D ROCK1 IN COMPLEX WITH LIGAND G4998	2.374E-04	1.000	135	151	331	621	49	192	257	181	0.291	0.560
LOKIASV2_1322_ESMFold_hypothetical_protein	4bwk-assembly1.cif.gz_A	4bwk-assembly1.cif.gz_A Structure of Neurospora crassa PAN3 pseudokinase	4.529E-05	1.000	134	151	483	621	3	286	392	353	0.536	0.724
LOKIASV2_1322_ESMFold_hypothetical_protein	4czy-assembly1.cif.gz_D	4czy-assembly1.cif.gz_D Complex of Neurospora crassa PAN2 (WD40-CS1) with PAN3 (pseudokinase and C-term)	1.694E-05	1.000	134	150	483	621	3	291	403	359	0.538	0.717
LOKIASV2_1322_ESMFold_hypothetical_protein	6dfl-assembly1.cif.gz_A	6dfl-assembly1.cif.gz_A WaaP in complex with acyl carrier protein	5.023E-05	1.000	128	165	478	621	26	241	241	324	0.506	0.896
LOKIASV2_1322_ESMFold_hypothetical_protein	4bwp-assembly1.cif.gz_A	4bwp-assembly1.cif.gz_A Structure of Drosophila Melanogaster PAN3 pseudokinase	1.490E-04	1.000	124	161	483	621	1	274	386	339	0.520	0.710
LOKIASV2_1322_ESMFold_hypothetical_protein	3att-assembly1.cif.gz_A	3att-assembly1.cif.gz_A Crystal structure of Rv3168 with ATP	9.368E-03	0.795	61	151	485	621	4	332	352	405	0.539	0.935
LOKIASV2_1322_ESMFold_hypothetical_protein	3d33-assembly1.cif.gz_A	3d33-assembly1.cif.gz_A Crystal structure of a duf3244 family protein with an immunoglobulin-like beta-sandwich fold (bvu_0276) from bacteroides vulgatus atcc 8482 at 1.70 A resolution	1.184E-01	0.663	56	537	621	621	12	93	94	87	0.137	0.872
LOKIASV2_1322_ESMFold_hypothetical_protein	3d33-assembly2.cif.gz_B	3d33-assembly2.cif.gz_B Crystal structure of a duf3244 family protein with an immunoglobulin-like beta-sandwich fold (bvu_0276) from bacteroides vulgatus atcc 8482 at 1.70 A resolution	1.383E-01	0.601	54	541	621	621	15	92	93	83	0.130	0.839
LOKIASV2_1322_ESMFold_hypothetical_protein	3nrd-assembly1.cif.gz_A	3nrd-assembly1.cif.gz_A Crystal structure of a histidine triad (HIT) protein (SMc02904) from SINORHIZOBIUM MELILOTI 1021 at 2.06 A resolution	8.913E-01	0.214	40	164	265	621	1	99	135	108	0.164	0.733
LOKIASV2_1322_ESMFold_hypothetical_protein	3i4s-assembly1.cif.gz_B	3i4s-assembly1.cif.gz_B CRYSTAL STRUCTURE OF HISTIDINE TRIAD PROTEIN blr8122 FROM Bradyrhizobium japonicum	3.798E+00	0.090	30	172	265	621	11	97	134	100	0.151	0.649
LOKIASV2_1322_ESMFold_hypothetical_protein	3ohe-assembly1.cif.gz_B	3ohe-assembly1.cif.gz_B Crystal structure of a Histidine triad protein (Maqu_1709) from Marinobacter aquaeolei VT8 at 1.20 A resolution	5.456E+00	0.069	27	167	266	621	1	98	137	108	0.161	0.715
LOKIASV2_1322_ESMFold_hypothetical_protein	6xms-assembly1.cif.gz_A	6xms-assembly1.cif.gz_A Structure of P5A-ATPase Spf1, AlF4-bound form	3.333E-01	0.069	27	163	350	621	548	726	1091	216	0.303	0.164
LOKIASV2_1322_ESMFold_hypothetical_protein	1hwk-assembly1.cif.gz_D	1hwk-assembly1.cif.gz_D COMPLEX OF THE CATALYTIC PORTION OF HUMAN HMG-COA REDUCTASE WITH ATORVASTATIN	4.436E+00	0.011	15	224	346	621	133	321	387	195	0.198	0.488
